0001493152-18-013792.txt : 20180927 0001493152-18-013792.hdr.sgml : 20180927 20180927061213 ACCESSION NUMBER: 0001493152-18-013792 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 72 CONFORMED PERIOD OF REPORT: 20180630 FILED AS OF DATE: 20180927 DATE AS OF CHANGE: 20180927 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Agape ATP Corp CENTRAL INDEX KEY: 0001713210 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] IRS NUMBER: 364838886 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-220144 FILM NUMBER: 181089393 BUSINESS ADDRESS: STREET 1: NO. 17, 17-1, 17-2, 17-3, WISMA LAXTON, STREET 2: JALAN DESA, TAMAN DESA, OFF JALAN KLANG CITY: KUALA LUMPUR STATE: N8 ZIP: 58100 BUSINESS PHONE: 60-192230099 MAIL ADDRESS: STREET 1: NO. 17, 17-1, 17-2, 17-3, WISMA LAXTON, STREET 2: JALAN DESA, TAMAN DESA, OFF JALAN KLANG CITY: KUALA LUMPUR STATE: N8 ZIP: 58100 10-K 1 form10-k.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For The Fiscal Year Ended June 30, 2018

 

or

 

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _______________ to _______________

 

Commission File Number 333-220144

 

AGAPE ATP CORPORATION

(Exact name of registrant issuer as specified in its charter)

 

Nevada   36-4838886

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

1705 – 1708, Level 17, Tower 2, Faber Towers, Jalan Desa Bahagia,

Taman Desa, 58100 Kuala Lumpur, Malaysia.

(Address of principal executive offices, including zip code)

 

Registrant’s phone number, including area code

(60) 192230099

 

Securities registered pursuant to Section 12(b) of the Securities Exchange Act: None

 

Securities registered pursuant to Section 12(g) of the Securities Exchange Act: None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes [  ] No [X]

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes [  ] No [X]

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES [X] NO [  ]

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (section 232.405 of this chapter) during the preceding twelve months (or shorter period that the registrant was required to submit and post such files). YES [  ] NO [X]

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [X]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer [  ] Accelerated Filer [  ] Non-accelerated Filer [  ] Smaller reporting company [X]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [  ] No [X]

 

The aggregate market value of the Company’s common stock held by non-affiliates computed by reference to the closing bid price of the Company’s common stock, as of the last business day of the registrant’s most recently completed second fiscal quarter:

 

N/A.

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

Class   Outstanding at September 27, 2018
Common Stock, $.0001 par value   376,275,500

 

 

 

   
 

 

AGAPE ATP CORPORATION

FORM 10-K

For the Fiscal Year Ended June 30, 2018

Index

 

    Page #
PART I    
     
Item 1. Business 2
Item 1A. Risk Factors 8
Item 1B. Unresolved Staff Comments 8
Item 2. Properties 9
Item 3. Legal Proceedings 9
Item 4. Mine Safety Disclosure 9
     
PART II    
     
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 10
Item 6. Selected Financial Data 11
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations 11
Item 7A. Quantitative and Qualitative Disclosures About Market Risk 15
Item 8. Financial Statements and Supplementary Data 15
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 15
Item 9A. Controls and Procedures 15
Item 9B. Other Information 16
     
PART III    
     
Item 10. Directors, Executive Officers and Corporate Governance 17
Item 11. Executive Compensation 19
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 21
Item 13. Certain Relationships and Related Transactions, and Director Independence 22
Item 14. Principal Accounting Fees and Services 22
     
PART IV    
     
Item 15. Exhibits, Financial Statement Schedules 23
     
SIGNATURES 24

 

   
 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Annual Report on Form 10-K contains forward-looking statements. These forward-looking statements are not historical facts but rather are based on current expectations, estimates and projections. We may use words such as “anticipate,” “expect,” “intend,” “plan,” “believe,” “foresee,” “estimate” and variations of these words and similar expressions to identify forward-looking statements. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors, some of which are beyond our control, are difficult to predict and could cause actual results to differ materially from those expressed or forecasted. These risks and uncertainties include the following:

 

  The availability and adequacy of our cash flow to meet our requirements;
     
  Economic, competitive, demographic, business and other conditions in our local and regional markets;
     
  Changes or developments in laws, regulations or taxes in our industry;
     
  Actions taken or omitted to be taken by third parties including our suppliers and competitors, as well as legislative, regulatory, judicial and other governmental authorities;
     
  Competition in our industry;
     
  The loss of or failure to obtain any license or permit necessary or desirable in the operation of our business;
     
  Changes in our business strategy, capital improvements or development plans;
     
  The availability of additional capital to support capital improvements and development; and
     
  Other risks identified in this report and in our other filings with the Securities and Exchange Commission or the SEC.

 

This report should be read completely and with the understanding that actual future results may be materially different from what we expect. The forward looking statements included in this report are made as of the date of this report and should be evaluated with consideration of any changes occurring after the date of this Report. We will not update forward-looking statements even though our situation may change in the future and we assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

 

Use of Defined Terms

 

Except as otherwise indicated by the context, references in this Report to:

 

  The “Company,” “we,” “us,” or “our,” “Agape” are references to Agape ATP Corporation, a Nevada corporation.
     
  “Common Stock” refers to the common stock, par value $.0001, of the Company;
     
  “U.S. dollar,” “$” and “US$” refer to the legal currency of the United States;
     
  “Securities Act” refers to the Securities Act of 1933, as amended; and
     
  “Exchange Act” refers to the Securities Exchange Act of 1934, as amended.

 

 1 
 

 

PART I

 

ITEM 1. BUSINESS

 

Corporate History

 

Agape ATP Corporation, a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on June 1, 2016.

 

Agape ATP Corporation operates through its wholly owned subsidiary, Agape ATP Corporation, a Company organized in Labuan, Malaysia.

 

Agape ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with 100% equity interest in Agape ATP International Holding Limited, a company incorporated in Hong Kong.

 

The Company and its subsidiaries are engaged in providing services in the Health and Wellness Industry. The principal activity of the Company and its subsidiaries is to supply high-quality health and wellness products, including supplement to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system in our body.

 

The Company, through its subsidiaries, mainly supplies high quality beauty products. Details of the Company’s subsidiaries and associates:

 

   Subsidiary company name 

Place and date

of

incorporation

 

Particulars of

issued capital

  Principal activities 

Proportional of ownership interest and voting power

held

 
1.  Agape ATP Corporation 

Labuan,

March 6, 2017

 

1 share of ordinary share of

US$1 each

  Investment holding   100%
                  
2.  Agape ATP International Holding Limited 

Hong Kong,

June 1, 2017

 

1 share of ordinary share of

HK$1 each

  Health and wellness products and health solution advisory services   100%

 

   Associate company name 

Place and date

of

incorporation

 

Particulars of

issued capital

  Principal activities 

Proportional of ownership interest and voting power

held

 
1.  Unreserved Sdn Bhd 

Malaysia,

August 25, 2008

  500,000 shares of ordinary share of RM7 each  Magazines publication and advertising   20%

 

  (1) Based on the contractual arrangements between the Company and other investors, the Company has the power to direct the relevant activities of these entities unilaterally, and hence the Company has control over these entities.

 

Business Overview

 

Agape ATP Corporation is a company which plans to develop and provide health solution advisory services to our future clients. We will, at least initially, primarily focus our efforts on attracting customers in Malaysia. Our advisory services will center on the “ATP Zeta Health Program”, which is a health program designed to assist in the elimination of various diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles. The program aims to promote improved health and longevity in our clients through a combination of modern medicine, proper nutrition and advice from skilled dieticians.

 

At its core, the ATP Zeta Super Health Program is focused upon biological energy, Adenosine Triphosphate (ATP), at the cellular level. The stimulation of ATP production at the cellular level can increase the metabolism and service to promote and maintain normal and healthy functioning of the body’s systems. Our program emphasizes nutrient absorption through the membrane ion channel to provide complete and balanced nutrients to improve cell health. Thus, ATP Zeta Super Health Program provides ionized and high zeta potential (high bioavailability) nutrients to enhance the absorption at the cellular level.

 

The ATP Zeta Super Health Program consists of ten products. None of these products are owned or produced by Agape ATP Corporation, nor do we have any agreements or arrangements with the third-party manufacturers of these products. In the event that any of these products are no longer produced, or are otherwise unavailable, we may have to devote significant effort to identifying and obtaining comparable replacement products. We will also evaluate adding additional products to the ATP Zeta Super Health Program as operations continue, but we have no plans to do so at present. The ten products that comprise the ATP Zeta Super Health Program are ATP1s Survivor Select, ATP2 Energized Mineral Concentrate, ATP3 Ionized Cal-Mag, ATP4 Omega Blend, ATP5 BetaMaxx, AGN-Vege Fruit Fiber, AGP1-Iron, YFA-Young Formula, Mitogize and ORYC-Organic Youth Care Cleansing Bar.

 

We plan to acquire products from third party manufacturers located in Australia, the United States, Germany and Malaysia. We do not have any existing contracts or agreements with any third party manufacturers. All products are acquired from unrelated third parties and rebranded by the Company. The Company plans to market and sell all products in Malaysia, and due to the contents and combination of the main ingredients in the products they are categorized as health food rather than medicines or drugs. As such, all products require authorization from the Food and Quality Division of Ministry of Health according to the Food Act of 1983 and Food Regulation 1985 in order to be sold in Malaysia. All of the products in the ATP Zeta Super Health Program have obtained the appropriate authorizations. Our health solution advisory services are mainly based on combining these ten products in order to eliminate the clients’ diseases. The combination of these ten products may vary based upon the disease(s) of each client.

 

Our salespeople, who we have yet to hire, will meet with prospective clients at their homes, public locations, or at office space which has not yet been obtained. Our salespeople will evaluate the condition of clients and based upon their health issues, will recommend a combination of the ten products that comprise the ATP Zeta Super Health Program. Agape ATP Corporation will purchase the products that make up the ATP Zeta Super Health Program from their manufacturers and will then directly sell these products to our future clients based upon their health conditions. Exact pricing for these advisory services have not been determined at this point in time, but will be based upon the cost of acquiring inventory. At present, we do not have storage space for any acquired inventory.

 

 2 
 

 

Our Products

 

ATP1s Survivor Select

 

ATP1s Survivor Select supplies various nutrients and energy to human body in order to enhance physical and mental health, and helps the body to build up resistance to diseases.

 

 

It Helps To:

 

  Stimulate instant bio-energy production at cellular level to ensure sufficient supply of bio energy for body cell
  Promote better metabolism at cellular level
  Promote healthy and optimal growth of bone system, teeth structure and muscle tissue of children
  Improve the digestion and nutrient absorption powers of body cell
  Promote cell detoxification and repair capabilities in order to enhance cell self-healing ability

 

ATP2 Energized Mineral Concentrate

 

The ATP2 is a nutritional supplement made from the finest plant substances and also is a proprietary formulation of a super-energized colloidal concentrate developed from a dibase solution. Its formula supports and enhances nutritional biochemical activities.

 

 

It Helps To:

 

  Provide a series of enzymes to break down the toxins and by-products
  Promote better detoxification at cellular level and improve blood circulation
  Enhance energy production to reduce tiredness and keep the body energetic
  Create high oxygen environment to prevent growth of harmful bacteria and minimize inflammatory of infection diseases
  Neutralize excessive free radical in body to protect body cell from oxidation damages

 

 3 
 

 

ATP3 Ionized Cal-Mag

 

ATP3 Ionized Cal-Mag is a specialized calcium supplement that is designed to become totally ionic before entering the body. It is the world first balance formulation which can be absorbed completely through human intestine wall.

 

 

It Helps to:

 

  Strengthen the bone system and promote better bone development
  Strengthen the teeth structure and prevent teeth damages
  Provide abundant of ionic trace minerals to prevent chronic diseases through better blood circulation and acid-base regulation
  Promote better relaxing of centre nerves system and enhance sleep quality
  Promote better relaxing of muscle to prevent muscle sore and cramps

 

ATP4 Omega Blend

 

ATP4 Omega Blend is polyunsaturated fatty acid that is fully extracted from plant. It is mainly complete series of Omega 3, Omega 6 and Omega 9 and contains high active bio-energy.

 

 

It Helps To:

 

  Regulate cholesterol and triglycerides levels to promote better blood circulation
  Eliminate inflammatory and promote better cell repairing through Omega 3
  Regulate hormone production and regulation in body through Omega 3 and Omega 6
  Promote healthy growth of brain cell through essential fatty acids such as DHA to increase the memory and concentration powers

 

 4 
 

 

ATP5 BetaMaxx

 

ATP5 BetaMaxx is derived from the cell wall of baker’s yeast and is a medical breakthrough in history. It is a 100% natural immune enhancer and does not cause any allergy reactions.

 

 

It Helps To:

 

  Strengthen the function of immune cells to build up better immune response of body for external and internal protections
  Promote better cell repairing and prevent inflammatory in wound healing through Beta-1,3 glucan
  Enhance the function of immune cell to protect body cell from radiation damages through Beta-1,3 glucan
  Prevent faster absorption of sugar into bloodstream to normalize blood sugar level

 

AGN-Vege Fruit Fiber

 

AGN-Vege Fruit Fiber is the special nutrition-based formula for intestines and stomach. It consists of four most essential components for gastrointestinal health effects such as fiber, friendly bacteria, fructooligosaccharides (FOS) and enzymes.

 

 

It Helps To:

 

  Promote better bowel movement and prevent constipation
  Remove accumulated toxins to prevent skin diseases and promote healthy skin
  Prevent rapid absorption of sugar into bloodstream and normalize the blood sugar level
  Prevent over absorption of fat and bad cholesterol into body to prevent cardiovascular diseases
  Reduce food intake to achieve an ideal weight management
  Prevent ulcer and tumor or cancer formation

 

 5 
 

 

AGP1-Iron

 

AGP1-Iron is the purest and most advanced Colloidal Iron that is sourced from the remains of an ancient rainforest which contains the most active plant-based element from the nature.

 

 

It Helps To:

 

  Promote better haemoglobin production to improve iron deficiency and anaemia
  Improve blood circulation and prevent some oxygen deficiency symptoms through enhancement of oxygen and nutrient circulation and toxins excretion
  Promote haemoglobin production after bleeding especially after menstrual and accidental bleedings

 

YFA-Young Formula

 

YFA-Young Formula is a 100% natural unique formula which combined with the amino acid, vitamins and minerals and is the best anti-ageing and youthful maintenance supplement. It stimulates pituitary gland to release growth hormone, anti-ageing and strengthening organ functioning.

 

 

It Helps To:

 

  Enhance metabolism, reduce fat accumulation and promote strong muscles
  Stimulate the production of collagen to restore skin elasticity and reduce wrinkles
  Reduce pigmentation and spots on face
  Stimulate hair re-growth and colour restoration
  Improve pre-menopause symptoms (PMS)
  Enhance memory and cardiovascular function and prevent various chronic diseases

 

 6 
 

 

Mitogize

 

Mitogize is the finest quality formula by Medical Advisory Superlife Team. It is a combination of varies types of the most powerful antioxidant super fruits in the world. It protects and energizes cell’s mitochondrion to produce more ATP for optimum cell functioning.

 

 

It Helps To:

 

  Slow down ageing process
  Become more energetic
  Firm up, smoothen and brighten up skin texture
  Attain and retain ideal body weight and shape
  Enhance and fortify health level
  Improve eyesight and relieve fatigue of eyes
  Regulate the blood lipid, blood pressure and blood glucose level
  Prevent arteriosclerosis and cardiovascular ailments
  Boost up immune system
  Increase skin hydration, elasticity and promote the production of collagen

 

ORYC-Organic Youth Care Cleansing Bar

 

ORYC-Organic Youth Care Cleansing Bar is a natural, organic cleansing soap for skin. It contains pure Australian-accredited plant essential oils acting as a high quality and natural skin lubricant. It maintains the softness of the skin while promoting skin beauty and radiance.

 

 

It Helps To:

 

  Remove impurities, leaving skin clear, fresh and clean
  Moisturize and texturize the skin to prevent skin drying
  Promote skin repairing and rejuvenation at cellular level
  Neutralize free radicals in the body and protect the skin from being oxidized
  Act as natural anti-bacteria and anti-inflammatory agents which can reduce plenty of skin infections and allergic reactions

 

*References alluding to the efficacy and effects of our products are based on client testimonials.

 

*We have no expenditures or expenses relating to research and development of our products for our last two fiscal years. We have not internally developed any of our products. Rather we purchase our products from third party suppliers as we see fit and we rebrand them under the ATP name. Any research efforts are with the intent to discover products we feel would be marketable to our customers and that we, in the Company’s opinion, feel are effective at carrying out the products intended purpose.

 

 7 
 

 

Future Plan

 

In the future, we plan to hire at least five to ten salespeople for every country in which we will operate. At present, we do not have any salesforce, and we will need to hire salespeople for our Malaysia market initially. It will also be necessary for us to acquire office space from which we can conduct operations, have meetings with potential clients, and store acquired inventory. We anticipate expanding into the Asian market, with a particular focus, at least initially, on expanding into Thailand, Indonesia and Taiwan. At present, we do not have any distinct timeline in place for expansion into these countries.

 

When we begin these efforts, we plan to hire more employees to support our operations in different countries. We believe that hiring fifteen to twenty employees will be sufficient in order to support our operations. We also plan to allocate funds to research new products for the ATP Zeta Super Health Program. However, such development will require intensive research, development and testing so we cannot accurately determine a concrete timeline at present nor have we determined an appropriate budget for these future activities. We may also evaluate potential acquisitions in the future which we feel may have some synergy with our current operations.

 

Marketing

 

Agape ATP Corporation plans to penetrate the marketplace and attract customers by building our brand image through print ads, and possibly online paid advertisements, in order to create brand awareness. We are developing a corporate website which will introduce the ATP Zeta Super Health Program. We will market our advisory services through this corporate website and utilize search engine marketing to improve the number of consumers who can find and view our website. Finally, we also have as of yet unidentified plans to market our health program through social networking websites. All of the above marketing plans have not yet been determined in sufficient detail to outline at this time, and remain under development.

 

Competition

 

Agape ATP Corporation plans to operate in a mature, competitive industry. We consider our focus to be on adults ranging in age from 18-65 years old. Competition in the health and wellness industry, with a focus on health supplements in particular, is very intense in Malaysia. We face competition from various retail health supplement providers, pharmacies, and Multi-Level Marketing Companies which supply health supplement products, such as Bio-Life Marketing Sdn Bhd, Elken Group, Usana Group, BMS Organics, NHF Group and their respective affiliates. These competitors generate significant traffic and have established brand recognition and financial resources.

 

We believe that the principal competitive factors in our market include the quality of health supplements, the efficiency and effectiveness of the health supplements, strength and depth of relationships with clients, the ability to identify the changing needs and requirements of prospective clients, and the scope of service. Through utilizing our competitive strengths we believe that we have a competitive edge over other competitors due to the breadth of our product offerings, one stop convenience, pricing, our service, our reputation and product safety. We are confident we can develop and enlarge our market share in the Malaysian market and potentially further into the overseas market.

 

Customers

 

For the year ended June 30, 2018, the Company has generated $487,005 revenue from clients under the ordinary course of business of Agape. The revenue mainly derived from the sale of healthy food products.

 

Employees

 

We have no employees as of the date of this prospectus, with the exception of our sole officer and director, Mr. How Kok Choong. Mr. How currently devotes approximately 30 hours per week to the Company’s matters. After receiving funding, Mr. How Kok Choong plans to devote as much time as the Board of Directors determines is necessary for him to manage the affairs of the Company. As our business and operations increase, we plan to hire full time management and administrative support personnel.

 

Government regulation

 

We are subject to the laws and regulations of the jurisdictions in which we operate, which may include business licensing requirements, income taxes and payroll taxes. In general, the development and operation of our business is not subject to special regulatory and supervisory requirements.

 

ITEM 1A. RISK FACTORS

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

 

ITEM 1B. UNRESOLVED STAFF COMMENTS

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

 

 8 
 

 

ITEM 2. PROPERTIES

 

Our principal executive office is located at 1705 – 1708, Level 17, Tower 2, Faber Towers, Jalan Desa Bahagia, Taman Desa, 58100 Kuala Lumpur, Malaysia.

 

ITEM 3. LEGAL PROCEEDINGS

 

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. There are currently no pending legal proceedings or claims that we believe will have a material adverse effect on our business, financial condition or operating results. None of our directors, officers or affiliates is involved in a proceeding adverse to our business or has a material interest adverse to our business.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

 9 
 

 

PART II

 

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

 

Presently, there is no public market for the common shares. There has been no trading in the Company’s securities, and there has been no bid or ask prices quoted. We cannot assure you that there will be a market for our common stock in the future.

 

Holders

 

As of June 30, 2018, we had 376,275,500 shares of our Common Stock par value, $.0001 issued and outstanding. There were 618 beneficial owners of our Common Stock.

 

Transfer Agent and Registrar

 

The transfer agent for our capital stock is VStock Transfer, LLC, with an address at 18, Lafayette Place, Woodmere, New York 11598 and telephone number is +1 (212)828-843.

 

Penny Stock Regulations

 

The Securities and Exchange Commission has adopted regulations which generally define “penny stock” to be an equity security that has a market price of less than $5.00 per share. Our Common Stock, when and if a trading market develops, may fall within the definition of penny stock and be subject to rules that impose additional sales practice requirements on broker-dealers who sell such securities to persons other than established customers and accredited investors (generally those with assets in excess of $1,000,000, or annual incomes exceeding $200,000 individually, or $300,000, together with their spouse).

 

For transactions covered by these rules, the broker-dealer must make a special suitability determination for the purchase of such securities and have received the purchaser’s prior written consent to the transaction. Additionally, for any transaction, other than exempt transactions, involving a penny stock, the rules require the delivery, prior to the transaction, of a risk disclosure document mandated by the Securities and Exchange Commission relating to the penny stock market. The broker-dealer also must disclose the commissions payable to both the broker-dealer and the registered representative, current quotations for the securities and, if the broker-dealer is the sole market-maker, the broker-dealer must disclose this fact and the broker-dealer’s presumed control over the market. Finally, monthly statements must be sent disclosing recent price information for the penny stock held in the account and information on the limited market in penny stocks. Consequently, the “penny stock” rules may restrict the ability of broker-dealers to sell our Common Stock and may affect the ability of investors to sell their Common Stock in the secondary market.

 

In addition to the “penny stock” rules promulgated by the Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) has adopted rules that require that in recommending an investment to a customer, a broker-dealer must have reasonable grounds for believing that the investment is suitable for that customer. Prior to recommending speculative low priced securities to their non-institutional customers, broker-dealers must make reasonable efforts to obtain information about the customer’s financial status, tax status, investment objectives and other information. Under interpretations of these rules, FINRA believes that there is a high probability that speculative low-priced securities will not be suitable for at least some customers. The FINRA requirements make it more difficult for broker-dealers to recommend that their customers buy our common stock, which may limit the investors’ ability to buy and sell our stock.

 

Dividend Policy

 

Any future determination as to the declaration and payment of dividends on shares of our Common Stock will be made at the discretion of our board of directors out of funds legally available for such purpose. We are under no contractual obligations or restrictions to declare or pay dividends on our shares of Common Stock. In addition, we currently have no plans to pay such dividends. Our board of directors currently intends to retain all earnings for use in the business for the foreseeable future.

 

Equity Compensation Plan Information

 

Currently, there is no equity compensation plan in place.

 

Unregistered Sales of Equity Securities

 

Currently, there is no unregistered sales of equity securities.

 

 10 
 

 

Purchases of Equity Securities by the Registrant and Affiliated Purchasers

 

We have not repurchased any shares of our common stock during the fiscal year ended June 30, 2018.

 

ITEM 6. SELECTED FINANCIAL DATA

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

 

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion of our financial condition and results of operations should be read in conjunction with our audited consolidated financial statements and the notes to those financial statements appearing elsewhere in this Report.

 

Certain statements in this Report constitute forward-looking statements. These forward-looking statements include statements, which involve risks and uncertainties, regarding, among other things, (a) our projected sales, profitability, and cash flows, (b) our growth strategy, (c) anticipated trends in our industry, (d) our future financing plans, and (e) our anticipated needs for, and use of, working capital. They are generally identifiable by use of the words “may,” “will,” “should,” “anticipate,” “estimate,” “plan,” “potential,” “project,” “continuing,” “ongoing,” “expects,” “management believes,” “we believe,” “we intend,” or the negative of these words or other variations on these words or comparable terminology. In light of these risks and uncertainties, there can be no assurance that the forward-looking statements contained in this filing will in fact occur. You should not place undue reliance on these forward-looking statements.

 

The forward-looking statements speak only as of the date on which they are made, and, except to the extent required by federal securities laws, we undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date on which the statements are made or to reflect the occurrence of unanticipated events.

 

Overview

 

Agape ATP Corporation, a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on June 1, 2016. Agape ATP Corporation owns 100% of Agape ATP International Holding Limited, a Hong Kong Company.

 

Agape ATP Corporation is a company which plans to develop and provide health solution advisory services to our future clients. We will, at least initially, primarily focus our efforts on attracting customers in Malaysia. Our advisory services will center on the “ATP Zeta Health Program”, which is a health program designed to assist in the elimination of various diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles. The program aims to promote improved health and longevity in our clients through a combination of modern medicine, proper nutrition and advice from skilled dieticians.

 

At its core, the ATP Zeta Super Health Program is focused upon biological energy, Adenosine Triphosphate (ATP), at the cellular level. The stimulation of ATP production at the cellular level can increase the metabolism and service to promote and maintain normal and healthy functioning of the body’s systems. Our program emphasizes nutrient absorption through the membrane ion channel to provide complete and balanced nutrients to improve cell health. Thus, ATP Zeta Super Health Program provides ionized and high zeta potential (high bioavailability) nutrients to enhance the absorption at the cellular level.

 

The ATP Zeta Super Health Program consists of ten products. None of these products are owned or produced by Agape ATP Corporation, nor do we have any agreements or arrangements with the third-party manufacturers of these products. In the event that any of these products are no longer produced, or are otherwise unavailable, we may have to devote significant effort to identifying and obtaining comparable replacement products. We will also evaluate adding additional products to the ATP Zeta Super Health Program as operations continue, but we have no plans to do so at present. The ten products that comprise the ATP Zeta Super Health Program are ATP1s Survivor Select, ATP2 Energized Mineral Concentrate, ATP3 Ionized Cal-Mag, ATP4 Omega Blend, ATP5 BetaMaxx, AGN-Vege Fruit Fiber, AGP1-Iron, YFA-Young Formula, Mitogize and ORYC-Organic Youth Care Cleansing Bar.

 

 11 
 

 

We plan to acquire products from third party manufacturers located in Australia, the United States, Germany and Malaysia. We do not have any existing contracts or agreements with any third party manufacturers. All products are acquired from unrelated third parties and rebranded by the Company. The Company plans to market and sell all products in Malaysia, and due to the contents and combination of the main ingredients in the products they are categorized as health food rather than medicines or drugs. As such, all products require authorization from the Food and Quality Division of Ministry of Health according to the Food Act of 1983 and Food Regulation 1985 in order to be sold in Malaysia. All of the products in the ATP Zeta Super Health Program have obtained the appropriate authorizations. Our health solution advisory services are mainly based on combining these ten products in order to eliminate the clients’ diseases. The combination of these ten products may vary based upon the disease(s) of each client.

 

Our salespeople, who we have yet to hire, will meet with prospective clients at their homes, public locations, or at office space which has not yet been obtained. Our salespeople will evaluate the condition of clients and based upon their health issues, will recommend a combination of the ten products that comprise the ATP Zeta Super Health Program. Agape ATP Corporation will purchase the products that make up the ATP Zeta Super Health Program from their manufacturers and will then directly sell these products to our future clients based upon their health conditions. Exact pricing for these advisory services have not been determined at this point in time, but will be based upon the cost of acquiring inventory. At present, we do not have storage space for any acquired inventory.

 

As of June 30, 2018, and June 30, 2017, our accumulated loss was $230,636 and $100,362 respectively. Our stockholders’ equity was $5,098,781 and $2,304,648 respectively. We have so far generated $487,005 in revenue. Our losses were principally attributed to selling expenses, administrative and operating expenses.

 

Results of Operations

 

Year Ended June 30, 2018 and Year Ended June 30, 2017

 

Revenues

 

The Company generated revenue of $487,005 for the year ended June 30, 2018 as compared to nil revenue for the year ended June 30, 2017. The revenue mainly derived from the sale of healthy food products.

 

Cost of Revenue

 

Cost of revenue for the year ended June 30, 2018 amounted to $441,409 as compared to nil for the year ended June 30, 2017. The cost mainly consists of cost of production and packing materials.

 

Operating Expenses

 

Administrative and other operating expenses for the year ended June 30, 2018 amounted to $279,682 as compared to $75,362 for the year ended June 30, 2017. The increase in the operating expenses were primarily consisted of comprised of filing and professional fees.

 

Other Income

 

For the year ended June 30, 2018, the Company recorded an amount of $3,211 as other income. This income is derived from the interest income earned through the time deposits placed with banks.

 

Net Loss

 

The net loss for the year was $130,274 for the year ended June 30, 2018 as compared to $75,362 for the year ended June 30, 2017. The net loss mainly due to higher operating expenses incurred on professional fees and equity loss in investee company. Furthermore, the reason for the loss was due to minimal revenue being generated for the year of 2018.

 

Liquidity and Capital Resources

 

As of June 30, 2018, we had working capital surplus of $3,766,446 consisting of cash on hand of $1,046,706 and time deposit of $2,484,549 as compared to working capital of $2,304,648 and our cash of $2,312,748 as of June 30, 2017.

 

Net cash used in operating activities for the year ended June 30, 2018 was $347,977 as compared to net cash used in operating activities of $100,262 for the year ended June 30, 2017. The cash used in operating activities are mainly for professional fees and business license fees.

 

Net cash used in investing activities for the year ended June 30, 2018 was $1,362,490 as compared to net cash used in investing activities for the year ended June 30, 2017 were nil. The cash used in investing activities consist of investment in investee company and marketable securities.

 

Net cash provided by financing activities for the year ended June 30, 2018 was $2,930,267 as compared to $2,413,000 for the year ended June 30, 2017. The cash provided by financing activities is from proceeds from issuance of common stock.

 

The revenues, if any, generated from our current business operations alone may not be sufficient to fund our operations or planned growth. We will likely require additional capital to continue to operate our business, and to further expand our business. Sources of additional capital through various financing transactions or arrangements with third parties may include equity or debt financing, bank loans or revolving credit facilities. We may not be successful in locating suitable financing transactions in the time period required or at all, and we may not obtain the capital we require by other means. Our inability to raise additional funds when required may have a negative impact on our operations, business development and financial results.

 

Critical Accounting Policies and Estimates

 

Use of estimates

 

In preparing these consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets, and revenues and expenses during the periods reported. Actual results may differ from these estimates.

 

Cash and cash equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of six months or less as of the purchase date of such investments.

 

 12 
 

 

Revenue recognition

 

In accordance with the Accounting Standard Codification Topic 605 “Revenue Recognition” (“ASC 605”), the Company recognizes revenue when the following four criteria are met: (1) delivery has occurred or services rendered; (2) persuasive evidence of an arrangement exists; (3) there are no continuing obligations to the customer; and (4) the collection of related accounts receivable is probable.

 

Revenue is measured at the fair value of the consideration received or receivable, net of discounts and taxes applicable to the revenue.

 

Revenue from supplies of health products is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded. Based on limited operating history, management estimates that there was no sale return for the period reported.

 

Cost of revenues

 

Cost of revenues includes the purchase cost of retail goods for re-sale to customers and the packing materials (such as boxes). It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.

 

Selling, general and administrative expenses

 

Selling, general and administrative expenses are primarily comprised of travelling and accommodation fees such as petrol, toll and parking.

 

Cash and cash equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments.

 

Income taxes

 

Income taxes are determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC Topic 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

 13 
 

 

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

 

The Company conducts major business solely in Malaysia. The Company is subject to tax in these jurisdictions. As a result of its business activities, the Company will file tax returns that are subject to examination by the foreign tax authority.

 

The Company did not have any unrecognized tax positions or benefits and there was no effect on the financial conditions or results of operations for the year ended June 30, 2018 and year ended June 30, 2017. The Company and its subsidiary are subject to local and various foreign tax jurisdictions. The Company’s tax returns remain open subject to examination by major tax jurisdictions.

 

Net loss per share

 

The Company calculates net loss per share in accordance with ASC Topic 260 “Earnings per share”. Basic loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.

 

Foreign currencies translation

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income

 

The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. In addition, the Company’s subsidiaries in Labuan and Hong Kong maintains their books and record in United States Dollars (“US$”), Hong Kong Dollars (“HK$”) and Malaysian Ringgit (“MYR”) respectively, which is functional currency as being the primary currency of the economic environment in which the entity operates.

 

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity.

 

Translation of amounts from RM into US$1 has been made at the following exchange rates for the respective periods:

 

   As of and for the year ended June 30, 
   2018   2017 
         
Period-end MYR : US$1 exchange rate   4.03    4.38 
Period-average MYR : US$1 exchange rate   4.21    4.43 

 

Related parties

 

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

 

Fair value of financial instruments:

 

The carrying value of the Company’s financial instruments: cash and cash equivalents, accounts payable and accrued liabilities, and amount due to a director approximate at their fair values because of the short-term nature of these financial instruments.

 

The Company also follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

 

  Level 1: Observable inputs such as quoted prices in active markets;
   
  Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and

 

 14 
 

 

  Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

 

Fair value estimates are made at a specific point in time based on relevant market information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates.

 

Recent accounting pronouncements

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:

 

In May 2014, the FASB issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”). ASU 2014-09 supersedes the revenue recognition requirements in “Revenue Recognition (Topic 605)”, and requires entities to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is not permitted. In August 2015, the FASB issued an Accounting Standards Update to defer by one year the effective dates of its new revenue recognition standard until annual reporting periods beginning after December 15, 2017 (2018 for calendar-year public entities) and interim periods therein. Management is currently assessing the impact of the adoption of ASU 2014-09 and has not determined the effect of the standard on our ongoing financial reporting.

 

In February 2016, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842). Under the new guidance, lessees will be required recognize the following for all leases (with the exception of short-term leases) at the commencement date: 1) A lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and 2) A right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. The new lease guidance simplified the accounting for sale and leaseback transactions primarily because lessees must recognize lease assets and lease liabilities. Lessees will no longer be provided with a source of off-balance sheet financing. The amendments in this ASU are effective for fiscal years beginning after December 15, 2019, including interim periods within those years. The Company is evaluating this ASU and has not determined the effect of this standard on its ongoing financial reporting.

 

In September 2017, the FASB has issued ASU No. 2017-13, Revenue Recognition (Topic 605), Revenue from Contracts with Customers (Topic 606), Leases (Topic 840), and Leases (Topic 842): Amendments to SEC Paragraphs Pursuant to the Staff Announcement at the July 20, 2017 EITF Meeting and Rescission of Prior SEC Staff Announcements and Observer Comments.” The amendments in ASU No. 2017-13 amends the early adoption date option for certain companies related to the adoption of ASU No. 2014-09 and ASU No. 2016-02. Both of the below entities may still adopt using the public company adoption guidance in the related ASUs, as amended. The effective date is the same as the effective date and transition requirements for the amendments for ASU 2014-09 and ASU 2016-02.

 

In January 2017, the FASB issued ASU No. 2017-01 , “Business Combinations (Topic 805): Clarifying the Definition of a Business”, which clarifies the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. This amendment was effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. The adoption of ASU No. 2017-01 did not have a material impact on the Company’s financial position, results of operations and liquidity.

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.

 

Off-Balance Sheet Arrangements

 

As of June 30, 2018, we have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in our financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to our stockholders.

 

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

The financial statements required by this item are located in PART IV of this Annual Report.

 

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 

None.

 

ITEM 9A. CONTROLS AND PROCEDURES

 

Disclosure Controls and Procedures

 

Disclosures Control and Procedures

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is defined in Rule 13a-15(f) or 15d-15(f) promulgated under the Exchange Act as a process designed by, or under the supervision of, the company’s principal executive and principal financial officers and effected by the company’s board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America and includes those policies and procedures that:

 

  Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the company;
     
  Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and
     
  Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the company’s assets that could have a material effect on the financial statements.

 

 15 
 

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Because of the inherent limitations of internal control, there is a risk that material misstatements may not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.

 

As of June 30, 2018, management assessed the effectiveness of our internal control over financial reporting based on the criteria for effective internal control over financial reporting established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) and SEC guidance on conducting such assessments. Based on such evaluation, the Company’s management concluded that, during the period covered by this Report, internal controls and procedures over were not effective. This was due to deficiencies that existed in the design or operation of our internal controls over financial reporting that adversely affected our internal controls and that may be considered to be material weaknesses.

 

Identified Material Weakness

 

A material weakness in internal control over financial reporting is a control deficiency, or combination of control deficiencies, that results in more than a remote likelihood that a material misstatement of the financial statements will not be prevented or detected.

 

Management identified the following material weakness during its assessment of internal controls over financial reporting as of June 30, 2018.

 

1. We do not have Written Policies & Procedures – Due to lack of written policies and procedures for accounting and financial reporting with respect to the requirements and application of both US GAAP and SEC guidelines, the Company did not establish a formal process to close our books monthly and account for all transactions and thus failed to properly record the Private Placement or disclose such transactions in its SEC filings in a timely manner.
   
2. We do not have adequate segregation of duties and effective risk assessment – Lack of segregation of duties and effective risk assessment may cause the Company to face the likelihood of fraud or theft, due to poor oversight, governance and review to detect errors.

 

Accordingly, the Company concluded that these control deficiencies resulted in a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis by the company’s internal controls.

 

As a result of the material weaknesses described above, management has concluded that the Company did not maintain effective internal control over financial reporting as of June 30, 2018 based on criteria established in Internal Control—Integrated Framework issued by COSO.

 

Management’s Remediation Initiatives

 

In an effort to remediate the identified material weaknesses and other deficiencies and enhance our internal controls, we have initiated, or plan to initiate, the following series of measures:

 

1. We plan to create a position to segregate duties consistent with control objectives and will increase our personnel resources and technical accounting expertise within the accounting function when funds are available to us. The accounting personnel is responsible for reviewing the financing activities, facilitate the approval of the financing, record the information regarding the financing, and submit SEC filing related documents to our legal counsel in order to comply with the filing requirements of SEC.
   
2. We plan to prepare written policies and procedures for accounting and financial reporting to establish a formal process to close our books monthly on an accrual basis and account for all transactions, including equity and debt transactions.
   
3. We intend to add staff members to our management team for making sure that information required to be disclosed in our reports filed and submitted under the Exchange Act is recorded, processed, summarized and reported as and when required and will the staff members will have segregated responsibilities with regard to these responsibilities.

 

We anticipate that these initiatives will be at least partially, if not fully, implemented by the end of fiscal year 2017.

 

Changes in internal controls over financial reporting

 

There was no change in our internal controls over financial reporting that occurred during the period covered by this Report, which has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting:

 

This annual report does not include an attestation report of the Company’s registered independent public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered independent public accounting firm pursuant to rules of the Securities and Exchange Commission that permit the Company to provide only management’s report in this Annual Report on Form 10-K.

 

ITEM 9B. OTHER INFORMATION

 

None.

 

 16 
 

 

PART III

 

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 

Our executive officer’s and director’s and their respective ages as of the date hereof are as follows:

 

NAME   AGE   POSITION
How Kok Choong   54   Chief Executive Officer, President, Secretary, Treasurer, Director

 

Set forth below is a brief description of the background and business experience of our executive officer and director for the past five years.

 

How Kok Choong - President, Chief Executive Officer, Secretary, Treasurer, Director

 

Mr. How Kok Choong earned a Master and Doctorate in Business Administrative from Newport University, USA. He is also a Fellow Member of the Chartered Institute of Management in the United Kingdom and a Fellow Member of the Canadian Chartered Institute of Business Administration in Canada.

 

Mr. How has served as the Chief Executive Officer of San Hin Group since 1993, and continues to hold this position at present. San Hin Group is a group of companies whose primary business activities range across the following industries in Malaysia: property development, civil and building construction, machinery and transportation, ready mixed concrete and shopping complex management. From 1994 to present he has also served as a Managing Director of Wawasan Saga, Kota Kinabalu. Wawasan Saga, Kota Kinabalu is a shopping complex and hotel at the heart of Kota Kinabalu, Malaysia.

 

From 1997 to present Mr. How has served as a group Chief Executive Officer of Tang Dynasty Hotel Group, which is one of, if not the, largest chain hotel in Sabah, Malaysia. In 2004 Mr. How began to work as Global President of AGAPE Superior Living International Group, and continues to hold this position. AGAPE Superior Living International Group is a leading health and wellness company in nine countries. Additionally, from 2010 to present Mr. How has served as President of TH3 Holdings Sdn Bhd, a company specialized in IT, academics, online education, mobile Apps, e-Commerce and digital marketing.

 

In Malaysia, Mr. How received the Outstanding Asian Community Contribution Award in 2011, Malaysia Top Team 50 Enterprise Award in 2011, The Contributor Award (Medical and Health Research) in 2012, “Man of The Year” in Worldwide Excellence Award in 2015 and “Man of The Year” in McMillan Global Award in 2016. Since December 2016, he started to serve as Independent Director of Greenpro Capital Corp, which specializes in providing cloud accounting solutions, cross-border business solutions, record management services, and accounting outsourcing services.

 

Mr. How’s strong academic background and business experience and numerous qualifications have led the Board of Directors to reach the conclusion that he should serve as our Chief Executive Officer and Director of the Company.

 

 17 
 

 

Corporate Governance

 

The Company promotes accountability for adherence to honest and ethical conduct; endeavors to provide full, fair, accurate, timely and understandable disclosure in reports and documents that the Company files with the Securities and Exchange Commission (the “SEC”) and in other public communications made by the Company; and strives to be compliant with applicable governmental laws, rules and regulations. The Company has not formally adopted a written code of business conduct and ethics that governs the Company’s employees, officers and Directors as the Company is not required to do so.

 

In lieu of an Audit Committee, the Company’s Board of Directors, is responsible for reviewing and making recommendations concerning the selection of outside auditors, reviewing the scope, results and effectiveness of the annual audit of the Company’s financial statements and other services provided by the Company’s independent public accountants. The Board of Directors, the Chief Executive Officer and the Chief Financial Officer of the Company review the Company’s internal accounting controls, practices and policies.

 

Committees of the Board

 

Our Company currently does not have nominating, compensation, or audit committees or committees performing similar functions nor does our Company have a written nominating, compensation or audit committee charter. Our Directors believes that it is not necessary to have such committees, at this time, because the Director(s) can adequately perform the functions of such committees.

 

Audit Committee Financial Expert

 

Our Board of Directors has determined that we do not have a board member that qualifies as an “audit committee financial expert” as defined in Item 407(D)(5) of Regulation S-K, nor do we have a Board member that qualifies as “independent” as the term is used in Item 7(d)(3)(iv)(B) of Schedule 14A under the Securities Exchange Act of 1934, as amended, and as defined by Rule 4200(a)(14) of the FINRA Rules.

 

We believe that our Director(s) are capable of analyzing and evaluating our financial statements and understanding internal controls and procedures for financial reporting. The Director(s) of our Company does not believe that it is necessary to have an audit committee because management believes that the Board of Directors can adequately perform the functions of an audit committee. In addition, we believe that retaining an independent Director who would qualify as an “audit committee financial expert” would be overly costly and burdensome and is not warranted in our circumstances given the stage of our development and the fact that we have not generated any positive cash flows from operations to date.

 

Involvement in Certain Legal Proceedings

 

Our Directors and our Executive officers have not been involved in any of the following events during the past ten years:

 

1. bankruptcy petition filed by or against any business of which such person was a general partner or executive officer either at the time of the bankruptcy or within two years prior to that time;
2. any conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);
3. being subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining, barring, suspending or otherwise limiting his/her involvement in any type of business, securities or banking activities; or
4. being found by a court of competent jurisdiction (in a civil action), the Commission or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated.
5. Such person was found by a court of competent jurisdiction in a civil action or by the Commission to have violated any Federal or State securities law, and the judgment in such civil action or finding by the Commission has not been subsequently reversed, suspended, or vacated;
6. Such person was found by a court of competent jurisdiction in a civil action or by the Commodity Futures Trading Commission to have violated any Federal commodities law, and the judgment in such civil action or finding by the Commodity Futures Trading Commission has not been subsequently reversed, suspended or vacated;
7. Such person was the subject of, or a party to, any Federal or State judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated, relating to an alleged violation of:(i) Any Federal or State securities or commodities law or regulation; or(ii) Any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order; or(iii) Any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; or
8. Such person was the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act (15 U.S.C. 78c(a)(26))), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act (7 U.S.C. 1(a)(29))), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.

 

 18 
 

 

Code of Ethics

 

We have not adopted a formal Code of Ethics. The Board of Directors evaluated the business of the Company and the number of employees and determined that since the business is operated by a small number of persons, general rules of fiduciary duty and federal and state criminal, business conduct and securities laws are adequate ethical guidelines. In the event our operations, employees and/or Directors expand in the future, we may take actions to adopt a formal Code of Ethics.

 

Shareholder Proposals

 

Our Company does not have any defined policy or procedural requirements for shareholders to submit recommendations or nominations for Directors. The Board of Directors believes that, given the stage of our development, a specific nominating policy would be premature and of little assistance until our business operations develop to a more advanced level. Our Company does not currently have any specific or minimum criteria for the election of nominees to the Board of Directors and we do not have any specific process or procedure for evaluating such nominees. The Board of Directors will assess all candidates, whether submitted by management or shareholders, and make recommendations for election or appointment.

 

A shareholder who wishes to communicate with our Board of Directors may do so by directing a written request addressed to our President, at the address appearing on the first page of this Information Statement.

 

ITEM 11. EXECUTIVE COMPENSATION

 

*The below figures are in relation to our last two fiscal years.

 

Summary Compensation Table:

 

Name and principal position

(a)

 

Year ended June 30

(b)

   

Salary ($)

(c)

   

Bonus ($)

(d)

   

Stock Compensation ($)

(e)

   

Option Awards ($)

(f)

   

Non-Equity Incentive Plan Compensation ($)

(g)

   

Nonqualified Deferred Compensation Earnings ($)

(h)

   

All Other Compensation ($)

(i)

   

Total ($)

(j)

 
How Kok Choong, Chief Executive Officer, President, Secretary, Treasurer, Director   2017       -       -       -       -       -       -       -     $ -  
    2018       -       -       -       -       -       -       -     $ -  

 

Compensation of Directors:

 

Name and principal position

(a)

 

Year ended June 30

(b)

   

Salary ($)

(c)

   

Bonus ($)

(d)

   

Stock Compensation ($)

(e)

   

Option Awards ($)

(f)

   

Non-Equity Incentive Plan Compensation ($)

(g)

   

Nonqualified Deferred Compensation Earnings ($)

(h)

   

All Other Compensation ($)

(i)

   

Total ($)

(j)

 
How Kok Choong, President, Chief Executive Officer, Secretary, Treasurer and Director   2017       -       -       -       -       -       -       -     $ -  
    2018       -       -       -       -       -       -       -     $ -  

 

 19 
 

 

Summary of Compensation

 

Stock Option Grants

 

We have not granted any stock options to our executive officers since our incorporation.

 

Employment Agreements

 

We do not have an employment or consulting agreement with any officers or Directors.

 

Compensation Discussion and Analysis

 

Director Compensation

 

Our Board of Directors does not currently receive any consideration for their services as members of the Board of Directors. The Board of Directors reserves the right in the future to award the members of the Board of Directors cash or stock based consideration for their services to the Company, which awards, if granted shall be in the sole determination of the Board of Directors.

 

Executive Compensation Philosophy

 

Our Board of Directors determines the compensation given to our executive officers in their sole determination. Our Board of Directors reserves the right to pay our executive or any future executives a salary, and/or issue them shares of common stock in consideration for services rendered and/or to award incentive bonuses which are linked to our performance, as well as to the individual executive officer’s performance. This package may also include long-term stock based compensation to certain executives, which is intended to align the performance of our executives with our long-term business strategies. Additionally, while our Board of Directors has not granted any performance base stock options to date, the Board of Directors reserves the right to grant such options in the future, if the Board in its sole determination believes such grants would be in the best interests of the Company.

 

Incentive Bonus

 

The Board of Directors may grant incentive bonuses to our executive officer and/or future executive officers in its sole discretion, if the Board of Directors believes such bonuses are in the Company’s best interest, after analyzing our current business objectives and growth, if any, and the amount of revenue we are able to generate each month, which revenue is a direct result of the actions and ability of such executives.

 

Long-term, Stock Based Compensation

 

In order to attract, retain and motivate executive talent necessary to support the Company’s long-term business strategy we may award our executive and any future executives with long-term, stock-based compensation in the future, at the sole discretion of our Board of Directors, which we do not currently have any immediate plans to award.

 

 20 
 

 


ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 

As of June 30, 2018, the Company has 376,275,500 shares of common stock issued and outstanding, which number of issued and outstanding shares of common stock have been used throughout this report.

 

Name and Address of Beneficial Owner  Shares of Common Stock Beneficially Owned   Common Stock Voting Percentage Beneficially Owned   Voting Shares of Preferred Stock   Preferred Stock Voting Percentage Beneficially Owned   Total Voting Percentage Beneficially Owned 
Executive Officers and Directors                         
How Kok Choong, President, Chief Executive Officer, Secretary, Treasurer and Director; collectively this includes HKC Holdings Sdn. Bhd.*   315,100,000    83.74%   none    n/a    83.74%
5% Shareholders                         
-   -    -    -    -    - 

 

*HKC Holdings Sdn. Bhd. is owned and controlled by How Kok Choong who is our sole officer and director.

 

Beneficial ownership has been determined in accordance with Rule 13d-3 under the Exchange Act. Under this rule, certain shares may be deemed to be beneficially owned by more than one person (if, for example, persons share the power to vote or the power to dispose of the shares). In addition, shares are deemed to be beneficially owned by a person if the person has the right to acquire shares (for example, upon exercise of an option or warrant) within 60 days of the date as of which the information is provided. In computing the percentage ownership of any person, the amount of shares is deemed to include the amount of shares beneficially owned by such person by reason of such acquisition rights. As a result, the percentage of outstanding shares of any person as shown in the following table does not necessarily reflect the person’s actual voting power at any particular date.

 

 21 
 

 


ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, DIRECTOR INDEPENDENCE

 

On June 1, 2016, Mr. How Kok Choong was appointed as CEO, President, Secretary, Treasurer and a member of our Board of Directors. Additionally, on June 1, 2016, the Company issued 100,000 shares of restricted common stock, each with a par value of $0.0001 per share, to Mr. How Kok Choong for initial working capital of $10.

 

On April 5, 2017, the Company acquired Agape ATP Corporation, a company incorporated in Labuan, Malaysia.

 

On April 10, 2017, the Company issued 245,000,000 and 70,000,000 shares of restricted common stock to Mr. How Kok Choong and HKC Holdings Sdn Bhd respectively, each with a par value of $0.0001 per share, for total additional working capital of $31,500.

 

*HKC Holdings Sdn. Bhd. is owned and controlled by How Kok Choong who is our sole officer and director. As a result we believe HKC Holdings Sdn. Bhd to be a related party.

 

In regards to all of the above transactions we claim an exemption from registration afforded by Section 4a(2) and/or Regulation S of the Securities Act of 1933, as amended (“Regulation S”) due to the fact that all sales of stock were made to non-U.S. persons (as defined under Rule 902 section (k)(2)(i) of Regulation S), pursuant to offshore transactions, and no directed selling efforts were made in the United States by the issuer, a distributor, any of their respective affiliates, or any person acting on behalf of any of the foregoing.

 

Related Party Transactions

 

As of June 30, 2018 and 2017, our Director, Mr. How Kok Choong, advanced $3,922 and $100, respectively to the Company, which is unsecured, interest-free with no fixed repayment term, for working capital purpose. Imputed interest is considered insignificant.

 

Greenpro Capital Corp., through its wholly owned subsidiaries (collectively “Greenpro”), is a 4.7% shareholder in the Company, and provides services to the Company. Greenpro Venture Capital Limited is owned by Greenpro Capital Corp. The controlling shareholders of Greenpro Capital Corp. are Mr. Lee Chong Kuang and Mr. Loke Che Chan. During the year ended June 30, 2018 and period ended June 30, 2017, the Company incurred incorporation fees of $1,419 and professional fees of $214,000. Mr.How Kok Choong is the director of Greenpro Capital Corp. Hence, Mr. How Kok Choong is the common director of Greenpro Capital Corp. and the Company.

 

As at June 30, 2018, the Company owed an amount of $745 to a related party, Agape Superior Living Sdn Bhd. Mr. How Kok Choong is the director of Agape Superior Living Sdn Bhd. Hence, Mr. How Kok Choong is the common director of Agape Superior Living Sdn Bhd and the Company.

 

For the year ended June 30, 2018, the Company earned revenue of $487,005 from its only customer, Agape S.E.A. Sdn Bhd. Mr. How Kok Choong is the director of Agape S.E.A. Sdn Bhd. Hence, Mr. How Kok Choong is the common director of Agape S.E.A. Sdn Bhd and the Company.

 

At May 17, 2018, the Company had an investment in Greenpro Capital Corp. of $500,000. The Company purchased the shares of Greenpro Capital Corp. at a price of $6 per share.

 

* How Kok Choong has acted as the sole promoter of the Company since inception. He has not been provided any form of compensation as of the date of this registration statement.

 

Review, Approval and Ratification of Related Party Transactions

 

Given our small size and limited financial resources, we have not adopted formal policies and procedures for the review, approval or ratification of transactions, such as those described above, with our executive officer(s), Director(s) and significant stockholders. We intend to establish formal policies and procedures in the future, once we have sufficient resources and have appointed additional Directors, so that such transactions will be subject to the review, approval or ratification of our Board of Directors, or an appropriate committee thereof. On a moving forward basis, our Directors will continue to approve any related party transaction.

 

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

 

Below is the aggregate amount of fees billed for professional services rendered by our principal accountants with respect to our last two fiscal years.

 

  

For the Year

Ended June 30,
2018

  

For the Year

Ended June 30,
2017

 
Audit fees  $25,000   $8,000 
Audit related fees   -    - 
Tax fees   -    - 
All other fees   -    - 
Total  $25,000   $8,000 

 

The category of “Audit fees” includes fees for our annual audit, quarterly reviews and services rendered in connection with regulatory filings with the SEC, such as the issuance of comfort letters and consents.

 

The category of “Audit-related fees” includes employee benefit plan audits, internal control reviews and accounting consultation.

 

All of the professional services rendered by principal accountants for the audit of our annual financial statements that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for last two fiscal years were approved by our board of directors.

 

 22 
 

 

PART IV

 

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

 

(a) Financial Statements

 

The following are filed as part of this report:

 

Financial Statements

 

The following financial statements of AGAPE ATP Corporation. and Report of Independent Registered Public Accounting Firm are presented in the “F” pages of this Report:

 

  Page
   
Index F-1
   
Report of Independent Registered Public Accounting Firm F-2
   
Financial Statements  
   
Consolidated Balance Sheets F-3
   
Consolidated Statements of Operations F-4
   
Consolidated Statements of Stockholders’ Equity F-5
   
Consolidated Statements of Cash Flows F-6
   
Notes to Consolidated Financial Statements F-7 – F-16

 

(b) Exhibits

 

The following exhibits are filed or “furnished” herewith:

 

3.1 Articles of Incorporation**
   
3.2 Bylaws**
   
31.1 Rule 13(a)-14(a)/15(d)-14(a) Certification of principal executive officer*
   
32.1 Section 1350 Certification of principal executive officer*

 

* Filed herewith.

 

** As filed in the Registrant’s Registration Statement on Form S-1 Amendment No.8 (File No. 333-220144) on October 26, 2017.

 

 23 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  AGAPE ATP CORPORATION.
  (Name of Registrant)
     
Date: September 27, 2018    
     
  By: /s/ How Kok Choong
  Title: Chief Executive Officer, President, Secretary, Treasurer, Director
   

Principal Executive Officer

Principal Financial Officer

Principal Accounting Officer

 

 24 
 

 

INDEX TO FINANCIAL STATEMENTS

 

  Page
Financial Statements  
 
Report of Independent Registered Public Accounting Firm F-2
   
Consolidated Balance Sheets F-3
   
Consolidated Statements of Operations and Comprehensive Loss F-4
   
Consolidated Statements of Changes in Stockholders’ Equity F-5
   
Consolidated Statements of Cash Flows F-6
   
Notes to Consolidated Financial Statements F-7 - F-16

 

 F-1 
 

 

TOTAL ASIA ASSOCIATES PLT (LLP0016837-LCA & AF002128)

Firm registered with US PCAOB and Malaysian MIA

 

106-2A, Jalan PJU 1/3B, SunwayMas Commercial Centre

47301 Petaling Jaya, Selangor Darul Ehsan

Tel : (603) 7805 2850

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Shareholders and Board of Directors of Agape ATP Corporation

1705 - 1708, Level 17,

Tower 2, Faber Towers,

Jalan Desa Bahagia, Taman Desa,
58100 Kuala Lumpur, Malaysia

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of Agape ATP Corporation (the ‘Company’) as of June 30, 2018 and 2017, and the related consolidated statements of income, stockholders’ equity, and cash flows for the each of the two years in the period ended of June 30, 2018 and 2017, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of June 30, 2018 and 2017, and the results of its operations and its cash flows for each of the two years in the period ended June 30, 2018 and 2017, in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

/S/ Total Asia Associates PLT  
TOTAL ASIA ASSOCIATES PLT  

 

We have served as the Company’s auditor since 2018.

 

Selangor, Malaysia

 

September 27, 2018

 

 F-2 
 

 

AGAPE ATP CORPORATION

CONSOLIDATED BALANCE SHEETS

AS OF JUNE 30, 2018 and 2017

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Audited)

 

   As of June 30, 
   2018   2017 
ASSETS          
CURRENT ASSETS          
Cash and cash equivalents  $3,531,255   $2,312,748 
Prepayments and deposits   264,941    - 
           
Total current assets   3,796,196    2,312,748 
           
NON-CURRENT ASSETS          
Investment in investee company   832,335    - 
Investment in marketable securities   500,000    - 
           
Total non-current assets   1,332,335    - 
           
TOTAL ASSETS  $5,128,531   $2,312,748 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
CURRENT LIABILITIES          
Other payables and accrued liabilities  $19,749   $8,000 
Amounts due to a related party   745    - 
Amounts due to a director   3,922    100 
Provision for income tax   5,334    - 
           
Total current liabilities   29,750    8,100 
           
TOTAL LIABILITIES   29,750    8,100 
           
STOCKHOLDERS’ EQUITY          
Preferred stock, $0.0001 par value, 200,000,000 shares authorized, None issued and outstanding   -    - 
Common stock, $0.0001 par value, 1,000,000,000 shares authorized, 376,275,500 and 371,350,000 shares issued and outstanding as of June 30, 2018 and 2017 respectively   37,628    37,135 
Additional paid-in capital   5,293,082    2,367,875 
Accumulated other comprehensive losses   (1,293)   - 
Accumulated deficit   (230,636)   (100,362)
           
TOTAL STOCKHOLDERS’ EQUITY   5,098,781    2,304,648 
           
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY  $5,128,531   $2,312,748 

 

See accompanying notes to consolidated financial statements.

 

 F-3 
 

 

AGAPE ATP CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

FOR YEARS ENDED JUNE 30, 2018 AND 2017

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Audited)

 

   For the year ended
June 30, 2018
   For the year ended
June 30, 2017
 
REVENUE  $487,005   $- 
           
COST OF REVENUE   (441,409)   - 
           
GROSS PROFIT   45,596    - 
           
REALISED GAIN ON FOREIGN EXCHANGE   1,698    - 
           
UNREALISED GAIN ON FOREIGN EXCHANGE   134,392    - 
           
OTHER INCOME   3,211    - 
           
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES   (265,682)   (75,362)
           
OPERATING EXPENSES   (14,000)   - 
           
LOSS BEFORE INCOME TAX   (94,785)   (75,362)
           
SHARE OF RESULT OF INVESTEE COMPANY   (30,155)   - 
    (124,940)   - 
           
INCOME TAXES PROVISION   (5,334)   - 
           
NET LOSS  $(130,274)  $(75,362)
           
Other comprehensive income/(loss):          
- Foreign currency translation adjustment   (1,293)   - 
TOTAL COMPREHENSIVE LOSS  $(131,567)  $(75,362)
           
Net loss per share- Basic and diluted  $(0.00)  $(0.00)
           
Weighted average number of common shares outstanding - Basic and diluted   373,017,955    80,860,137 

 

See accompanying notes to consolidated financial statements.

 

 F-4 
 

 

AGAPE ATP CORPORATION

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

FOR YEARS ENDED JUNE 30, 2018 AND 2017

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Audited)

 

   COMMON STOCK   ADDITIONAL   ACCUMULATED   ACCUMULATED     
   Number of shares   Amount  

PAID-IN

CAPITAL

  

COMPREHENSIVE

INCOME/(LOSS)

   SURPLUS/
(DEFICIT)
   TOTAL
EQUITY
 
Balance as of July 1, 2016   100,000   $10    -   $-   $(25,000)  $(24,990)
                               
Issuance of share capital - founder’s shares   350,000,000   $35,000   $-   $-   $-   $35,000 
Share issued in private placement completed on May 03, 2017 at $0.05 per share   1,400,000   $140   $69,860   $-   $-   $70,000 
Share issued in private placement completed on June 01, 2017 at $0.10 per share   17,400,000   $1,740   $1,738,260   $-   $-   $1,740,000 
Share issued in private placement completed on June 28, 2017 at $0.20 per share   2,100,000   $210   $419,790   $-   $-   $420,000 
Share issued in private placement completed on June 29, 2017 at $0.40 per share   350,000   $35   $139,965   $-   $-   $140,000 
Net loss for the year   -   $-   $-   $-   $(75,362)  $(75,362)
Balance as of June 30, 2017   371,350,000   $37,135   $2,367,875   $-   $(100,362)  $2,304,648 
Net loss for the year   -   $-   $-   $-   $(130,274)  $(130,274)
IPO completed on March 9, 2018 at $1.00 per share   2,925,500   $293   $2,925,207   $-   $-   $2,925,500 
Share issued to Adam, Network 1 and Damon completed on April 16, 2018 at $0.0001 per share   2,000,000   $200   $-   $-   $-   $200 
Foreign currency translation adjustment   -   $-   $-   $(1,293)  $-   $(1,293)
Balance as of June 30, 2018   376,275,500   $37,628   $5,293,082   $(1,293)  $(230,636)  $5,098,781 

 

See accompanying notes to consolidated financial statements

 

 F-5 
 

 

AGAPE ATP CORPORATION

CONSOLIDATED STATEMENT OF CASH FLOWS

FOR YEARS ENDED JUNE 30, 2018 AND 2017

(Currency expressed in United States Dollars (“US$”))

(Audited)

 

   For the year ended June 30, 2018   For the year ended June 30, 2017 
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net loss  $(130,274)  $(75,362)
Adjustments to reconcile net loss to net cash used in operating activities:          
Share of result of investee company   30,155    - 
Changes in operating assets and liabilities:          
Prepayments and deposits   (264,941)   (24,900)
Other payables and accrued liabilities   11,749    - 
Provision for income tax   5,334    - 
Cash used in operating activities   (347,977)   (100,262)
Taxation refund   -    - 
Taxation paid   -    - 
Net cash used in operating activities   (347,977)   (100,262)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Investment in investee company   (862,490)   - 
Investment in financial assets   (500,000)   - 
Net cash used in investing activities   (1,362,490)   - 
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Increase in share capital   493    37,125 
Proceed from sale of common stock   2,925,207    2,367,875 
Amount due to a related party   745    8,000 
Amount due to a director   3,822    - 
           
Net cash provided by financing activities   2,930,267    2,413,000 
           
Effect of exchange rate changes on cash and cash equivalents   (1,293)   - 
           
Net change in cash and cash equivalents   1,218,507    2,312,738 
Cash and cash equivalents, beginning of year   2,312,748    10 
           
CASH AND CASH EQUIVALENTS, END OF YEAR  $3,531,255   $2,312,748 
SUPPLEMENTAL CASH FLOWS INFORMATION          
Income taxes paid  $-   $- 
Interest paid  $-   $- 

 

See accompanying notes to consolidated financial statements.

 

 F-6 
 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2018 AND 2017

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

1. ORGANIZATION AND BUSINESS BACKGROUND

 

Agape ATP Corporation, a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on June 1, 2016.

 

Agape ATP Corporation operates through its wholly owned subsidiary, Agape ATP Corporation, a Company organized in Labuan, Malaysia.

 

Agape ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with 100% equity interest in Agape ATP International Holding Limited, a company incorporated in Hong Kong.

 

The Company and its subsidiaries are engaged in providing services in the Health and Wellness Industry. The principal activity of the Company and its subsidiaries is to supply high-quality health and wellness products, including supplement to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system in our body.

 

The Company, through its subsidiaries, mainly supplies high quality beauty products. Details of the Company’s subsidiaries and associates:

 

  

Subsidiary company

name

 

Place and date of

incorporation

  Particulars of issued capital  Principal activities 

Proportional of ownership

interest and

voting power

held

 
1.  Agape ATP Corporation  Labuan,
March 6, 2017
 

1 share of ordinary share of

US$1 each

  Investment holding   100%
                  
2.  Agape ATP International Holding Limited  Hong Kong,
June 1, 2017
 

1 share of ordinary share of

HK$1 each

  Health and wellness products and health solution advisory services   100%

 

  

Associate company

name

  Place and date of incorporation  Particulars of issued capital  Principal activities 

Proportional of ownership interest and voting power

held

 
1.  Unreserved Sdn Bhd 

Malaysia,

August 25, 2008

  500,000 shares of ordinary share of RM7 each  Magazines publication and advertising   20%

 

  (1) Based on the contractual arrangements between the Company and other investors, the Company has the power to direct the relevant activities of these entities unilaterally, and hence the Company has control over these entities.

 

 F-7 
 

 

Business Overview

 

Agape ATP Corporation is a company which plans to develop and provide health solution advisory services to our future clients. We will, at least initially, primarily focus our efforts on attracting customers in Malaysia. Our advisory services will center on the “ATP Zeta Health Program”, which is a health program designed to assist in the elimination of various diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles. The program aims to promote improved health and longevity in our clients through a combination of modern medicine, proper nutrition and advice from skilled dieticians.

 

At its core, the ATP Zeta Super Health Program is focused upon biological energy, Adenosine Triphosphate (ATP), at the cellular level. The stimulation of ATP production at the cellular level can increase the metabolism and service to promote and maintain normal and healthy functioning of the body’s systems. Our program emphasizes nutrient absorption through the membrane ion channel to provide complete and balanced nutrients to improve cell health. Thus, ATP Zeta Super Health Program provides ionized and high zeta potential (high bioavailability) nutrients to enhance the absorption at the cellular level.

 

The ATP Zeta Super Health Program consists of ten products. None of these products are owned or produced by Agape ATP Corporation, nor do we have any agreements or arrangements with the third-party manufacturers of these products. In the event that any of these products are no longer produced, or are otherwise unavailable, we may have to devote significant effort to identifying and obtaining comparable replacement products. We will also evaluate adding additional products to the ATP Zeta Super Health Program as operations continue, but we have no plans to do so at present.

 

We plan to acquire products from third party manufacturers located in Australia, the United States, Germany and Malaysia. We do not have any existing contracts or agreements with any third party manufacturers. All products are acquired from unrelated third parties and rebranded by the Company. The Company plans to market and sell all products in Malaysia, and due to the contents and combination of the main ingredients in the products they are categorized as health food rather than medicines or drugs. As such, all products require authorization from the Food and Quality Division of Ministry of Health according to the Food Act of 1983 and Food Regulation 1985 in order to be sold in Malaysia. All of the products in the ATP Zeta Super Health Program have obtained the appropriate authorizations. Our health solution advisory services are mainly based on combining these ten products in order to eliminate the clients’ diseases. The combination of these ten products may vary based upon the disease(s) of each client.

 

Our salespeople, who we have yet to hire, will meet with prospective clients at their homes, public locations, or at office space which has not yet been obtained. Our salespeople will evaluate the condition of clients and based upon their health issues, will recommend a combination of the ten products that comprise the ATP Zeta Super Health Program. Agape ATP Corporation will purchase the products that make up the ATP Zeta Super Health Program from their manufacturers and will then directly sell these products to our future clients based upon their health conditions. Exact pricing for these advisory services have not been determined at this point in time, but will be based upon the cost of acquiring inventory. At present, we do not have storage space for any acquired inventory.

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

The accompanying consolidated financial statements reflect the application of certain significant accounting policies as described in this note and elsewhere in the accompanying consolidated financial statements and notes.

 

Basis of presentation

 

These accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).

 

Basis of consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its subsidiaries in which the Company is the primary beneficiary. All inter-company accounts and transactions have been eliminated upon consolidation.

 

 F-8 
 

 

Use of estimates

 

In preparing these consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets, and revenues and expenses during the periods reported. Actual results may differ from these estimates.

 

Cash and cash equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of six months or less as of the purchase date of such investments.

 

Investment in investee company

 

The Company evaluates investment in investee company as it holds an equity interest based on the amount of control it exercises over the operations of the investee, exposure to losses in excess of its investment, the ability to significantly influence the investee and whether the Company is the primary beneficiary of the investee.

 

Investment in marketable securities

 

Marketable securities included in marketable securities (current) and other investments (non-current) are stated at the lower of cost or market in the aggregate. Other marketable securities included in marketable securities (current) are stated at the lower of cost or market in the aggregate and investments other than marketable equity securities in other investments (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary.
Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.

 

Revenue recognition

 

In accordance with ASC Topic 605, “Revenue Recognition”, the Company recognizes revenue from sales of goods when the following four revenue criteria are met: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) selling price is fixed or determinable; and (4) collectability is reasonably assured.

 

Revenue from trading of retail goods is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded. Based on limited operating history, management estimates that there was no sale return for the period reported.

 

The Company mainly derives its revenue from the sale of healthy food products. Generally, the Company recognizes revenue when products are sold and accepted by the customers and there are no continuing obligations to the customer.

 

 F-9 
 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2018 AND 2017

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Cost of revenue

 

Cost of revenue includes the purchase cost of retail goods for re-sale to customers and packing materials (such as boxes). It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.

 

Selling and distribution expenses

 

Selling and distribution expenses are primarily comprised of travelling and accommodation, transportation fees such as petrol, toll and parking.

 

Income taxes

 

The provision of income taxes is determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

 

The Company conducts much of its businesses activities in Hong Kong and is subject to tax in this jurisdiction. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.

 

Net loss per share

 

The Company calculates net loss per share in accordance with ASC Topic 260 “Earnings per share”. Basic loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.

 

 F-10 
 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2018 AND 2017

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Foreign currencies translation

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income

 

The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. In addition, the Company’s subsidiaries in Labuan and Hong Kong maintains their books and record in United States Dollars (“US$”), Hong Kong Dollars (“HK$”) and Malaysian Ringgit (“MYR”) respectively, which is functional currency as being the primary currency of the economic environment in which the entity operates.

 

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity.

 

Translation of amounts from MYR into US$1 have been made at the following exchange rates for the respective periods:

 

   As of and for the year ended June 30, 
   2018   2017 
         
Period-end MYR : US$1 exchange rate   4.03    4.38 
Period-average MYR : US$1 exchange rate   4.21    4.43 

 

Related parties

 

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

 

Fair value of financial instruments:

 

The carrying value of the Company’s financial instruments: cash and cash equivalents, subscription receivables, prepayment and deposits, accounts payable, and other payables and accrued liabilities approximate at their fair values because of the short-term nature of these financial instruments.

 

 F-11 
 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2018 AND 2017

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

The Company also follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

 

  Level 1: Observable inputs such as quoted prices in active markets;
   
  Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
   
  Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

 

Fair value estimates are made at a specific point in time based on relevant market information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates.

 

Recent accounting pronouncements

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:

 

In May 2014, the FASB issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”). ASU 2014-09 supersedes the revenue recognition requirements in “Revenue Recognition (Topic 605)”, and requires entities to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is not permitted. In August 2015, the FASB issued an Accounting Standards Update to defer by one year the effective dates of its new revenue recognition standard until annual reporting periods beginning after December 15, 2017 (2018 for calendar-year public entities) and interim periods therein. Management is currently assessing the impact of the adoption of ASU 2014-09 and has not determined the effect of the standard on our ongoing financial reporting.

 

In February 2016, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842). Under the new guidance, lessees will be required recognize the following for all leases (with the exception of short-term leases) at the commencement date: 1) A lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and 2) A right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. The new lease guidance simplified the accounting for sale and leaseback transactions primarily because lessees must recognize lease assets and lease liabilities. Lessees will no longer be provided with a source of off-balance sheet financing. The amendments in this ASU are effective for fiscal years beginning after December 15, 2019, including interim periods within those years. The Company is evaluating this ASU and has not determined the effect of this standard on its ongoing financial reporting.

 

In September 2017, the FASB has issued ASU No. 2017-13, Revenue Recognition (Topic 605), Revenue from Contracts with Customers (Topic 606), Leases (Topic 840), and Leases (Topic 842): Amendments to SEC Paragraphs Pursuant to the Staff Announcement at the July 20, 2017 EITF Meeting and Rescission of Prior SEC Staff Announcements and Observer Comments.” The amendments in ASU No. 2017-13 amends the early adoption date option for certain companies related to the adoption of ASU No. 2014-09 and ASU No. 2016-02. Both of the below entities may still adopt using the public company adoption guidance in the related ASUs, as amended. The effective date is the same as the effective date and transition requirements for the amendments for ASU 2014-09 and ASU 2016-02.

 

In January 2017, the FASB issued ASU No. 2017-01 , “Business Combinations (Topic 805): Clarifying the Definition of a Business”, which clarifies the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. This amendment was effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. The adoption of ASU No. 2017-01 did not have a material impact on the Company’s financial position, results of operations and liquidity.

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.

 

 F-12 
 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2018 AND 2017

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

3. STOCKHOLDERS’ EQUITY

 

On June 1, 2016, the founder of the Company, Mr. How Kok Choong purchased 100,000 shares of restricted common stock of the Company at a par value of $0.0001 per share for the Company’s initial working capital.

 

On April 10, 2017, the Company issued 245,000,000 and 70,000,000 shares of restricted common stock to How Kok Choong and HKC Holdings Sdn Bhd respectively, each with a par value of $0.0001 per share, for total additional working capital of $31,500.

 

On April 13, 2017, the Company issued 17,500,000 shares of restricted common stock to Greenpro Asia Strategic Fund SPC, with a par value of $0.0001 per share, for additional working capital of $1,750.

 

On April 14, 2017, the Company issued 17,500,000 shares of restricted common stock to Greenpro Venture Capital Limited, with a par value of $0.0001 per share, for additional working capital of $1,750.

 

On May 3, 2017, the Company sold shares to 2 shareholders, of whom reside in Malaysia. A total of 1,400,000 shares of restricted common stock were sold at a price of $0.05 per share. The total proceeds to the Company amounted to a total of $70,000.

 

In between May 8, 2017 and May 25, 2017, the Company sold shares to 67 shareholders, of whom reside in Malaysia. A total of 17,400,000 shares of restricted common stock were sold at a price of $0.1 per share. The total proceeds to the Company amounted to a total of $1,740,000.

 

In between June 6, 2017 and June 23, 2017, the Company sold shares to 19 shareholders, of whom reside in Malaysia. A total of 2,100,000 shares of restricted common stock were sold at a price of $0.2 per share. The total proceeds to the Company amounted to a total of $420,000.

 

On June 26, 2017, the Company sold shares to 7 shareholders of whom reside in Malaysia. A total of 350,000 shares of restricted common stock were sold at a price of $0.4 per share. The total proceeds to the Company amounted to a total of $140,000.

 

In between November 25, 2017 and March 31, 2018, the Company sold shares to 298 shareholders, of whom reside in Malaysia. A total of 2,925,500 shares of IPO stock were sold at a price of $1.00 per share. The total proceeds to the Company amounted to a total of $2,925,500.

 

On April 16, 2018, the Company sold shares to Adam, Network 1 and Damon, of whom reside in United States. A total of 2,000,000 of restricted common stock were sold at a price of $0.0001 per share. The total proceeds to the Company amounted to a total of $200.

 

As of June 30, 2018 and 2017, there were 376,275,500 and 371,350,000 of common stocks issued and outstanding respectively.

 

 F-13 
 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2018 AND 2017

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

4. CASH AND CASH EQUIVALENTS

 

As at June 30, 2018, the Company recorded $3,531,255 of cash and cash equivalents which consists $1,046,706 of cash on hand and $2,484,549 of time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of six months or less as of the purchase date of such investments. The effective interest rate for the time deposits is 2.95% per annum.

 

5. PREPAYMENTS AND DEPOSITS

 

   As of June 30,   As of June 30, 
   2018   2017 
Prepaid expenses  $264,941   $- 
Total prepaid expenses and deposits  $264,941   $- 

 

6. INVESTMENT IN INVESTEE COMPANY

 

The Company invested in Unreserved Sdn Bhd with investment amount of $862,490 (MYR3,500,000), approximated 20% of equity interest of Unreserved Sdn Bhd and is accounted for under the equity method of accounting. The investment is stated at cost plus profit share in the investee company as at June 30, 2018. Unreserved Sdn Bhd is incorporated in Malaysia with 2,500,000 ordinary shares authorized, issued and outstanding. Mr Lim Hun Soon @ David Lim, Ms Aniza Helina Akmi Karim, and Mr How Kok Choong are the directors of Unreserved Sdn Bhd. Mr How Kok Choong is the common director of Unreserved Sdn Bhd and the Company.

 

   As of June 30,   As of June 30, 
   2018   2017 
Cost of investment   862,490    - 
Less: impairment loss   -    - 
Less: share of result of investee company   (30,155)   - 
Investment in investee company  $832,335   $- 

 

7. INVESTMENT IN MARKETABLE SECURITIES

 

At May 17, 2018, the Company had an investment in Greenpro Capital Corp. of $500,000. The Company purchased the shares of Greenpro Capital Corp. at a price of $6 per share.

 

8. OTHER PAYABLES AND ACCRUED LIABILITIES

 

   As of June 30,   As of June 30, 
   2018   2017 
Accrued audit fees   19,000    8,000 
Accrued professional fees   749    - 
Total payables and accrued liabilities  $19,749   $- 

 

9. RELATED PARTY TRANSACTION

 

As at June 30, 2018, the Company owed an amount of $745 to a related party, Agape Superior Living Sdn Bhd. Mr How Kok Choong is the director of Agape Superior Living Sdn Bhd. Hence, Mr How Kok Choong is the common director of Agape Superior Living Sdn Bhd and the Company.

 

Greenpro Capital Corp., through its wholly owned subsidiaries (collectively “Greenpro”), is a 4.7% shareholder in the Company, and provides services to the Company. Greenpro Venture Capital Limited is owned by Greenpro Capital Corp. The controlling shareholders of Greenpro Capital Corp. are Mr. Lee Chong Kuang and Mr. Loke Che Chan. During the year ended June 30, 2018 and period ended June 30, 2017, the Company incurred incorporation fees of $1,419 and professional fees of $214,000. Mr.How Kok Choong is the director of Greenpro Capital Corp. Hence, Mr. How Kok Choong is the common director of Greenpro Capital Corp. and the Company.

 

For the year ended June 30, 2018, the Company earned revenue of $487,005 from its only customer, Agape S.E.A. Sdn Bhd. Mr. How Kok Choong is the director of Agape S.E.A. Sdn Bhd. Hence, Mr. How Kok Choong is the common director of Agape S.E.A. Sdn Bhd and the Company.

 

At May 17, 2018, the Company had an investment in Greenpro Capital Corp. of $500,000. The Company purchased the shares of Greenpro Capital Corp. at a price of $6 per share.

 

 F-14 
 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2018 AND 2017

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

10. AMOUNT DUE TO A DIRECTOR

 

As of June 30, 2018, a director of the Company advanced $3,922 to the Company, which is unsecured, interest-free with no fixed repayment term, for working capital purpose. Imputed interest is considered insignificant.

 

11. INCOME TAXES

 

For the year ended June 30, 2018 and year ended June 30, 2017, the local (United States) and foreign components of loss before income taxes were comprised of the following:

 

   For the year ended
June 30, 2018
   For the year ended
June 30, 2017
 
         
Tax jurisdictions from:          
- Local  $(261,918)  $(75,200)
- Foreign, representing          
Labuan   134,806    (162)
Hong Kong   2,172    - 
Loss before income tax  $(124,940)  $(75,362)

 

The provision for income taxes consisted of the following:

 

   For the year ended
June 30, 2018
   For the year ended
June 30, 2017
 
         
Current:                  
- Local  $-   $- 
- Foreign   5,334    - 
           
Deferred:          
- Local   -    - 
- Foreign   -    - 
           
Income tax expense  $

5,334

   $- 

 

The effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rates. The Company and its subsidiary that operate in various countries: United States, Labuan and Hong Kong that are subject to taxes in the jurisdictions in which they operate, as follows:

 

United States of America

 

Agape ATP Corporation is registered in the State of Nevada and is subject to the tax laws of the United States of America. As of June 30, 2018, the operations in the United States of America incurred $362,118 of cumulative net operating losses which can be carried forward to offset future taxable income. The net operating loss carry forwards begin to expire in 2038, if unutilized. The tax valuation allowance for June 30, 2018 and June 30, 2017 are $76,045 and $35,070 respectively.

 

Labuan

 

Under the current laws of the Labuan, Agape ATP Corporation is governed under the Labuan Business Activity Act, 1990. The tax charge for such company is based on 3% of net audited profit or at a fixed rate of RM20,000.

 

Hong Kong

 

Agape ATP International Holding (HK) Limited is subject to Hong Kong Profits Tax, which is charged at the statutory income rate of 16.5% on its assessable income. The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of June 30, 2018 and June 30, 2017:

 

The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of June 30, 2018 and 2017:

 

   For the year ended
June 30, 2018
   For the year ended
June 30, 2017
 
         
Deferred tax assets:          
Net operating loss carry forwards          
-United States of America   76,045    35,070 
-Hong Kong   -    - 
Less: valuation allowance   (76,045)   (35,070)
Deferred tax asset   -    - 

 

 F-15 
 

 

AGAPE ATP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, 2018 AND 2017

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

12. CONCENTRATIONS OF RISKS

 

(a) Major customers

 

For the year ended June 30, 2018, the customers who accounted for 10% or more of the Company’s revenues and its account receivables balance at year-end are presented as follows:

 

  

For the year ended June 30, 2018

  

As of

June 30, 2018

 
   Revenue   Percentage of revenue  

Accounts

receivable

 
             
Customer A  $487,005    100%  $           - 
Total:  $487,005    100%  $- 

 

For the year ended June 30, 2017, there was no customer who accounted for 10% or more of the Company’s revenues with no account receivables balance at year end.

 

(b) Major vendors

 

For the year ended June 30, 2018, the vendors who accounted for 10% or more of the Company’s purchases and its account payables balance at year-end are presented as follows:

 

   For the year ended June 30, 2018  

As of

June 30, 2018

 
   Purchases   Percentage of purchases   Accounts payable 
             
Vendor A   441,409    100%              - 
Total:  $441,409    100%  $- 

 

For the year ended June 30, 2017, there was no vendor who accounted for 10% or more of the Company’s purchases with no account payables balance at year end.

 

(c) Credit risk

 

Financial instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration of credit risk in its trade receivables is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.

 

(d) Exchange rate risk

 

The Company cannot guarantee that the current exchange rate will remain steady; therefore, there is a possibility that the Company could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower profit depending on exchange rate of RM$ converted to US$ on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.

 

13. SUBSEQUENT EVENTS

 

In accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred after June 30, 2018 up through the date the Company issued the audited consolidated financial statements. During this period, there was no subsequent event that required recognition or disclosure.

 

 F-16 
 

GRAPHIC 2 image_001.jpg begin 644 image_001.jpg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image_002.jpg begin 644 image_002.jpg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end GRAPHIC 4 image_003.jpg begin 644 image_003.jpg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end GRAPHIC 5 image_004.jpg begin 644 image_004.jpg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end GRAPHIC 6 image_005.jpg begin 644 image_005.jpg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image_006.jpg begin 644 image_006.jpg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end GRAPHIC 8 image_007.jpg begin 644 image_007.jpg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end GRAPHIC 9 image_008.jpg begin 644 image_008.jpg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end GRAPHIC 10 image_009.jpg begin 644 image_009.jpg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image_010.jpg begin 644 image_010.jpg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image_011.jpg begin 644 image_011.jpg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end EX-31.1 13 ex31-1.htm

 

EXHIBIT 31.1

 

CERTIFICATION

 

I, HOW KOK CHOONG, certify that:

 

1. I have reviewed this annual report on Form 10-K of Agape ATP Corporation (the “Company”) for the year ended June 30, 2018;

 

2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b. Designed such internal control over financial reporting, or caused such internal control to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.
     
  c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: September 27, 2018 By: /s/ How Kok Choong
    HOW KOK CHOONG
   

Chief Executive Officer,

President, Director, Secretary, Treasurer

    (Principal Executive Officer)

 

 
 

 

EX-32.1 14 ex32-1.htm

 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Agape ATP Corporation (the “Company”) on Form 10-K for the year ended June 30, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), The undersigned hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Date: September 27, 2018 By: /s/ How Kok Choong
    HOW KOK CHOONG
    Chief Executive Officer, President, Director
    (Principal Executive Officer)

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 
 

 

EX-101.INS 15 aac-20180630.xml XBRL INSTANCE FILE 0001713210 2017-07-01 2018-06-30 0001713210 2018-06-30 0001713210 2017-06-30 0001713210 2016-07-01 2017-06-30 0001713210 2016-06-30 0001713210 AAC:MrHowKokChoongMember 2016-06-01 0001713210 AAC:MrHowKokChoongMember 2017-04-09 2017-04-10 0001713210 AAC:MrHowKokChoongMember 2017-04-10 0001713210 AAC:GreenproAsiaStrategicFundSpcMember 2017-04-12 2017-04-13 0001713210 AAC:GreenproAsiaStrategicFundSpcMember 2017-04-13 0001713210 AAC:UnitedStatesOfAmericaMember 2018-06-30 0001713210 AAC:UnitedStatesOfAmericaMember 2017-07-01 2018-06-30 0001713210 AAC:LabuanMember 2017-07-01 2018-06-30 0001713210 AAC:LabuanMember currency:MYR 2017-07-01 2018-06-30 0001713210 AAC:HongKongMember 2017-07-01 2018-06-30 0001713210 AAC:HongKongMember 2016-07-01 2017-06-30 0001713210 AAC:HongKongMember 2018-06-30 0001713210 us-gaap:AccountsReceivableMember AAC:CustomerAMember 2018-06-30 0001713210 us-gaap:SalesRevenueNetMember 2017-07-01 2018-06-30 0001713210 us-gaap:CostOfSalesMember 2017-07-01 2018-06-30 0001713210 us-gaap:SalesRevenueNetMember AAC:CustomerAMember 2017-07-01 2018-06-30 0001713210 us-gaap:CostOfSalesMember AAC:VendorAMember 2017-07-01 2018-06-30 0001713210 us-gaap:AccountsReceivableMember 2018-06-30 0001713210 us-gaap:AccountsPayableMember AAC:VendorAMember 2018-06-30 0001713210 us-gaap:AccountsPayableMember 2018-06-30 0001713210 AAC:UnitedStatesOfAmericaMember 2017-06-30 0001713210 AAC:HongKongMember 2017-06-30 0001713210 AAC:CustomersMember 2017-07-01 2018-06-30 0001713210 AAC:CustomersMember 2016-07-01 2017-06-30 0001713210 AAC:VendorMember 2017-07-01 2018-06-30 0001713210 AAC:VendorMember 2016-07-01 2017-06-30 0001713210 us-gaap:DirectorMember 2018-06-30 0001713210 us-gaap:DirectorMember currency:MYR 2018-06-30 0001713210 2018-09-27 0001713210 us-gaap:CommonStockMember 2016-07-01 2017-06-30 0001713210 us-gaap:CommonStockMember 2017-07-01 2018-06-30 0001713210 us-gaap:CommonStockMember 2016-06-30 0001713210 us-gaap:CommonStockMember 2017-06-30 0001713210 us-gaap:CommonStockMember 2018-06-30 0001713210 us-gaap:AdditionalPaidInCapitalMember 2016-07-01 2017-06-30 0001713210 us-gaap:AdditionalPaidInCapitalMember 2017-07-01 2018-06-30 0001713210 us-gaap:AdditionalPaidInCapitalMember 2016-06-30 0001713210 us-gaap:AdditionalPaidInCapitalMember 2017-06-30 0001713210 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0001713210 us-gaap:ComprehensiveIncomeMember 2016-07-01 2017-06-30 0001713210 us-gaap:ComprehensiveIncomeMember 2017-07-01 2018-06-30 0001713210 us-gaap:ComprehensiveIncomeMember 2016-06-30 0001713210 us-gaap:ComprehensiveIncomeMember 2017-06-30 0001713210 us-gaap:ComprehensiveIncomeMember 2018-06-30 0001713210 us-gaap:RetainedEarningsMember 2016-07-01 2017-06-30 0001713210 us-gaap:RetainedEarningsMember 2017-07-01 2018-06-30 0001713210 us-gaap:RetainedEarningsMember 2016-06-30 0001713210 us-gaap:RetainedEarningsMember 2017-06-30 0001713210 us-gaap:RetainedEarningsMember 2018-06-30 0001713210 2017-12-31 0001713210 AAC:AgapeATPInternationalHoldingLimitedMember 2018-06-30 0001713210 AAC:GreenproCapitalCorpMember 2018-05-17 0001713210 AAC:UnitedStatesOfAmericaMember 2016-07-01 2017-06-30 0001713210 AAC:LabuanMember 2016-07-01 2017-06-30 0001713210 AAC:SubsidiaryCompanyMember 2017-07-01 2018-06-30 0001713210 AAC:SubsidiaryCompanyMember 2018-06-30 0001713210 AAC:SubsidiaryCompanyOneMember 2017-07-01 2018-06-30 0001713210 AAC:SubsidiaryCompanyOneMember 2018-06-30 0001713210 AAC:AssociateCompanyMember AAC:UnreservedSdnBhdMember 2017-07-01 2018-06-30 0001713210 AAC:AssociateCompanyMember AAC:UnreservedSdnBhdMember 2018-06-30 0001713210 currency:MYR 2018-06-30 0001713210 currency:MYR 2017-06-30 0001713210 currency:MYR 2016-07-01 2017-06-30 0001713210 currency:MYR 2017-07-01 2018-06-30 0001713210 AAC:MrHowKokChoongMember 2016-05-29 2016-06-01 0001713210 AAC:HkcHoldingsSdnBhdMember 2017-04-09 2017-04-10 0001713210 AAC:HkcHoldingsSdnBhdMember 2017-04-10 0001713210 AAC:GreenproVentureCapitalLimitedMember 2017-04-12 2017-04-14 0001713210 AAC:GreenproVentureCapitalLimitedMember 2017-04-14 0001713210 AAC:MalaysiaMember 2017-05-02 2017-05-03 0001713210 AAC:MalaysiaMember 2017-05-03 0001713210 AAC:MalaysiaMember 2017-05-08 2017-05-25 0001713210 AAC:MalaysiaMember 2017-05-25 0001713210 AAC:MalaysiaMember 2017-06-06 2017-06-23 0001713210 AAC:MalaysiaMember 2017-06-23 0001713210 AAC:MalaysiaMember 2017-06-25 2017-06-26 0001713210 AAC:MalaysiaMember 2017-06-26 0001713210 AAC:MalaysiaMember us-gaap:IPOMember 2017-11-25 2018-03-31 0001713210 AAC:MalaysiaMember us-gaap:IPOMember 2018-03-31 0001713210 country:US AAC:AdamNetworkOneandDamonMember 2018-04-15 2018-04-16 0001713210 country:US AAC:AdamNetworkOneandDamonMember 2018-04-16 0001713210 us-gaap:PrivatePlacementMember 2017-05-03 0001713210 us-gaap:PrivatePlacementMember 2017-06-01 0001713210 us-gaap:PrivatePlacementMember 2017-06-28 0001713210 us-gaap:PrivatePlacementMember 2017-06-29 0001713210 us-gaap:IPOMember 2018-03-09 0001713210 AAC:AdamNetworkOneandDamonMember 2018-04-16 0001713210 2018-05-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure AAC:Integer Agape ATP Corp 0001713210 10-K 2018-06-30 false --06-30 Smaller Reporting Company FY 2018 376275500 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 200000000 200000000 1000000000 1000000000 2500000 376275500 371350000 2500000 376275500 371350000 2500000 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>1. ORGANIZATION AND BUSINESS BACKGROUND</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Agape ATP Corporation, a Nevada corporation (&#8220;the Company&#8221;) was incorporated under the laws of the State of Nevada on June 1, 2016.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Agape ATP Corporation operates through its wholly owned subsidiary, Agape ATP Corporation, a Company organized in Labuan, Malaysia.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Agape ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with 100% equity interest in Agape ATP International Holding Limited, a company incorporated in Hong Kong.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company and its subsidiaries are engaged in providing services in the Health and Wellness Industry. The principal activity of the Company and its subsidiaries is to supply high-quality health and wellness products, including supplement to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system in our body.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company, through its subsidiaries, mainly supplies high quality beauty products. Details of the Company&#8217;s subsidiaries and associates:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Subsidiary company</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>name</b></p></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Place and date of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>incorporation</b></p></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Particulars of issued capital</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Principal activities</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Proportional of ownership</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>interest and</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>voting power</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>held</b></p></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 3%"><font style="font-size: 10pt">1.</font></td> <td style="width: 1%">&#160;</td> <td style="width: 19%"><font style="font-size: 10pt">Agape ATP Corporation</font></td> <td style="width: 1%">&#160;</td> <td style="width: 12%"><font style="font-size: 10pt">Labuan, </font><br /> <font style="font-size: 10pt">March 6, 2017</font></td> <td style="width: 1%">&#160;</td> <td style="width: 30%"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">1 share of ordinary share of</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">US$1 each</p></td> <td style="width: 1%">&#160;</td> <td style="width: 17%"><font style="font-size: 10pt">Investment holding</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 12%; text-align: right"><font style="font-size: 10pt">100</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">2.</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">Agape ATP International Holding Limited</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">Hong Kong, </font><br /> <font style="font-size: 10pt">June 1, 2017</font></td> <td>&#160;</td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">1 share of ordinary share of</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">HK$1 each</p></td> <td>&#160;</td> <td><font style="font-size: 10pt">Health and wellness products and health solution advisory services</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">100</font></td> <td><font style="font-size: 10pt">%</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Associate company</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>name</b></p></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Place and date of incorporation</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Particulars of issued capital</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Principal activities</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Proportional of ownership interest and voting power</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>held</b></p></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 3%"><font style="font-size: 10pt">1.</font></td> <td style="width: 1%">&#160;</td> <td style="width: 19%"><font style="font-size: 10pt">Unreserved Sdn Bhd</font></td> <td style="width: 1%">&#160;</td> <td style="width: 12%"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Malaysia,</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">August 25, 2008</p></td> <td style="width: 1%">&#160;</td> <td style="width: 30%"><font style="font-size: 10pt">500,000 shares of ordinary share of RM7 each</font></td> <td style="width: 1%">&#160;</td> <td style="width: 17%"><font style="font-size: 10pt">Magazines publication and advertising</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 12%; text-align: right"><font style="font-size: 10pt">20</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td></tr> <tr> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 19px; text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">(1) Based on the contractual arrangements between the Company and other investors, the Company has the power to direct the relevant activities of these entities unilaterally, and hence the Company has control over these entities.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Business Overview</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Agape ATP Corporation is a company which plans to develop and provide health solution advisory services to our future clients. We will, at least initially, primarily focus our efforts on attracting customers in Malaysia. Our advisory services will center on the &#8220;ATP Zeta Health Program&#8221;, which is a health program designed to assist in the elimination of various diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles. The program aims to promote improved health and longevity in our clients through a combination of modern medicine, proper nutrition and advice from skilled dieticians.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At its core, the ATP Zeta Super Health Program is focused upon biological energy, Adenosine Triphosphate (ATP), at the cellular level. The stimulation of ATP production at the cellular level can increase the metabolism and service to promote and maintain normal and healthy functioning of the body&#8217;s systems. Our program emphasizes nutrient absorption through the membrane ion channel to provide complete and balanced nutrients to improve cell health. Thus, ATP Zeta Super Health Program provides ionized and high zeta potential (high bioavailability) nutrients to enhance the absorption at the cellular level.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The ATP Zeta Super Health Program consists of ten products. None of these products are owned or produced by Agape ATP Corporation, nor do we have any agreements or arrangements with the third-party manufacturers of these products. In the event that any of these products are no longer produced, or are otherwise unavailable, we may have to devote significant effort to identifying and obtaining comparable replacement products. We will also evaluate adding additional products to the ATP Zeta Super Health Program as operations continue, but we have no plans to do so at present.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We plan to acquire products from third party manufacturers located in Australia, the United States, Germany and Malaysia. We do not have any existing contracts or agreements with any third party manufacturers. All products are acquired from unrelated third parties and rebranded by the Company. The Company plans to market and sell all products in Malaysia, and due to the contents and combination of the main ingredients in the products they are categorized as health food rather than medicines or drugs. As such, all products require authorization from the Food and Quality Division of Ministry of Health according to the Food Act of 1983 and Food Regulation 1985 in order to be sold in Malaysia. All of the products in the ATP Zeta Super Health Program have obtained the appropriate authorizations. Our health solution advisory services are mainly based on combining these ten products in order to eliminate the clients&#8217; diseases. The combination of these ten products may vary based upon the disease(s) of each client.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our salespeople, who we have yet to hire, will meet with prospective clients at their homes, public locations, or at office space which has not yet been obtained. Our salespeople will evaluate the condition of clients and based upon their health issues, will recommend a combination of the ten products that comprise the ATP Zeta Super Health Program. Agape ATP Corporation will purchase the products that make up the ATP Zeta Super Health Program from their manufacturers and will then directly sell these products to our future clients based upon their health conditions. Exact pricing for these advisory services have not been determined at this point in time, but will be based upon the cost of acquiring inventory. At present, we do not have storage space for any acquired inventory.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying consolidated financial statements reflect the application of certain significant accounting policies as described in this note and elsewhere in the accompanying consolidated financial statements and notes.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Basis of presentation</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">These accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;US GAAP&#8221;).</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Basis of consolidation</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The condensed consolidated financial statements include the accounts of the Company and its subsidiaries in which the Company is the primary beneficiary. All inter-company accounts and transactions have been eliminated upon consolidation.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Use of estimates</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In preparing these consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets, and revenues and expenses during the periods reported. Actual results may differ from these estimates.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Cash and cash equivalents</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of six months or less as of the purchase date of such investments.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Investment in investee company</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates investment in investee company as it holds an equity interest based on the amount of control it exercises over the operations of the investee, exposure to losses in excess of its investment, the ability to significantly influence the investee and whether the Company is the primary beneficiary of the investee.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Investment in marketable securities</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Marketable securities included in marketable securities (current) and other investments (non-current) are stated at the lower of cost or market in the aggregate. Other marketable securities included in marketable securities (current) are stated at the lower of cost or market in the aggregate and investments other than marketable equity securities in other investments (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary.<br /> Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Revenue recognition</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">In accordance with ASC Topic 605, &#8220;Revenue Recognition&#8221;, the Company recognizes revenue from sales of goods when the following four revenue criteria are met: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) selling price is fixed or determinable; and (4) collectability is reasonably assured.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Revenue from trading of retail goods is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company&#8217;s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management&#8217;s best estimates and historical experience and are provided for in the same period as the related revenues are recorded. Based on limited operating history, management estimates that there was no sale return for the period reported.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Company mainly derives its revenue from the sale of healthy food products. Generally, the Company recognizes revenue when products are sold and accepted by the customers and there are no continuing obligations to the customer.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Cost of revenue</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Cost of revenue includes the purchase cost of retail goods for re-sale to customers and packing materials (such as boxes). It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><u>Selling and distribution expenses</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Selling and distribution expenses are primarily comprised of travelling and accommodation, transportation fees such as petrol, toll and parking.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Income taxes</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The provision of income taxes is determined in accordance with the provisions of ASC Topic 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company conducts much of its businesses activities in Hong Kong and is subject to tax in this jurisdiction. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Net loss per share</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company calculates net loss per share in accordance with ASC Topic 260 &#8220;<i>Earnings per share</i>&#8221;. Basic loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Foreign currencies translation</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The reporting currency of the Company is United States Dollars (&#8220;US$&#8221;) and the accompanying financial statements have been expressed in US$. In addition, the Company&#8217;s subsidiaries in Labuan and Hong Kong maintains their books and record in United States Dollars (&#8220;US$&#8221;), Hong Kong Dollars (&#8220;HK$&#8221;) and Malaysian Ringgit (&#8220;MYR&#8221;) respectively, which is functional currency as being the primary currency of the economic environment in which the entity operates.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, &#8220;<i>Translation of Financial Statement&#8221;</i>, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders&#8217; equity.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Translation of amounts from MYR into US$1 have been made at the following exchange rates for the respective periods:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">As of and for the year ended June 30,</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2018</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2017</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Period-end MYR : US$1 exchange rate</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 14%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">4.03</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 14%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">4.38</font></td> <td style="width: 1%; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Period-average MYR : US$1 exchange rate</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">4.21</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">4.43</font></td> <td style="line-height: 107%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Related parties</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Fair value of financial instruments:</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The carrying value of the Company&#8217;s financial instruments: cash and cash equivalents, subscription receivables, prepayment and deposits, accounts payable, and other payables and accrued liabilities approximate at their fair values because of the short-term nature of these financial instruments.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company also follows the guidance of the ASC Topic 820-10, &#8220;<i>Fair Value Measurements and Disclosures</i>&#8221; (&#8220;ASC 820-10&#8221;), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify; line-height: 107%">&#160;</td> <td style="text-align: justify; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Level 1: Observable inputs such as quoted prices in active markets;</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; line-height: 107%">&#160;</td> <td style="text-align: justify; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; line-height: 107%">&#160;</td> <td style="text-align: justify; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; line-height: 107%">&#160;</td> <td style="text-align: justify; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify; line-height: 107%">&#160;</td> <td style="text-align: justify; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Fair value estimates are made at a specific point in time based on relevant market information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Recent accounting pronouncements</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In May 2014, the FASB issued Accounting Standards Update No. 2014-09, &#8220;Revenue from Contracts with Customers&#8221; (&#8220;ASU 2014-09&#8221;). ASU 2014-09 supersedes the revenue recognition requirements in &#8220;Revenue Recognition (Topic 605)&#8221;, and requires entities to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is not permitted. In August 2015, the FASB issued an Accounting Standards Update to defer by one year the effective dates of its new revenue recognition standard until annual reporting periods beginning after December 15, 2017 (2018 for calendar-year public entities) and interim periods therein. Management is currently assessing the impact of the adoption of ASU 2014-09 and has not determined the effect of the standard on our ongoing financial reporting.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2016, the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2016-02, Leases (Topic 842). Under the new guidance, lessees will be required recognize the following for all leases (with the exception of short-term leases) at the commencement date: 1) A lease liability, which is a lessee&#8217;s obligation to make lease payments arising from a lease, measured on a discounted basis; and 2) A right-of-use asset, which is an asset that represents the lessee&#8217;s right to use, or control the use of, a specified asset for the lease term. The new lease guidance simplified the accounting for sale and leaseback transactions primarily because lessees must recognize lease assets and lease liabilities. Lessees will no longer be provided with a source of off-balance sheet financing. The amendments in this ASU are effective for fiscal years beginning after December 15, 2019, including interim periods within those years. The Company is evaluating this ASU and has not determined the effect of this standard on its ongoing financial reporting.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">In September 2017, the FASB has issued ASU No. 2017-13, <i>Revenue Recognition </i>(Topic 605), <i>Revenue from Contracts with Customers </i>(Topic 606), <i>Leases </i>(Topic 840), and Leases (Topic 842): Amendments to SEC Paragraphs Pursuant to the Staff Announcement at the July 20, 2017 EITF Meeting and Rescission of Prior SEC Staff Announcements and Observer Comments.&#8221; The amendments in ASU No. 2017-13 amends the early adoption date option for certain companies related to the adoption of ASU No. 2014-09 and ASU No. 2016-02. Both of the below entities may still adopt using the public company adoption guidance in the related ASUs, as amended. The effective date is the same as the effective date and transition requirements for the amendments for ASU 2014-09 and ASU 2016-02.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In January 2017, the FASB issued ASU No. 2017-01 , &#8220;Business Combinations (Topic 805): Clarifying the Definition of a Business&#8221;, which clarifies the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. This amendment was effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. The adoption of ASU No. 2017-01 did not have a material impact on the Company&#8217;s financial position, results of operations and liquidity.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>3. STOCKHOLDERS&#8217; EQUITY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 1, 2016, the founder of the Company, Mr. How Kok Choong purchased 100,000 shares of restricted common stock of the Company at a par value of $0.0001 per share for the Company&#8217;s initial working capital.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 10, 2017, the Company issued 245,000,000 and 70,000,000 shares of restricted common stock to How Kok Choong and HKC Holdings Sdn Bhd respectively, each with a par value of $0.0001 per share, for total additional working capital of $31,500.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 13, 2017, the Company issued 17,500,000 shares of restricted common stock to Greenpro Asia Strategic Fund SPC, with a par value of $0.0001 per share, for additional working capital of $1,750.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 14, 2017, the Company issued 17,500,000 shares of restricted common stock to Greenpro Venture Capital Limited, with a par value of $0.0001 per share, for additional working capital of $1,750.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 3, 2017, the Company sold shares to 2 shareholders, of whom reside in Malaysia. A total of 1,400,000 shares of restricted common stock were sold at a price of $0.05 per share. The total proceeds to the Company amounted to a total of $70,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In between May 8, 2017 and May 25, 2017, the Company sold shares to 67 shareholders, of whom reside in Malaysia. A total of 17,400,000 shares of restricted common stock were sold at a price of $0.1 per share. The total proceeds to the Company amounted to a total of $1,740,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In between June 6, 2017 and June 23, 2017, the Company sold shares to 19 shareholders, of whom reside in Malaysia. A total of 2,100,000 shares of restricted common stock were sold at a price of $0.2 per share. The total proceeds to the Company amounted to a total of $420,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 26, 2017, the Company sold shares to 7 shareholders of whom reside in Malaysia. A total of 350,000 shares of restricted common stock were sold at a price of $0.4 per share. The total proceeds to the Company amounted to a total of $140,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In between November 25, 2017 and March 31, 2018, the Company sold shares to 298 shareholders, of whom reside in Malaysia. A total of 2,925,500 shares of IPO stock were sold at a price of $1.00 per share. The total proceeds to the Company amounted to a total of $2,925,500.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 16, 2018, the Company sold shares to Adam, Network 1 and Damon, of whom reside in United States. A total of 2,000,000 of restricted common stock were sold at a price of $0.0001 per share. The total proceeds to the Company amounted to a total of $200.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of June 30, 2018 and 2017, there were 376,275,500 and 371,350,000 of common stocks issued and outstanding respectively.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>11. INCOME TAXES</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">For the year ended June 30, 2018 and year ended June 30, 2017, the local (United States) and foreign components of loss before income taxes were comprised of the following:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">For the year ended</font><br /> <font style="font: 10pt Times New Roman, Times, Serif">June 30, 2018</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">For the year ended</font><br /> <font style="font: 10pt Times New Roman, Times, Serif">June 30, 2017</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Tax jurisdictions from:</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 64%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">- Local</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">(261,918</font></td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">(75,200</font></td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">- Foreign, representing</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Labuan</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">134,806</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">(162</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Hong Kong</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2,172</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Loss before income tax</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">(124,940</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">(75,362</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The provision for income taxes consisted of the following:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">For the year ended </font><br /> <font style="font: 10pt Times New Roman, Times, Serif">June 30, 2018</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">For the year ended </font><br /> <font style="font: 10pt Times New Roman, Times, Serif">June 30, 2017</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Current:</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">- Local</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 64%; padding-left: 10pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">- Foreign</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 15%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">5,334</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 15%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="width: 1%; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Deferred:</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">- Local</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">- Foreign</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Income tax expense</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">5,334</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 107%">&#160;</td></tr> </table> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rates. The Company and its subsidiary that operate in various countries: United States, Labuan and Hong Kong that are subject to taxes in the jurisdictions in which they operate, as follows:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>United States of America</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Agape ATP Corporation is registered in the State of Nevada and is subject to the tax laws of the United States of America. As of June 30, 2018, the operations in the United States of America incurred $362,118 of cumulative net operating losses which can be carried forward to offset future taxable income. The net operating loss carry forwards begin to expire in 2038, if unutilized. The tax valuation allowance for June 30, 2018 and June 30, 2017 are $76,045 and $35,070 respectively.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Labuan</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Under the current laws of the Labuan, Agape ATP Corporation is governed under the Labuan Business Activity Act, 1990. The tax charge for such company is based on 3% of net audited profit or at a fixed rate of RM20,000.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Hong Kong</i></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Agape ATP International Holding (HK) Limited is subject to Hong Kong Profits Tax, which is charged at the statutory income rate of 16.5% on its assessable income. The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of June 30, 2018 and June 30, 2017:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of June 30, 2018 and 2017:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">For the year ended</font><br /> <font style="font: 10pt Times New Roman, Times, Serif">June 30, 2018</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">For the year ended</font><br /> <font style="font: 10pt Times New Roman, Times, Serif">June 30, 2017</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Deferred tax assets:</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Net operating loss carry forwards</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 64%; padding-left: 10pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-United States of America</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 15%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">76,045</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 15%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">35,070</font></td> <td style="width: 1%; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-Hong Kong</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Less: valuation allowance</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">(76,045</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">(35,070</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Deferred tax asset</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 107%">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>8. OTHER PAYABLES AND ACCRUED LIABILITIES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>As of June 30,</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>As of June 30,</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2017</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%"><font style="font-size: 10pt">Accrued audit fees</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">19,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">8,000</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Accrued professional fees</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">749</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total payables and accrued liabilities</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">19,749</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>10. AMOUNT DUE TO A DIRECTOR</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of June 30, 2018, a director of the Company advanced $3,922 to the Company, which is unsecured, interest-free with no fixed repayment term, for working capital purpose. Imputed interest is considered insignificant.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>9. RELATED PARTY TRANSACTION</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">As at June 30, 2018, the Company owed an amount of $745 to a related party, Agape Superior Living Sdn Bhd. Mr How Kok Choong is the director of Agape Superior Living Sdn Bhd. Hence, Mr How Kok Choong is the common director of Agape Superior Living Sdn Bhd and the Company.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Greenpro Capital Corp., through its wholly owned subsidiaries (collectively &#8220;Greenpro&#8221;), is a 4.7% shareholder in the Company, and provides services to the Company. Greenpro Venture Capital Limited is owned by Greenpro Capital Corp. The controlling shareholders of Greenpro Capital Corp. are Mr. Lee Chong Kuang and Mr. Loke Che Chan. During the year ended June 30, 2018 and period ended June 30, 2017, the Company incurred incorporation fees of $1,419 and professional fees of $214,000. Mr.How Kok Choong is the director of Greenpro Capital Corp. Hence, Mr. How Kok Choong is the common director of Greenpro Capital Corp. and the Company.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">For the year ended June 30, 2018, the Company earned revenue of $487,005 from its only customer, Agape S.E.A. Sdn Bhd. Mr. How Kok Choong is the director of Agape S.E.A. Sdn Bhd. Hence, Mr. How Kok Choong is the common director of Agape S.E.A. Sdn Bhd and the Company.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">At May 17, 2018, the Company had an investment in Greenpro Capital Corp. of $500,000. The Company purchased the shares of Greenpro Capital Corp. at a price of $6 per share.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>12. CONCENTRATIONS OF RISKS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(a) Major customers</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the year ended June 30, 2018, the customers who accounted for 10% or more of the Company&#8217;s revenues and its account receivables balance at year-end are presented as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">For the year ended June 30, 2018</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">As of</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">June 30, 2018</p></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Revenue</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Percentage of revenue</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Accounts</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">receivable</p></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 49%; padding-bottom: 1.5pt"><font style="font-size: 10pt">Customer A</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="width: 14%; border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">487,005</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid">&#160;</td> <td style="width: 14%; border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">100</font></td> <td style="width: 1%; padding-bottom: 1.5pt"><font style="font-size: 10pt">%</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="width: 14%; border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total:</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">487,005</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">100</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">%</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the year ended June 30, 2017, there was no customer who accounted for 10% or more of the Company&#8217;s revenues with no account receivables balance at year end.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(b) Major vendors</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the year ended June 30, 2018, the vendors who accounted for 10% or more of the Company&#8217;s purchases and its account payables balance at year-end are presented as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">For the year ended June 30, 2018</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">As of</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">June 30, 2018</p></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Purchases</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Percentage of purchases</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Accounts payable</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 49%; padding-bottom: 1.5pt"><font style="font-size: 10pt">Vendor A</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid">&#160;</td> <td style="width: 14%; border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">441,409</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid">&#160;</td> <td style="width: 14%; border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">100</font></td> <td style="width: 1%; padding-bottom: 1.5pt"><font style="font-size: 10pt">%</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid">&#160;</td> <td style="width: 14%; border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total:</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">441,409</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">100</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">%</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the year ended June 30, 2017, there was no vendor who accounted for 10% or more of the Company&#8217;s purchases with no account payables balance at year end.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(c) Credit risk</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration of credit risk in its trade receivables is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(d) Exchange rate risk</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Company cannot guarantee that the current exchange rate will remain steady; therefore, there is a possibility that the Company could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower profit depending on exchange rate of RM$ converted to US$ on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>13. SUBSEQUENT EVENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with ASC Topic 855, &#8220;<i>Subsequent Events</i>&#8221;, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred after June 30, 2018 up through the date the Company issued the audited consolidated financial statements. During this period, there was no subsequent event that required recognition or disclosure.</p> 4.03 4.38 0.047 0.20 1.00 1.00 1.00 0.20 487005 487005 487005 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Basis of presentation</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;US GAAP&#8221;).</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Basis of consolidation</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The condensed consolidated financial statements include the accounts of the Company and its subsidiaries in which the Company is the primary beneficiary. All inter-company accounts and transactions have been eliminated upon consolidation.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Use of estimates</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In preparing these consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets, and revenues and expenses during the periods reported. Actual results may differ from these estimates.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Revenue recognition</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">In accordance with ASC Topic 605, &#8220;Revenue Recognition&#8221;, the Company recognizes revenue from sales of goods when the following four revenue criteria are met: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) selling price is fixed or determinable; and (4) collectability is reasonably assured.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Revenue from trading of retail goods is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company&#8217;s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management&#8217;s best estimates and historical experience and are provided for in the same period as the related revenues are recorded. Based on limited operating history, management estimates that there was no sale return for the period reported.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Company mainly derives its revenue from the sale of healthy food products. Generally, the Company recognizes revenue when products are sold and accepted by the customers and there are no continuing obligations to the customer.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Cost of revenue</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cost of revenue includes the purchase cost of retail goods for re-sale to customers and packing materials (such as boxes). It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Cash and cash equivalents</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of six months or less as of the purchase date of such investments.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Income taxes</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The provision of income taxes is determined in accordance with the provisions of ASC Topic 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company conducts much of its businesses activities in Hong Kong and is subject to tax in this jurisdiction. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Net loss per share</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company calculates net loss per share in accordance with ASC Topic 260 &#8220;<i>Earnings per share</i>&#8221;. Basic loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Related parties</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Fair value of financial instruments:</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The carrying value of the Company&#8217;s financial instruments: cash and cash equivalents, subscription receivables, prepayment and deposits, accounts payable, and other payables and accrued liabilities approximate at their fair values because of the short-term nature of these financial instruments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company also follows the guidance of the ASC Topic 820-10, &#8220;<i>Fair Value Measurements and Disclosures</i>&#8221; (&#8220;ASC 820-10&#8221;), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">Level 1: Observable inputs such as quoted prices in active markets;</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and</font></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify">&#160;</td> <td style="text-align: justify"><font style="font-size: 10pt">Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fair value estimates are made at a specific point in time based on relevant market information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Recent accounting pronouncements</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In May 2014, the FASB issued Accounting Standards Update No. 2014-09, &#8220;Revenue from Contracts with Customers&#8221; (&#8220;ASU 2014-09&#8221;). ASU 2014-09 supersedes the revenue recognition requirements in &#8220;Revenue Recognition (Topic 605)&#8221;, and requires entities to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is not permitted. In August 2015, the FASB issued an Accounting Standards Update to defer by one year the effective dates of its new revenue recognition standard until annual reporting periods beginning after December 15, 2017 (2018 for calendar-year public entities) and interim periods therein. Management is currently assessing the impact of the adoption of ASU 2014-09 and has not determined the effect of the standard on our ongoing financial reporting.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2016, the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2016-02, Leases (Topic 842). Under the new guidance, lessees will be required recognize the following for all leases (with the exception of short-term leases) at the commencement date: 1) A lease liability, which is a lessee&#8217;s obligation to make lease payments arising from a lease, measured on a discounted basis; and 2) A right-of-use asset, which is an asset that represents the lessee&#8217;s right to use, or control the use of, a specified asset for the lease term. The new lease guidance simplified the accounting for sale and leaseback transactions primarily because lessees must recognize lease assets and lease liabilities. Lessees will no longer be provided with a source of off-balance sheet financing. The amendments in this ASU are effective for fiscal years beginning after December 15, 2019, including interim periods within those years. The Company is evaluating this ASU and has not determined the effect of this standard on its ongoing financial reporting.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">In September 2017, the FASB has issued ASU No. 2017-13, <i>Revenue Recognition </i>(Topic 605), <i>Revenue from Contracts with Customers </i>(Topic 606), <i>Leases </i>(Topic 840), and Leases (Topic 842): Amendments to SEC Paragraphs Pursuant to the Staff Announcement at the July 20, 2017 EITF Meeting and Rescission of Prior SEC Staff Announcements and Observer Comments.&#8221; The amendments in ASU No. 2017-13 amends the early adoption date option for certain companies related to the adoption of ASU No. 2014-09 and ASU No. 2016-02. Both of the below entities may still adopt using the public company adoption guidance in the related ASUs, as amended. The effective date is the same as the effective date and transition requirements for the amendments for ASU 2014-09 and ASU 2016-02.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In January 2017, the FASB issued ASU No. 2017-01 , &#8220;Business Combinations (Topic 805): Clarifying the Definition of a Business&#8221;, which clarifies the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. This amendment was effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. The adoption of ASU No. 2017-01 did not have a material impact on the Company&#8217;s financial position, results of operations and liquidity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.</p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">For the year ended June 30, 2018 and year ended June 30, 2017, the local (United States) and foreign components of loss before income taxes were comprised of the following:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">For the year ended</font><br /> <font style="font: 10pt Times New Roman, Times, Serif">June 30, 2018</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">For the year ended</font><br /> <font style="font: 10pt Times New Roman, Times, Serif">June 30, 2017</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Tax jurisdictions from:</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 64%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">- Local</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">(261,918</font></td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="width: 15%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">(75,200</font></td> <td style="width: 1%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">- Foreign, representing</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Labuan</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">134,806</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">(162</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Hong Kong</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2,172</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Loss before income tax</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">(124,940</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">(75,362</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The provision for income taxes consisted of the following:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">For the year ended </font><br /> <font style="font: 10pt Times New Roman, Times, Serif">June 30, 2018</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">For the year ended </font><br /> <font style="font: 10pt Times New Roman, Times, Serif">June 30, 2017</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Current:</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">- Local</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 64%; padding-left: 10pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">- Foreign</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 15%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">5,334</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 15%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="width: 1%; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Deferred:</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">- Local</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">- Foreign</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Income tax expense</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">5,334</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 107%">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of June 30, 2018 and 2017:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">For the year ended</font><br /> <font style="font: 10pt Times New Roman, Times, Serif">June 30, 2018</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">For the year ended</font><br /> <font style="font: 10pt Times New Roman, Times, Serif">June 30, 2017</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Deferred tax assets:</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Net operating loss carry forwards</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 64%; padding-left: 10pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-United States of America</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 15%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">76,045</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 15%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">35,070</font></td> <td style="width: 1%; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-Hong Kong</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Less: valuation allowance</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">(76,045</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; line-height: 107%">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">(35,070</font></td> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Deferred tax asset</font></td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 107%">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td> <td style="line-height: 107%">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>As of June 30,</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>As of June 30,</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2017</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%"><font style="font-size: 10pt">Accrued audit fees</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">19,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">8,000</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Accrued professional fees</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">749</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total payables and accrued liabilities</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">19,749</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(a) Major customers</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the year ended June 30, 2018, the customers who accounted for 10% or more of the Company&#8217;s revenues and its account receivables balance at year-end are presented as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">For the year ended June 30, 2018</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">As of</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">June 30, 2018</p></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Revenue</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Percentage of revenue</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Accounts</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">receivable</p></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 49%; padding-bottom: 1.5pt"><font style="font-size: 10pt">Customer A</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="width: 14%; border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">487,005</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid">&#160;</td> <td style="width: 14%; border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">100</font></td> <td style="width: 1%; padding-bottom: 1.5pt"><font style="font-size: 10pt">%</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="width: 14%; border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total:</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">487,005</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">100</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">%</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the year ended June 30, 2017, there was no customer who accounted for 10% or more of the Company&#8217;s revenues with no account receivables balance at year end.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(b) Major vendors</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the year ended June 30, 2018, the vendors who accounted for 10% or more of the Company&#8217;s purchases and its account payables balance at year-end are presented as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">For the year ended June 30, 2018</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">As of</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">June 30, 2018</p></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Purchases</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Percentage of purchases</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Accounts payable</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 49%; padding-bottom: 1.5pt"><font style="font-size: 10pt">Vendor A</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid">&#160;</td> <td style="width: 14%; border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">441,409</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid">&#160;</td> <td style="width: 14%; border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">100</font></td> <td style="width: 1%; padding-bottom: 1.5pt"><font style="font-size: 10pt">%</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td> <td style="width: 1%; border-bottom: black 1.5pt solid">&#160;</td> <td style="width: 14%; border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td> <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total:</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">441,409</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">100</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">%</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the year ended June 30, 2017, there was no vendor who accounted for 10% or more of the Company&#8217;s purchases with no account payables balance at year end.</p> 745 <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Translation of amounts from MYR into US$1 have been made at the following exchange rates for the respective periods:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">As of and for the year ended June 30,</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2018</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2017</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Period-end MYR : US$1 exchange rate</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 14%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">4.03</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 14%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">4.38</font></td> <td style="width: 1%; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Period-average MYR : US$1 exchange rate</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">4.21</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">4.43</font></td> <td style="line-height: 107%">&#160;</td></tr> </table> <p style="margin: 0pt"></p> 832335 862490 3500000 500000 500000 45596 3211 -124940 5334 -130274 -75362 -75362 -130274 -1293 -1293 -131567 -75362 -0.00 -0.00 373017955 80860137 3531255 2312748 10 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>6. INVESTMENT IN INVESTEE COMPANY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company invested in Unreserved Sdn Bhd with investment amount of $862,490 (MYR3,500,000), approximated 20% of equity interest of Unreserved Sdn Bhd and is accounted for under the equity method of accounting. The investment is stated at cost plus profit share in the investee company as at June 30, 2018. Unreserved Sdn Bhd is incorporated in Malaysia with 2,500,000 ordinary shares authorized, issued and outstanding. Mr Lim Hun Soon @ David Lim, Ms Aniza Helina Akmi Karim, and Mr How Kok Choong are the directors of Unreserved Sdn Bhd. Mr How Kok Choong is the common director of Unreserved Sdn Bhd and the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>As of June 30,</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>As of June 30,</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2017</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%"><font style="font-size: 10pt">Cost of investment</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">862,490</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt"><i>Less: impairment loss</i></font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt"><i>Less: share of result of investee company</i></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(30,155</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Investment in investee company</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">832,335</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Investment in investee company</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates investment in investee company as it holds an equity interest based on the amount of control it exercises over the operations of the investee, exposure to losses in excess of its investment, the ability to significantly influence the investee and whether the Company is the primary beneficiary of the investee.</p> -94785 -75362 -30155 No No Yes 0 3796196 2312748 1332335 5128531 2312748 19749 8000 5334 29750 8100 29750 8100 37628 37135 5293082 2367875 -1293 -230636 -100362 5098781 2304648 -24990 10 37135 37628 2367875 5293082 -1293 -25000 -100362 -230636 5128531 2312748 3922 100 3827 441409 441409 441409 -14000 1698 134392 100000 371350000 376275500 350000000 35000 35000 1400000 70000 140 69860 17400000 1740000 1740 1738260 2100000 420000 210 419790 350000 140000 35 139965 2925500 2925500 293 2925207 2000000 200 200 264941 24900 11749 862490 -1362490 2925207 2367875 70000 1740000 420000 140000 2925500 200 2930267 2413000 -1293 1218507 2312738 -347977 -100262 -347977 -100262 745 8000 493 37125 <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>4. CASH AND CASH EQUIVALENTS</b></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">As at June 30, 2018, the Company recorded $3,531,255 of cash and cash equivalents which consists $1,046,706 of cash on hand and $2,484,549 of time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of six months or less as of the purchase date of such investments. The effective interest rate for the time deposits is 2.95% per annum.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>5. PREPAYMENTS AND DEPOSITS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>As of June 30,</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>As of June 30,</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2017</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%"><font style="font-size: 10pt">Prepaid expenses</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">264,941</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total prepaid expenses and deposits</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">264,941</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>7. INVESTMENT IN MARKETABLE SECURITIES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At May 17, 2018, the Company had an investment in Greenpro Capital Corp. of $500,000. The Company purchased the shares of Greenpro Capital Corp. at a price of $6 per share.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Investment in marketable securities</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Marketable securities included in marketable securities (current) and other investments (non-current) are stated at the lower of cost or market in the aggregate. Other marketable securities included in marketable securities (current) are stated at the lower of cost or market in the aggregate and investments other than marketable equity securities in other investments (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary.<br /> Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><u>Selling and distribution expenses</u></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Selling and distribution expenses are primarily comprised of travelling and accommodation, transportation fees such as petrol, toll and parking.</p> <p style="margin: 0pt"></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>As of June 30,</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>As of June 30,</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2017</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%"><font style="font-size: 10pt">Prepaid expenses</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">264,941</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total prepaid expenses and deposits</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">264,941</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>As of June 30,</b></font></td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>As of June 30,</b></font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2017</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%"><font style="font-size: 10pt">Cost of investment</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">862,490</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt"><i>Less: impairment loss</i></font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt"><i>Less: share of result of investee company</i></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(30,155</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Investment in investee company</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">832,335</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Details of the Company&#8217;s subsidiaries and associates:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Subsidiary company</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>name</b></p></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Place and date of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>incorporation</b></p></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Particulars of issued capital</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Principal activities</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Proportional of ownership</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>interest and</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>voting power</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>held</b></p></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 3%"><font style="font-size: 10pt">1.</font></td> <td style="width: 1%">&#160;</td> <td style="width: 19%"><font style="font-size: 10pt">Agape ATP Corporation</font></td> <td style="width: 1%">&#160;</td> <td style="width: 12%"><font style="font-size: 10pt">Labuan, </font><br /> <font style="font-size: 10pt">March 6, 2017</font></td> <td style="width: 1%">&#160;</td> <td style="width: 30%"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">1 share of ordinary share of</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">US$1 each</p></td> <td style="width: 1%">&#160;</td> <td style="width: 17%"><font style="font-size: 10pt">Investment holding</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 12%; text-align: right"><font style="font-size: 10pt">100</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">2.</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">Agape ATP International Holding Limited</font></td> <td>&#160;</td> <td><font style="font-size: 10pt">Hong Kong, </font><br /> <font style="font-size: 10pt">June 1, 2017</font></td> <td>&#160;</td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">1 share of ordinary share of</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">HK$1 each</p></td> <td>&#160;</td> <td><font style="font-size: 10pt">Health and wellness products and health solution advisory services</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">100</font></td> <td><font style="font-size: 10pt">%</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Associate company</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>name</b></p></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Place and date of incorporation</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Particulars of issued capital</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Principal activities</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Proportional of ownership interest and voting power</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>held</b></p></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 3%"><font style="font-size: 10pt">1.</font></td> <td style="width: 1%">&#160;</td> <td style="width: 19%"><font style="font-size: 10pt">Unreserved Sdn Bhd</font></td> <td style="width: 1%">&#160;</td> <td style="width: 12%"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Malaysia,</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">August 25, 2008</p></td> <td style="width: 1%">&#160;</td> <td style="width: 30%"><font style="font-size: 10pt">500,000 shares of ordinary share of RM7 each</font></td> <td style="width: 1%">&#160;</td> <td style="width: 17%"><font style="font-size: 10pt">Magazines publication and advertising</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 12%; text-align: right"><font style="font-size: 10pt">20</font></td> <td style="width: 1%"><font style="font-size: 10pt">%</font></td></tr> <tr> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> 1046706 2484549 264941 862490 -30155 6 0.05 0.10 0.20 0.40 1.00 0.0001 6 19000 8000 749 214000 214000 362118 2038 76045 35070 0.03 0.165 -261918 -75200 134806 2172 -162 5334 76045 35070 76045 35070 1.00 1.00 1.00 1.00 0.10 0.10 0.10 0.10 Agape ATP Corporation Agape ATP International Holding Limited Unreserved Sdn Bhd Labuan, March 6, 2017 Hong Kong, June 1, 2017 Malaysia, August 25, 2008 1 share of ordinary share of US$1 each 1 share of ordinary share of HK$1 each 500,000 shares of ordinary share of RM7 each Investment holding Health and wellness products and health solution advisory services Magazines publication and advertising 4.21 4.43 1 1 245000000 17500000 100000 70000000 17500000 31500 1750 31500 1750 2 67 19 7 298 1400000 17400000 2100000 350000 2925500 2000000 0.05 0.1 0.2 0.4 1.00 0.0001 265682 75362 -3822 500000 264941 500000 1419 1419 20000 0.0295 <p style="margin: 0pt"></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Foreign currencies translation</u></p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The reporting currency of the Company is United States Dollars (&#8220;US$&#8221;) and the accompanying financial statements have been expressed in US$. In addition, the Company&#8217;s subsidiaries in Labuan and Hong Kong maintains their books and record in United States Dollars (&#8220;US$&#8221;), Hong Kong Dollars (&#8220;HK$&#8221;) and Malaysian Ringgit (&#8220;MYR&#8221;) respectively, which is functional currency as being the primary currency of the economic environment in which the entity operates.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, &#8220;<i>Translation of Financial Statement&#8221;</i>, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders&#8217; equity.</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Translation of amounts from MYR into US$1 have been made at the following exchange rates for the respective periods:</p> <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">As of and for the year ended June 30,</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2018</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">2017</font></td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td colspan="2" style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 66%; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Period-end MYR : US$1 exchange rate</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 14%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">4.03</font></td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 1%; line-height: 107%">&#160;</td> <td style="width: 14%; text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">4.38</font></td> <td style="width: 1%; line-height: 107%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">Period-average MYR : US$1 exchange rate</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">4.21</font></td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="line-height: 107%">&#160;</td> <td style="text-align: right; line-height: 107%"><font style="font: 10pt Times New Roman, Times, Serif">4.43</font></td> <td style="line-height: 107%">&#160;</td></tr> </table> <p style="margin: 0pt"></p> EX-101.SCH 16 aac-20180630.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000007 - Statement - Consolidated Statement of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Organization and Business Background link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Stockholders’ Equity link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Cash and Cash Equivalents link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Prepayments and Deposits link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Investment in Investee Company link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Investment in Marketable Securities link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Other Payables and Accrued Liabilities link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Related Party Transaction link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Amount Due to a Director link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Concentrations of Risks link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Organization and Business Background (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Prepayments and Deposits (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Investment in Investee Company (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Other Payables and Accrued Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Concentrations of Risks (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Organization and Business Background (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Organization and Business Background - Schedule of Subsidiaries and Associates (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Summary of Significant Accounting Policies - Schedule of Translation Exchange Rates (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Summary of Significant Accounting Policies - Schedule of Translation Exchange Rates (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Stockholders’ Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Cash and Cash Equivalents (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Prepayments and Deposits - Schedule of Prepaid Expenses and Deposits (Details) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Investment in Investee Company (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Investment in Investee Company - Schedule of Investments (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Investment in Marketable Securities (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Other Payables and Accrued Liabilities - Schedule of Other Payables and Accrued Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Related Party Transaction (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Amount Due to a Director (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Income Taxes (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Income Taxes - Schedule of Components of Income/(Loss) Before Income Tax (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Income Taxes - Schedule of Provision for Income Tax (Details) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Concentrations of Risks - Schedule of Concentrations of Risk (Details) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Concentrations of Risks - Schedule of Concentrations of Risk (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 17 aac-20180630_cal.xml XBRL CALCULATION FILE EX-101.DEF 18 aac-20180630_def.xml XBRL DEFINITION FILE EX-101.LAB 19 aac-20180630_lab.xml XBRL LABEL FILE Title of Individual [Axis] Mr. How Kok Choong [Member] Related Party [Axis] Greenpro Asia Strategic Fund SPC [Member] Geographical [Axis] United States of America [Member] Labuan [Member] Currency [Axis] MYR [Member] Hong Kong [Member] Concentration Risk Benchmark [Axis] Accounts Receivable [Member] Concentration Risk Type [Axis] Customer A [Member] Sales Revenue, Net [Member] Cost of Sales [Member] Vendor A [Member] Extinguishment of Debt [Axis] Accounts Payable [Member] Customer [Axis] Customer [Member] Vendor [Member] Director [Member] Equity Components [Axis] Common Stock [Member] Additional Paid-In Capital [Member] Accumulated Comprehensive Income / (Loss) [Member] Accumulated Surplus / (Deficit) [Member] Consolidated Entities [Axis] Agape ATP International Holding Limited [Member] Legal Entity [Axis] Greenpro Capital Corp. [Member] Subsidiary Company [Member] Subsidiary Company One [Member] Associate Company [Member] Unreserved Sdn Bhd [Member] HKC Holdings Sdn Bhd [Member] Greenpro Venture Capital Limited [Member] Malaysia [Member] Sale of Stock [Axis] IPO [Member] United States [Member] Adam, Network 1 and Damon [Member] Private Placement [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity a Well-known Seasoned Issuer Entity a Voluntary Filer Entity's Current Reporting Status Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS CURRENT ASSETS Cash and cash equivalents Prepayments and deposits Total current assets NON-CURRENT ASSETS Investment in investee company Investment in marketable securities Total non-current assets TOTAL ASSETS LIABILITIES AND STOCKHOLDERS' EQUITY CURRENT LIABILITIES Other payables and accrued liabilities Amounts due to a related party Amounts due to a director Provision for income tax Total current liabilities TOTAL LIABILITIES STOCKHOLDERS' EQUITY Preferred stock, $0.0001 par value, 200,000,000 shares authorized, None issued and outstanding Common stock, $0.0001 par value, 1,000,000,000 shares authorized, 376,275,500 and 371,350,000 shares issued and outstanding as of June 30, 2018 and 2017 respectively Additional paid-in capital Accumulated other comprehensive losses Accumulated deficit TOTAL STOCKHOLDERS' EQUITY TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] REVENUE COST OF REVENUE GROSS PROFIT REALISED GAIN ON FOREIGN EXCHANGE UNREALISED GAIN ON FOREIGN EXCHANGE OTHER INCOME SELLING, GENERAL AND ADMINISTRATIVE EXPENSES OPERATING EXPENSES LOSS BEFORE INCOME TAX SHARE OF RESULT OF INVESTEE COMPANY LOSS BEFORE INCOME TAX INCLUDING SHARE OF RESULT OF INVESTEE COMPANY INCOME TAXES PROVISION NET LOSS Other comprehensive income/(loss): - Foreign currency translation adjustment TOTAL COMPREHENSIVE LOSS Net loss per share- Basic and diluted Weighted average number of common shares outstanding - Basic and diluted Statement [Table] Statement [Line Items] Balance Balance, shares Issuance of share capital - founder's shares Issuance of share capital - founder's shares, shares Share issued in private placement completed on May 03, 2017 at $0.05 per share Share issued in private placement completed on May 03, 2017 at $0.05 per share, shares Share issued in private placement completed on June 01, 2017 at $0.10 per share Share issued in private placement completed on June 01, 2017 at $0.10 per share, shares Share issued in private placement completed on June 28, 2017 at $0.20 per share Share issued in private placement completed on June 28, 2017 at $0.20 per share, shares Share issued in private placement completed on June 29, 2017 at $0.40 per share Share issued in private placement completed on June 29, 2017 at $0.40 per share, shares Net loss IPO completed on March 9, 2018 at $1.00 per share IPO completed on March 9, 2018 at $1.00 per share, shares Share issued to Adam, Network 1 and Damon completed on April 16, 2018 at $0.0001 per share Share issued to Adam, Network 1 and Damon completed on April 16, 2018 at $0.0001 per share, shares Foreign currency translation adjustment Balance Balance, shares Shares issued price per share Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Adjustments to reconcile net loss to net cash used in operating activities: Share of result of investee company Changes in operating assets and liabilities: Prepayments and deposits Other payables and accrued liabilities Provision for income tax Cash used in operating activities Taxation refund Taxation paid Net cash used in operating activities CASH FLOWS FROM INVESTING ACTIVITIES: Investment in investee company Investment in financial assets Net cash used in investing activities CASH FLOWS FROM FINANCING ACTIVITIES: Increase in share capital Proceed from sale of common stock Amount due to a related party Amount due to a director Net cash provided by financing activities Effect of exchange rate changes on cash and cash equivalents Net change in cash and cash equivalents Cash and cash equivalents, beginning of year CASH AND CASH EQUIVALENTS, END OF YEAR SUPPLEMENTAL CASH FLOWS INFORMATION Income taxes paid Interest paid Accounting Policies [Abstract] Organization and Business Background Summary of Significant Accounting Policies Equity [Abstract] Stockholders' Equity Cash and Cash Equivalents [Abstract] Cash and Cash Equivalents Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Prepayments and Deposits Investments Schedule [Abstract] Investment in Investee Company Investments, Debt and Equity Securities [Abstract] Investment in Marketable Securities Other Liabilities Disclosure [Abstract] Other Payables and Accrued Liabilities Related Party Transactions [Abstract] Related Party Transaction Amount Due to a Director Income Tax Disclosure [Abstract] Income Taxes Risks and Uncertainties [Abstract] Concentrations of Risks Subsequent Events [Abstract] Subsequent Events Basis of Presentation Basis of Consolidation Use of Estimates Cash and Cash Equivalents Investment in Investee Company Investment in Marketable Securities Revenue Recognition Cost of Revenue Selling and Distribution Expenses Income Taxes Net Loss Per Share Foreign Currencies Translation Related Parties Fair Value of Financial Instruments Recent Accounting Pronouncements Schedule of Subsidiaries and Associates Schedule of Translation Exchange Rates Schedule of Prepaid Expenses and Deposits Schedule of Investments Schedule of Other Payables and Accrued Liabilities Schedule of Components of Income/(Loss) Before Income Tax Schedule of Provision for Income Tax Schedule of Deferred Tax Assets Schedule of Concentrations of Risks Ownership percentage Company name Place and date of incorporation Particulars of issued capital Principal activities Proportional of ownership interest and voting power held Period-end MYR : US$1 exchange rate Period-average MYR : US$1 exchange rate Exchange rate Number of restricted common stock shares issued, shares Common stock par value Working capital Number of shareholders Number of restricted common stock shares sold Sale of stock price per share Proceeds from issuance of common stock Common stock issued Common stock outstanding Cash on hand Time deposits Interest rate Prepaid expenses Total prepaid expenses and deposits Investment amount Equity interest percentage Ordinary shares authorized Ordinary shares issued Ordinary shares outstanding Cost of investment Less: impairment loss Less: share of result of investee company Purchased price per shares Accrued audit fees Accrued professional fees Total payables and accrued liabilities Incurred incorporation fees Professional fees Revenue Investment Share price per share Due to related party Cumulative net operating loss Operating loss carryforwards expire year Valuation allowance Tax percentage Fixed rate of foreign income tax amount Statutory income tax rate Local Foreign Loss before income tax Current, Local Current, Foreign Deferred, Local Deferred, Foreign Income tax expense Net operating loss carryforwards Less: valuation allowance Deferred tax asset Revenues Concentrations of risk percentage Accounts receivable, trade Purchase Accounts payable, trade Amount Due to a Director [Text Block] Customer A [Member] Customer [Member] Greenpro Asia Strategic Fund SPC [Member] Greenpro Venture Capital Limited [Member] HKC Holdings Sdn Bhd [Member] Hong Kong [Member] How Kok Choong and HKC Holdings Sdn Bhd [Member] Labuan, Malaysia [Member] Labuan [Member] Mr. How Kok Choong [Member] Period-average HKD : US$1 Exchange Rate [Member] Period-average RM : US$1 Exchange Rate [Member] Period-end HKD : US$1 Exchange Rate [Member] Period-end RM : US$1 Exchange Rate [Member] Related Parties [Policy Text Block] Related party A [Member] Related party B [Member] Schedule of Other Payables and Accrued Liabilities [Table Text Block] Shareholders [Member] United States of America [Member] Vendor A [Member] Vendor [Member] Share issued in private placement one. Share issued in private placement one shares. Share issued in private placement two. Share issued in private placement two shares. Shares issued in private placement three. Shares issued in private placement three shares. Shares issued in private placement four. Shares issued in private placement four shares. Issuance of initial public offering shares. Taxation refund. Taxation paid. Proceeds from amount due to a director. Prepayments and Deposits [Text Block] Schedule of Prepaid Expenses and Deposits [Table Text Block] Agape ATP International Holding Limited [Member] Place and date of incorporation. Particulars of issued capital. Principal activities. Period-end MYR : US$1 Exchange Rate [Member] Name of the company name. Impairment loss. Share of result of investee company. Greenpro Capital Corp. [Member] Accrued audit fees. Operating loss carryforwards expire year. Subsidiary Company [Member] Associate Company [Member] Unreserved Sdn Bhd [Member] Working capital. Number of shareholders. Malaysia [Member] Adam, Network 1 and Damon [Member] Subsidiary Company One [Member] Incurred incorporation fees. Assets, Current Assets, Noncurrent Assets Liabilities, Current Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Gross Profit Selling, General and Administrative Expense Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Income Tax Expense (Benefit) Other Comprehensive Income (Loss), Net of Tax Shares, Outstanding Increase (Decrease) in Prepaid Expense Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Operating Activities Payments to Acquire Investments Payments to Acquire Other Investments Net Cash Provided by (Used in) Investing Activities ProceedsFromAmountDueToDirector Net Cash Provided by (Used in) Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) Cash and Cash Equivalents, Policy [Policy Text Block] Investment, Policy [Policy Text Block] Marketable Securities, Policy [Policy Text Block] Income Tax, Policy [Policy Text Block] Deferred Tax Assets, Valuation Allowance EX-101.PRE 20 aac-20180630_pre.xml XBRL PRESENTATION FILE XML 21 R1.htm IDEA: XBRL DOCUMENT v3.10.0.1
Document and Entity Information - USD ($)
12 Months Ended
Jun. 30, 2018
Sep. 27, 2018
Dec. 31, 2017
Document And Entity Information      
Entity Registrant Name Agape ATP Corp    
Entity Central Index Key 0001713210    
Document Type 10-K    
Document Period End Date Jun. 30, 2018    
Amendment Flag false    
Current Fiscal Year End Date --06-30    
Entity a Well-known Seasoned Issuer No    
Entity a Voluntary Filer No    
Entity's Current Reporting Status Yes    
Entity Filer Category Smaller Reporting Company    
Entity Public Float     $ 0
Entity Common Stock, Shares Outstanding   376,275,500  
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2018    
XML 22 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Balance Sheets - USD ($)
Jun. 30, 2018
Jun. 30, 2017
CURRENT ASSETS    
Cash and cash equivalents $ 3,531,255 $ 2,312,748
Prepayments and deposits 264,941
Total current assets 3,796,196 2,312,748
NON-CURRENT ASSETS    
Investment in investee company 832,335
Investment in marketable securities 500,000
Total non-current assets 1,332,335
TOTAL ASSETS 5,128,531 2,312,748
CURRENT LIABILITIES    
Other payables and accrued liabilities 19,749 8,000
Amounts due to a related party 745
Amounts due to a director 3,922 100
Provision for income tax 5,334
Total current liabilities 29,750 8,100
TOTAL LIABILITIES 29,750 8,100
STOCKHOLDERS' EQUITY    
Preferred stock, $0.0001 par value, 200,000,000 shares authorized, None issued and outstanding
Common stock, $0.0001 par value, 1,000,000,000 shares authorized, 376,275,500 and 371,350,000 shares issued and outstanding as of June 30, 2018 and 2017 respectively 37,628 37,135
Additional paid-in capital 5,293,082 2,367,875
Accumulated other comprehensive losses (1,293)
Accumulated deficit (230,636) (100,362)
TOTAL STOCKHOLDERS' EQUITY 5,098,781 2,304,648
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 5,128,531 $ 2,312,748
XML 23 R3.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Balance Sheets (Parenthetical) - $ / shares
Jun. 30, 2018
Jun. 30, 2017
Statement of Financial Position [Abstract]    
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 200,000,000 200,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 1,000,000,000 1,000,000,000
Common stock, shares issued 376,275,500 371,350,000
Common stock, shares outstanding 376,275,500 371,350,000
XML 24 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
12 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Income Statement [Abstract]    
REVENUE $ 487,005
COST OF REVENUE (441,409)
GROSS PROFIT 45,596
REALISED GAIN ON FOREIGN EXCHANGE 1,698
UNREALISED GAIN ON FOREIGN EXCHANGE 134,392  
OTHER INCOME 3,211
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES (265,682) (75,362)
OPERATING EXPENSES (14,000)  
LOSS BEFORE INCOME TAX (94,785) (75,362)
SHARE OF RESULT OF INVESTEE COMPANY (30,155)
LOSS BEFORE INCOME TAX INCLUDING SHARE OF RESULT OF INVESTEE COMPANY (124,940)
INCOME TAXES PROVISION (5,334)
NET LOSS (130,274) (75,362)
Other comprehensive income/(loss):    
- Foreign currency translation adjustment (1,293)
TOTAL COMPREHENSIVE LOSS $ (131,567) $ (75,362)
Net loss per share- Basic and diluted $ (0.00) $ (0.00)
Weighted average number of common shares outstanding - Basic and diluted 373,017,955 80,860,137
XML 25 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Comprehensive Income / (Loss) [Member]
Accumulated Surplus / (Deficit) [Member]
Total
Balance at Jun. 30, 2016 $ 10 $ (25,000) $ (24,990)
Balance, shares at Jun. 30, 2016 100,000        
Issuance of share capital - founder's shares $ 35,000 35,000
Issuance of share capital - founder's shares, shares 350,000,000        
Share issued in private placement completed on May 03, 2017 at $0.05 per share $ 140 69,860 70,000
Share issued in private placement completed on May 03, 2017 at $0.05 per share, shares 1,400,000        
Share issued in private placement completed on June 01, 2017 at $0.10 per share $ 1,740 1,738,260 1,740,000
Share issued in private placement completed on June 01, 2017 at $0.10 per share, shares 17,400,000        
Share issued in private placement completed on June 28, 2017 at $0.20 per share $ 210 419,790 420,000
Share issued in private placement completed on June 28, 2017 at $0.20 per share, shares 2,100,000        
Share issued in private placement completed on June 29, 2017 at $0.40 per share $ 35 139,965 140,000
Share issued in private placement completed on June 29, 2017 at $0.40 per share, shares 350,000        
Net loss (75,362) (75,362)
Foreign currency translation adjustment        
Balance at Jun. 30, 2017 $ 37,135 2,367,875 (100,362) 2,304,648
Balance, shares at Jun. 30, 2017 371,350,000        
Net loss (130,274) (130,274)
IPO completed on March 9, 2018 at $1.00 per share $ 293 2,925,207 2,925,500
IPO completed on March 9, 2018 at $1.00 per share, shares 2,925,500        
Share issued to Adam, Network 1 and Damon completed on April 16, 2018 at $0.0001 per share $ 200 200
Share issued to Adam, Network 1 and Damon completed on April 16, 2018 at $0.0001 per share, shares 2,000,000        
Foreign currency translation adjustment (1,293) (1,293)
Balance at Jun. 30, 2018 $ 37,628 $ 5,293,082 $ (1,293) $ (230,636) $ 5,098,781
Balance, shares at Jun. 30, 2018 376,275,500        
XML 26 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Changes in Stockholders' Equity (Parenthetical) - $ / shares
Apr. 16, 2018
Mar. 09, 2018
Jun. 29, 2017
Jun. 28, 2017
Jun. 01, 2017
May 03, 2017
Adam, Network 1 and Damon [Member]            
Shares issued price per share $ 0.0001          
Private Placement [Member]            
Shares issued price per share     $ 0.40 $ 0.20 $ 0.10 $ 0.05
IPO [Member]            
Shares issued price per share   $ 1.00        
XML 27 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statement of Cash Flows - USD ($)
12 Months Ended
Jun. 30, 2018
Jun. 30, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (130,274) $ (75,362)
Adjustments to reconcile net loss to net cash used in operating activities:    
Share of result of investee company 30,155
Changes in operating assets and liabilities:    
Prepayments and deposits (264,941) (24,900)
Other payables and accrued liabilities 11,749
Provision for income tax 5,334
Cash used in operating activities (347,977) (100,262)
Taxation refund
Taxation paid
Net cash used in operating activities (347,977) (100,262)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Investment in investee company (862,490)
Investment in financial assets (500,000)
Net cash used in investing activities (1,362,490)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Increase in share capital 493 37,125
Proceed from sale of common stock 2,925,207 2,367,875
Amount due to a related party 745 8,000
Amount due to a director 3,822
Net cash provided by financing activities 2,930,267 2,413,000
Effect of exchange rate changes on cash and cash equivalents (1,293)
Net change in cash and cash equivalents 1,218,507 2,312,738
Cash and cash equivalents, beginning of year 2,312,748 10
CASH AND CASH EQUIVALENTS, END OF YEAR 3,531,255 2,312,748
SUPPLEMENTAL CASH FLOWS INFORMATION    
Income taxes paid
Interest paid
XML 28 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization and Business Background
12 Months Ended
Jun. 30, 2018
Accounting Policies [Abstract]  
Organization and Business Background

1. ORGANIZATION AND BUSINESS BACKGROUND

 

Agape ATP Corporation, a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on June 1, 2016.

 

Agape ATP Corporation operates through its wholly owned subsidiary, Agape ATP Corporation, a Company organized in Labuan, Malaysia.

 

Agape ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with 100% equity interest in Agape ATP International Holding Limited, a company incorporated in Hong Kong.

 

The Company and its subsidiaries are engaged in providing services in the Health and Wellness Industry. The principal activity of the Company and its subsidiaries is to supply high-quality health and wellness products, including supplement to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system in our body.

 

The Company, through its subsidiaries, mainly supplies high quality beauty products. Details of the Company’s subsidiaries and associates:

 

   

Subsidiary company

name

 

Place and date of

incorporation

  Particulars of issued capital   Principal activities  

Proportional of ownership

interest and

voting power

held

 
1.   Agape ATP Corporation   Labuan,
March 6, 2017
 

1 share of ordinary share of

US$1 each

  Investment holding     100 %
                         
2.   Agape ATP International Holding Limited   Hong Kong,
June 1, 2017
 

1 share of ordinary share of

HK$1 each

  Health and wellness products and health solution advisory services     100 %

 

   

Associate company

name

  Place and date of incorporation   Particulars of issued capital   Principal activities  

Proportional of ownership interest and voting power

held

 
1.   Unreserved Sdn Bhd  

Malaysia,

August 25, 2008

  500,000 shares of ordinary share of RM7 each   Magazines publication and advertising     20 %
                         

 

  (1) Based on the contractual arrangements between the Company and other investors, the Company has the power to direct the relevant activities of these entities unilaterally, and hence the Company has control over these entities.

  

Business Overview

 

Agape ATP Corporation is a company which plans to develop and provide health solution advisory services to our future clients. We will, at least initially, primarily focus our efforts on attracting customers in Malaysia. Our advisory services will center on the “ATP Zeta Health Program”, which is a health program designed to assist in the elimination of various diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles. The program aims to promote improved health and longevity in our clients through a combination of modern medicine, proper nutrition and advice from skilled dieticians.

 

At its core, the ATP Zeta Super Health Program is focused upon biological energy, Adenosine Triphosphate (ATP), at the cellular level. The stimulation of ATP production at the cellular level can increase the metabolism and service to promote and maintain normal and healthy functioning of the body’s systems. Our program emphasizes nutrient absorption through the membrane ion channel to provide complete and balanced nutrients to improve cell health. Thus, ATP Zeta Super Health Program provides ionized and high zeta potential (high bioavailability) nutrients to enhance the absorption at the cellular level.

 

The ATP Zeta Super Health Program consists of ten products. None of these products are owned or produced by Agape ATP Corporation, nor do we have any agreements or arrangements with the third-party manufacturers of these products. In the event that any of these products are no longer produced, or are otherwise unavailable, we may have to devote significant effort to identifying and obtaining comparable replacement products. We will also evaluate adding additional products to the ATP Zeta Super Health Program as operations continue, but we have no plans to do so at present.

 

We plan to acquire products from third party manufacturers located in Australia, the United States, Germany and Malaysia. We do not have any existing contracts or agreements with any third party manufacturers. All products are acquired from unrelated third parties and rebranded by the Company. The Company plans to market and sell all products in Malaysia, and due to the contents and combination of the main ingredients in the products they are categorized as health food rather than medicines or drugs. As such, all products require authorization from the Food and Quality Division of Ministry of Health according to the Food Act of 1983 and Food Regulation 1985 in order to be sold in Malaysia. All of the products in the ATP Zeta Super Health Program have obtained the appropriate authorizations. Our health solution advisory services are mainly based on combining these ten products in order to eliminate the clients’ diseases. The combination of these ten products may vary based upon the disease(s) of each client.

 

Our salespeople, who we have yet to hire, will meet with prospective clients at their homes, public locations, or at office space which has not yet been obtained. Our salespeople will evaluate the condition of clients and based upon their health issues, will recommend a combination of the ten products that comprise the ATP Zeta Super Health Program. Agape ATP Corporation will purchase the products that make up the ATP Zeta Super Health Program from their manufacturers and will then directly sell these products to our future clients based upon their health conditions. Exact pricing for these advisory services have not been determined at this point in time, but will be based upon the cost of acquiring inventory. At present, we do not have storage space for any acquired inventory.

XML 29 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies
12 Months Ended
Jun. 30, 2018
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

The accompanying consolidated financial statements reflect the application of certain significant accounting policies as described in this note and elsewhere in the accompanying consolidated financial statements and notes.

 

Basis of presentation

 

These accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).

 

Basis of consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its subsidiaries in which the Company is the primary beneficiary. All inter-company accounts and transactions have been eliminated upon consolidation.

 

Use of estimates

 

In preparing these consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets, and revenues and expenses during the periods reported. Actual results may differ from these estimates.

 

Cash and cash equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of six months or less as of the purchase date of such investments.

 

Investment in investee company

 

The Company evaluates investment in investee company as it holds an equity interest based on the amount of control it exercises over the operations of the investee, exposure to losses in excess of its investment, the ability to significantly influence the investee and whether the Company is the primary beneficiary of the investee.

 

Investment in marketable securities

 

Marketable securities included in marketable securities (current) and other investments (non-current) are stated at the lower of cost or market in the aggregate. Other marketable securities included in marketable securities (current) are stated at the lower of cost or market in the aggregate and investments other than marketable equity securities in other investments (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary.
Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.

 

Revenue recognition

 

In accordance with ASC Topic 605, “Revenue Recognition”, the Company recognizes revenue from sales of goods when the following four revenue criteria are met: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) selling price is fixed or determinable; and (4) collectability is reasonably assured.

 

Revenue from trading of retail goods is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded. Based on limited operating history, management estimates that there was no sale return for the period reported.

 

The Company mainly derives its revenue from the sale of healthy food products. Generally, the Company recognizes revenue when products are sold and accepted by the customers and there are no continuing obligations to the customer.

  

Cost of revenue

 

Cost of revenue includes the purchase cost of retail goods for re-sale to customers and packing materials (such as boxes). It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.

 

Selling and distribution expenses

 

Selling and distribution expenses are primarily comprised of travelling and accommodation, transportation fees such as petrol, toll and parking.

 

Income taxes

 

The provision of income taxes is determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

 

The Company conducts much of its businesses activities in Hong Kong and is subject to tax in this jurisdiction. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.

 

Net loss per share

 

The Company calculates net loss per share in accordance with ASC Topic 260 “Earnings per share”. Basic loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.

 

Foreign currencies translation

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income

 

The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. In addition, the Company’s subsidiaries in Labuan and Hong Kong maintains their books and record in United States Dollars (“US$”), Hong Kong Dollars (“HK$”) and Malaysian Ringgit (“MYR”) respectively, which is functional currency as being the primary currency of the economic environment in which the entity operates.

 

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity.

 

Translation of amounts from MYR into US$1 have been made at the following exchange rates for the respective periods:

 

    As of and for the year ended June 30,  
    2018     2017  
             
Period-end MYR : US$1 exchange rate     4.03       4.38  
Period-average MYR : US$1 exchange rate     4.21       4.43  

 

Related parties

 

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

 

Fair value of financial instruments:

 

The carrying value of the Company’s financial instruments: cash and cash equivalents, subscription receivables, prepayment and deposits, accounts payable, and other payables and accrued liabilities approximate at their fair values because of the short-term nature of these financial instruments.

 

The Company also follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

 

  Level 1: Observable inputs such as quoted prices in active markets;
   
  Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
   
  Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

 

Fair value estimates are made at a specific point in time based on relevant market information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates.

 

Recent accounting pronouncements

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:

 

In May 2014, the FASB issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”). ASU 2014-09 supersedes the revenue recognition requirements in “Revenue Recognition (Topic 605)”, and requires entities to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is not permitted. In August 2015, the FASB issued an Accounting Standards Update to defer by one year the effective dates of its new revenue recognition standard until annual reporting periods beginning after December 15, 2017 (2018 for calendar-year public entities) and interim periods therein. Management is currently assessing the impact of the adoption of ASU 2014-09 and has not determined the effect of the standard on our ongoing financial reporting.

 

In February 2016, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842). Under the new guidance, lessees will be required recognize the following for all leases (with the exception of short-term leases) at the commencement date: 1) A lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and 2) A right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. The new lease guidance simplified the accounting for sale and leaseback transactions primarily because lessees must recognize lease assets and lease liabilities. Lessees will no longer be provided with a source of off-balance sheet financing. The amendments in this ASU are effective for fiscal years beginning after December 15, 2019, including interim periods within those years. The Company is evaluating this ASU and has not determined the effect of this standard on its ongoing financial reporting.

 

In September 2017, the FASB has issued ASU No. 2017-13, Revenue Recognition (Topic 605), Revenue from Contracts with Customers (Topic 606), Leases (Topic 840), and Leases (Topic 842): Amendments to SEC Paragraphs Pursuant to the Staff Announcement at the July 20, 2017 EITF Meeting and Rescission of Prior SEC Staff Announcements and Observer Comments.” The amendments in ASU No. 2017-13 amends the early adoption date option for certain companies related to the adoption of ASU No. 2014-09 and ASU No. 2016-02. Both of the below entities may still adopt using the public company adoption guidance in the related ASUs, as amended. The effective date is the same as the effective date and transition requirements for the amendments for ASU 2014-09 and ASU 2016-02.

 

In January 2017, the FASB issued ASU No. 2017-01 , “Business Combinations (Topic 805): Clarifying the Definition of a Business”, which clarifies the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. This amendment was effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. The adoption of ASU No. 2017-01 did not have a material impact on the Company’s financial position, results of operations and liquidity.

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.

XML 30 R10.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders’ Equity
12 Months Ended
Jun. 30, 2018
Equity [Abstract]  
Stockholders' Equity

3. STOCKHOLDERS’ EQUITY

 

On June 1, 2016, the founder of the Company, Mr. How Kok Choong purchased 100,000 shares of restricted common stock of the Company at a par value of $0.0001 per share for the Company’s initial working capital.

 

On April 10, 2017, the Company issued 245,000,000 and 70,000,000 shares of restricted common stock to How Kok Choong and HKC Holdings Sdn Bhd respectively, each with a par value of $0.0001 per share, for total additional working capital of $31,500.

 

On April 13, 2017, the Company issued 17,500,000 shares of restricted common stock to Greenpro Asia Strategic Fund SPC, with a par value of $0.0001 per share, for additional working capital of $1,750.

 

On April 14, 2017, the Company issued 17,500,000 shares of restricted common stock to Greenpro Venture Capital Limited, with a par value of $0.0001 per share, for additional working capital of $1,750.

 

On May 3, 2017, the Company sold shares to 2 shareholders, of whom reside in Malaysia. A total of 1,400,000 shares of restricted common stock were sold at a price of $0.05 per share. The total proceeds to the Company amounted to a total of $70,000.

 

In between May 8, 2017 and May 25, 2017, the Company sold shares to 67 shareholders, of whom reside in Malaysia. A total of 17,400,000 shares of restricted common stock were sold at a price of $0.1 per share. The total proceeds to the Company amounted to a total of $1,740,000.

 

In between June 6, 2017 and June 23, 2017, the Company sold shares to 19 shareholders, of whom reside in Malaysia. A total of 2,100,000 shares of restricted common stock were sold at a price of $0.2 per share. The total proceeds to the Company amounted to a total of $420,000.

 

On June 26, 2017, the Company sold shares to 7 shareholders of whom reside in Malaysia. A total of 350,000 shares of restricted common stock were sold at a price of $0.4 per share. The total proceeds to the Company amounted to a total of $140,000.

 

In between November 25, 2017 and March 31, 2018, the Company sold shares to 298 shareholders, of whom reside in Malaysia. A total of 2,925,500 shares of IPO stock were sold at a price of $1.00 per share. The total proceeds to the Company amounted to a total of $2,925,500.

 

On April 16, 2018, the Company sold shares to Adam, Network 1 and Damon, of whom reside in United States. A total of 2,000,000 of restricted common stock were sold at a price of $0.0001 per share. The total proceeds to the Company amounted to a total of $200.

 

As of June 30, 2018 and 2017, there were 376,275,500 and 371,350,000 of common stocks issued and outstanding respectively.

XML 31 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1
Cash and Cash Equivalents
12 Months Ended
Jun. 30, 2018
Cash and Cash Equivalents [Abstract]  
Cash and Cash Equivalents

4. CASH AND CASH EQUIVALENTS

 

As at June 30, 2018, the Company recorded $3,531,255 of cash and cash equivalents which consists $1,046,706 of cash on hand and $2,484,549 of time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of six months or less as of the purchase date of such investments. The effective interest rate for the time deposits is 2.95% per annum.

XML 32 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
Prepayments and Deposits
12 Months Ended
Jun. 30, 2018
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Prepayments and Deposits

5. PREPAYMENTS AND DEPOSITS

 

    As of June 30,     As of June 30,  
    2018     2017  
Prepaid expenses   $ 264,941     $ -  
Total prepaid expenses and deposits   $ 264,941     $ -  

XML 33 R13.htm IDEA: XBRL DOCUMENT v3.10.0.1
Investment in Investee Company
12 Months Ended
Jun. 30, 2018
Investments Schedule [Abstract]  
Investment in Investee Company

6. INVESTMENT IN INVESTEE COMPANY

 

The Company invested in Unreserved Sdn Bhd with investment amount of $862,490 (MYR3,500,000), approximated 20% of equity interest of Unreserved Sdn Bhd and is accounted for under the equity method of accounting. The investment is stated at cost plus profit share in the investee company as at June 30, 2018. Unreserved Sdn Bhd is incorporated in Malaysia with 2,500,000 ordinary shares authorized, issued and outstanding. Mr Lim Hun Soon @ David Lim, Ms Aniza Helina Akmi Karim, and Mr How Kok Choong are the directors of Unreserved Sdn Bhd. Mr How Kok Choong is the common director of Unreserved Sdn Bhd and the Company.

 

    As of June 30,     As of June 30,  
    2018     2017  
Cost of investment     862,490       -  
Less: impairment loss     -       -  
Less: share of result of investee company     (30,155 )     -  
Investment in investee company   $ 832,335     $ -  

XML 34 R14.htm IDEA: XBRL DOCUMENT v3.10.0.1
Investment in Marketable Securities
12 Months Ended
Jun. 30, 2018
Investments, Debt and Equity Securities [Abstract]  
Investment in Marketable Securities

7. INVESTMENT IN MARKETABLE SECURITIES

 

At May 17, 2018, the Company had an investment in Greenpro Capital Corp. of $500,000. The Company purchased the shares of Greenpro Capital Corp. at a price of $6 per share.

XML 35 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1
Other Payables and Accrued Liabilities
12 Months Ended
Jun. 30, 2018
Other Liabilities Disclosure [Abstract]  
Other Payables and Accrued Liabilities

8. OTHER PAYABLES AND ACCRUED LIABILITIES

 

    As of June 30,     As of June 30,  
    2018     2017  
Accrued audit fees     19,000       8,000  
Accrued professional fees     749       -  
Total payables and accrued liabilities   $ 19,749     $ -  

XML 36 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
Related Party Transaction
12 Months Ended
Jun. 30, 2018
Related Party Transactions [Abstract]  
Related Party Transaction

9. RELATED PARTY TRANSACTION

 

As at June 30, 2018, the Company owed an amount of $745 to a related party, Agape Superior Living Sdn Bhd. Mr How Kok Choong is the director of Agape Superior Living Sdn Bhd. Hence, Mr How Kok Choong is the common director of Agape Superior Living Sdn Bhd and the Company.

 

Greenpro Capital Corp., through its wholly owned subsidiaries (collectively “Greenpro”), is a 4.7% shareholder in the Company, and provides services to the Company. Greenpro Venture Capital Limited is owned by Greenpro Capital Corp. The controlling shareholders of Greenpro Capital Corp. are Mr. Lee Chong Kuang and Mr. Loke Che Chan. During the year ended June 30, 2018 and period ended June 30, 2017, the Company incurred incorporation fees of $1,419 and professional fees of $214,000. Mr.How Kok Choong is the director of Greenpro Capital Corp. Hence, Mr. How Kok Choong is the common director of Greenpro Capital Corp. and the Company.

 

For the year ended June 30, 2018, the Company earned revenue of $487,005 from its only customer, Agape S.E.A. Sdn Bhd. Mr. How Kok Choong is the director of Agape S.E.A. Sdn Bhd. Hence, Mr. How Kok Choong is the common director of Agape S.E.A. Sdn Bhd and the Company.

 

At May 17, 2018, the Company had an investment in Greenpro Capital Corp. of $500,000. The Company purchased the shares of Greenpro Capital Corp. at a price of $6 per share.

XML 37 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1
Amount Due to a Director
12 Months Ended
Jun. 30, 2018
Related Party Transactions [Abstract]  
Amount Due to a Director

10. AMOUNT DUE TO A DIRECTOR

 

As of June 30, 2018, a director of the Company advanced $3,922 to the Company, which is unsecured, interest-free with no fixed repayment term, for working capital purpose. Imputed interest is considered insignificant.

XML 38 R18.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes
12 Months Ended
Jun. 30, 2018
Income Tax Disclosure [Abstract]  
Income Taxes

11. INCOME TAXES

 

For the year ended June 30, 2018 and year ended June 30, 2017, the local (United States) and foreign components of loss before income taxes were comprised of the following:

 

    For the year ended
June 30, 2018
    For the year ended
June 30, 2017
 
             
Tax jurisdictions from:                
- Local   $ (261,918 )   $ (75,200 )
- Foreign, representing                
Labuan     134,806       (162 )
Hong Kong     2,172       -  
Loss before income tax   $ (124,940 )   $ (75,362 )

 

The provision for income taxes consisted of the following:

 

    For the year ended
June 30, 2018
    For the year ended
June 30, 2017
 
             
Current:                
- Local   $ -     $ -  
- Foreign     5,334       -  
                 
Deferred:                
- Local     -       -  
- Foreign     -       -  
                 
Income tax expense   $ 5,334     $ -  

 

The effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rates. The Company and its subsidiary that operate in various countries: United States, Labuan and Hong Kong that are subject to taxes in the jurisdictions in which they operate, as follows:

 

United States of America

 

Agape ATP Corporation is registered in the State of Nevada and is subject to the tax laws of the United States of America. As of June 30, 2018, the operations in the United States of America incurred $362,118 of cumulative net operating losses which can be carried forward to offset future taxable income. The net operating loss carry forwards begin to expire in 2038, if unutilized. The tax valuation allowance for June 30, 2018 and June 30, 2017 are $76,045 and $35,070 respectively.

 

Labuan

 

Under the current laws of the Labuan, Agape ATP Corporation is governed under the Labuan Business Activity Act, 1990. The tax charge for such company is based on 3% of net audited profit or at a fixed rate of RM20,000.

 

Hong Kong

 

Agape ATP International Holding (HK) Limited is subject to Hong Kong Profits Tax, which is charged at the statutory income rate of 16.5% on its assessable income. The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of June 30, 2018 and June 30, 2017:

 

The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of June 30, 2018 and 2017:

 

    For the year ended
June 30, 2018
    For the year ended
June 30, 2017
 
             
Deferred tax assets:                
Net operating loss carry forwards                
-United States of America     76,045       35,070  
-Hong Kong     -       -  
Less: valuation allowance     (76,045 )     (35,070 )
Deferred tax asset     -       -  

XML 39 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1
Concentrations of Risks
12 Months Ended
Jun. 30, 2018
Risks and Uncertainties [Abstract]  
Concentrations of Risks

12. CONCENTRATIONS OF RISKS

 

(a) Major customers

 

For the year ended June 30, 2018, the customers who accounted for 10% or more of the Company’s revenues and its account receivables balance at year-end are presented as follows:

 

    For the year ended June 30, 2018    

As of

June 30, 2018

 
    Revenue     Percentage of revenue    

Accounts

receivable

 
                   
Customer A   $ 487,005       100 %   $            -  
Total:   $ 487,005       100 %   $ -  

 

For the year ended June 30, 2017, there was no customer who accounted for 10% or more of the Company’s revenues with no account receivables balance at year end.

 

(b) Major vendors

 

For the year ended June 30, 2018, the vendors who accounted for 10% or more of the Company’s purchases and its account payables balance at year-end are presented as follows:

 

    For the year ended June 30, 2018    

As of

June 30, 2018

 
    Purchases     Percentage of purchases     Accounts payable  
                   
Vendor A     441,409       100 %                -  
Total:   $ 441,409       100 %   $ -  

 

For the year ended June 30, 2017, there was no vendor who accounted for 10% or more of the Company’s purchases with no account payables balance at year end.

 

(c) Credit risk

 

Financial instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration of credit risk in its trade receivables is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.

 

(d) Exchange rate risk

 

The Company cannot guarantee that the current exchange rate will remain steady; therefore, there is a possibility that the Company could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower profit depending on exchange rate of RM$ converted to US$ on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.

XML 40 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1
Subsequent Events
12 Months Ended
Jun. 30, 2018
Subsequent Events [Abstract]  
Subsequent Events

13. SUBSEQUENT EVENTS

 

In accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred after June 30, 2018 up through the date the Company issued the audited consolidated financial statements. During this period, there was no subsequent event that required recognition or disclosure.

XML 41 R21.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies (Policies)
12 Months Ended
Jun. 30, 2018
Accounting Policies [Abstract]  
Basis of Presentation

Basis of presentation

 

These accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”).

Basis of Consolidation

Basis of consolidation

 

The condensed consolidated financial statements include the accounts of the Company and its subsidiaries in which the Company is the primary beneficiary. All inter-company accounts and transactions have been eliminated upon consolidation.

Use of Estimates

Use of estimates

 

In preparing these consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets, and revenues and expenses during the periods reported. Actual results may differ from these estimates.

Cash and Cash Equivalents

Cash and cash equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of six months or less as of the purchase date of such investments.

Investment in Investee Company

Investment in investee company

 

The Company evaluates investment in investee company as it holds an equity interest based on the amount of control it exercises over the operations of the investee, exposure to losses in excess of its investment, the ability to significantly influence the investee and whether the Company is the primary beneficiary of the investee.

Investment in Marketable Securities

Investment in marketable securities

 

Marketable securities included in marketable securities (current) and other investments (non-current) are stated at the lower of cost or market in the aggregate. Other marketable securities included in marketable securities (current) are stated at the lower of cost or market in the aggregate and investments other than marketable equity securities in other investments (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary.
Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.

Revenue Recognition

Revenue recognition

 

In accordance with ASC Topic 605, “Revenue Recognition”, the Company recognizes revenue from sales of goods when the following four revenue criteria are met: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) selling price is fixed or determinable; and (4) collectability is reasonably assured.

 

Revenue from trading of retail goods is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded. Based on limited operating history, management estimates that there was no sale return for the period reported.

 

The Company mainly derives its revenue from the sale of healthy food products. Generally, the Company recognizes revenue when products are sold and accepted by the customers and there are no continuing obligations to the customer.

Cost of Revenue

Cost of revenue

 

Cost of revenue includes the purchase cost of retail goods for re-sale to customers and packing materials (such as boxes). It excludes purchasing and receiving costs, inspection costs, warehousing costs, internal transfer costs and other costs of distribution network in cost of revenues.

Selling and Distribution Expenses

Selling and distribution expenses

 

Selling and distribution expenses are primarily comprised of travelling and accommodation, transportation fees such as petrol, toll and parking.

Income Taxes

Income taxes

 

The provision of income taxes is determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC 740”). Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted income tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

 

ASC 740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their financial statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized in the financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. Such tax positions must initially and subsequently be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts.

 

The Company conducts much of its businesses activities in Hong Kong and is subject to tax in this jurisdiction. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.

Net Loss Per Share

Net loss per share

 

The Company calculates net loss per share in accordance with ASC Topic 260 “Earnings per share”. Basic loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common stock equivalents had been issued and if the additional common shares were dilutive.

Foreign Currencies Translation

Foreign currencies translation

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Condensed Consolidated Statements of Operations and Comprehensive Income

 

The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. In addition, the Company’s subsidiaries in Labuan and Hong Kong maintains their books and record in United States Dollars (“US$”), Hong Kong Dollars (“HK$”) and Malaysian Ringgit (“MYR”) respectively, which is functional currency as being the primary currency of the economic environment in which the entity operates.

 

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity.

 

Translation of amounts from MYR into US$1 have been made at the following exchange rates for the respective periods:

 

    As of and for the year ended June 30,  
    2018     2017  
             
Period-end MYR : US$1 exchange rate     4.03       4.38  
Period-average MYR : US$1 exchange rate     4.21       4.43  

Related Parties

Related parties

 

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

Fair Value of Financial Instruments

Fair value of financial instruments:

 

The carrying value of the Company’s financial instruments: cash and cash equivalents, subscription receivables, prepayment and deposits, accounts payable, and other payables and accrued liabilities approximate at their fair values because of the short-term nature of these financial instruments.

  

The Company also follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”), with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value hierarchy that prioritizes the inputs used in measuring fair value as follows:

 

  Level 1: Observable inputs such as quoted prices in active markets;
   
  Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
   
  Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

 

Fair value estimates are made at a specific point in time based on relevant market information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates.

Recent Accounting Pronouncements

Recent accounting pronouncements

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:

 

In May 2014, the FASB issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”). ASU 2014-09 supersedes the revenue recognition requirements in “Revenue Recognition (Topic 605)”, and requires entities to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early adoption is not permitted. In August 2015, the FASB issued an Accounting Standards Update to defer by one year the effective dates of its new revenue recognition standard until annual reporting periods beginning after December 15, 2017 (2018 for calendar-year public entities) and interim periods therein. Management is currently assessing the impact of the adoption of ASU 2014-09 and has not determined the effect of the standard on our ongoing financial reporting.

 

In February 2016, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842). Under the new guidance, lessees will be required recognize the following for all leases (with the exception of short-term leases) at the commencement date: 1) A lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and 2) A right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. The new lease guidance simplified the accounting for sale and leaseback transactions primarily because lessees must recognize lease assets and lease liabilities. Lessees will no longer be provided with a source of off-balance sheet financing. The amendments in this ASU are effective for fiscal years beginning after December 15, 2019, including interim periods within those years. The Company is evaluating this ASU and has not determined the effect of this standard on its ongoing financial reporting.

 

In September 2017, the FASB has issued ASU No. 2017-13, Revenue Recognition (Topic 605), Revenue from Contracts with Customers (Topic 606), Leases (Topic 840), and Leases (Topic 842): Amendments to SEC Paragraphs Pursuant to the Staff Announcement at the July 20, 2017 EITF Meeting and Rescission of Prior SEC Staff Announcements and Observer Comments.” The amendments in ASU No. 2017-13 amends the early adoption date option for certain companies related to the adoption of ASU No. 2014-09 and ASU No. 2016-02. Both of the below entities may still adopt using the public company adoption guidance in the related ASUs, as amended. The effective date is the same as the effective date and transition requirements for the amendments for ASU 2014-09 and ASU 2016-02.

 

In January 2017, the FASB issued ASU No. 2017-01 , “Business Combinations (Topic 805): Clarifying the Definition of a Business”, which clarifies the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. This amendment was effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. The adoption of ASU No. 2017-01 did not have a material impact on the Company’s financial position, results of operations and liquidity.

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.

XML 42 R22.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization and Business Background (Tables)
12 Months Ended
Jun. 30, 2018
Accounting Policies [Abstract]  
Schedule of Subsidiaries and Associates

Details of the Company’s subsidiaries and associates:

 

   

Subsidiary company

name

 

Place and date of

incorporation

  Particulars of issued capital   Principal activities  

Proportional of ownership

interest and

voting power

held

 
1.   Agape ATP Corporation   Labuan,
March 6, 2017
 

1 share of ordinary share of

US$1 each

  Investment holding     100 %
                         
2.   Agape ATP International Holding Limited   Hong Kong,
June 1, 2017
 

1 share of ordinary share of

HK$1 each

  Health and wellness products and health solution advisory services     100 %

 

   

Associate company

name

  Place and date of incorporation   Particulars of issued capital   Principal activities  

Proportional of ownership interest and voting power

held

 
1.   Unreserved Sdn Bhd  

Malaysia,

August 25, 2008

  500,000 shares of ordinary share of RM7 each   Magazines publication and advertising     20 %
                         

XML 43 R23.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Jun. 30, 2018
Accounting Policies [Abstract]  
Schedule of Translation Exchange Rates

Translation of amounts from MYR into US$1 have been made at the following exchange rates for the respective periods:

 

    As of and for the year ended June 30,  
    2018     2017  
             
Period-end MYR : US$1 exchange rate     4.03       4.38  
Period-average MYR : US$1 exchange rate     4.21       4.43  

XML 44 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1
Prepayments and Deposits (Tables)
12 Months Ended
Jun. 30, 2018
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Schedule of Prepaid Expenses and Deposits

    As of June 30,     As of June 30,  
    2018     2017  
Prepaid expenses   $ 264,941     $ -  
Total prepaid expenses and deposits   $ 264,941     $ -  

XML 45 R25.htm IDEA: XBRL DOCUMENT v3.10.0.1
Investment in Investee Company (Tables)
12 Months Ended
Jun. 30, 2018
Investments Schedule [Abstract]  
Schedule of Investments

    As of June 30,     As of June 30,  
    2018     2017  
Cost of investment     862,490       -  
Less: impairment loss     -       -  
Less: share of result of investee company     (30,155 )     -  
Investment in investee company   $ 832,335     $ -  

XML 46 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1
Other Payables and Accrued Liabilities (Tables)
12 Months Ended
Jun. 30, 2018
Other Liabilities Disclosure [Abstract]  
Schedule of Other Payables and Accrued Liabilities

    As of June 30,     As of June 30,  
    2018     2017  
Accrued audit fees     19,000       8,000  
Accrued professional fees     749       -  
Total payables and accrued liabilities   $ 19,749     $ -  

XML 47 R27.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes (Tables)
12 Months Ended
Jun. 30, 2018
Income Tax Disclosure [Abstract]  
Schedule of Components of Income/(Loss) Before Income Tax

For the year ended June 30, 2018 and year ended June 30, 2017, the local (United States) and foreign components of loss before income taxes were comprised of the following:

 

    For the year ended
June 30, 2018
    For the year ended
June 30, 2017
 
             
Tax jurisdictions from:                
- Local   $ (261,918 )   $ (75,200 )
- Foreign, representing                
Labuan     134,806       (162 )
Hong Kong     2,172       -  
Loss before income tax   $ (124,940 )   $ (75,362 )

Schedule of Provision for Income Tax

The provision for income taxes consisted of the following:

 

    For the year ended
June 30, 2018
    For the year ended
June 30, 2017
 
             
Current:                
- Local   $ -     $ -  
- Foreign     5,334       -  
                 
Deferred:                
- Local     -       -  
- Foreign     -       -  
                 
Income tax expense   $ 5,334     $ -  

Schedule of Deferred Tax Assets

The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of June 30, 2018 and 2017:

 

    For the year ended
June 30, 2018
    For the year ended
June 30, 2017
 
             
Deferred tax assets:                
Net operating loss carry forwards                
-United States of America     76,045       35,070  
-Hong Kong     -       -  
Less: valuation allowance     (76,045 )     (35,070 )
Deferred tax asset     -       -  

XML 48 R28.htm IDEA: XBRL DOCUMENT v3.10.0.1
Concentrations of Risks (Tables)
12 Months Ended
Jun. 30, 2018
Risks and Uncertainties [Abstract]  
Schedule of Concentrations of Risks

(a) Major customers

 

For the year ended June 30, 2018, the customers who accounted for 10% or more of the Company’s revenues and its account receivables balance at year-end are presented as follows:

 

    For the year ended June 30, 2018    

As of

June 30, 2018

 
    Revenue     Percentage of revenue    

Accounts

receivable

 
                   
Customer A   $ 487,005       100 %   $            -  
Total:   $ 487,005       100 %   $ -  

 

For the year ended June 30, 2017, there was no customer who accounted for 10% or more of the Company’s revenues with no account receivables balance at year end.

 

(b) Major vendors

 

For the year ended June 30, 2018, the vendors who accounted for 10% or more of the Company’s purchases and its account payables balance at year-end are presented as follows:

 

    For the year ended June 30, 2018    

As of

June 30, 2018

 
    Purchases     Percentage of purchases     Accounts payable  
                   
Vendor A     441,409       100 %                -  
Total:   $ 441,409       100 %   $ -  

 

For the year ended June 30, 2017, there was no vendor who accounted for 10% or more of the Company’s purchases with no account payables balance at year end.

XML 49 R29.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization and Business Background (Details Narrative)
Jun. 30, 2018
Ownership percentage 4.70%
Agape ATP International Holding Limited [Member]  
Ownership percentage 100.00%
XML 50 R30.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization and Business Background - Schedule of Subsidiaries and Associates (Details)
12 Months Ended
Jun. 30, 2018
Proportional of ownership interest and voting power held 4.70%
Subsidiary Company [Member]  
Company name Agape ATP Corporation
Place and date of incorporation Labuan, March 6, 2017
Particulars of issued capital 1 share of ordinary share of US$1 each
Principal activities Investment holding
Proportional of ownership interest and voting power held 100.00%
Subsidiary Company One [Member]  
Company name Agape ATP International Holding Limited
Place and date of incorporation Hong Kong, June 1, 2017
Particulars of issued capital 1 share of ordinary share of HK$1 each
Principal activities Health and wellness products and health solution advisory services
Proportional of ownership interest and voting power held 100.00%
Associate Company [Member] | Unreserved Sdn Bhd [Member]  
Company name Unreserved Sdn Bhd
Place and date of incorporation Malaysia, August 25, 2008
Particulars of issued capital 500,000 shares of ordinary share of RM7 each
Principal activities Magazines publication and advertising
Proportional of ownership interest and voting power held 20.00%
XML 51 R31.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies - Schedule of Translation Exchange Rates (Details) - MYR [Member]
Jun. 30, 2018
Jun. 30, 2017
Period-end MYR : US$1 exchange rate 4.03 4.38
Period-average MYR : US$1 exchange rate 4.21 4.43
XML 52 R32.htm IDEA: XBRL DOCUMENT v3.10.0.1
Summary of Significant Accounting Policies - Schedule of Translation Exchange Rates (Details) (Parenthetical) - USD ($)
12 Months Ended
Jun. 30, 2018
Jun. 30, 2017
MYR [Member]    
Exchange rate $ 1 $ 1
XML 53 R33.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders’ Equity (Details Narrative)
1 Months Ended 4 Months Ended 12 Months Ended
Apr. 16, 2018
USD ($)
$ / shares
shares
Jun. 26, 2017
USD ($)
Integer
$ / shares
shares
May 03, 2017
USD ($)
Integer
$ / shares
shares
Apr. 14, 2017
USD ($)
$ / shares
shares
Apr. 13, 2017
USD ($)
$ / shares
shares
Apr. 10, 2017
USD ($)
$ / shares
shares
Jun. 01, 2016
$ / shares
shares
Jun. 23, 2017
USD ($)
Integer
$ / shares
shares
May 25, 2017
USD ($)
Integer
$ / shares
shares
Mar. 31, 2018
USD ($)
Integer
$ / shares
shares
Jun. 30, 2018
USD ($)
$ / shares
shares
Jun. 30, 2017
USD ($)
$ / shares
shares
Common stock par value | $ / shares                     $ 0.0001 $ 0.0001
Proceeds from issuance of common stock | $                     $ 2,925,207 $ 2,367,875
Common stock issued                     376,275,500 371,350,000
Common stock outstanding                     376,275,500 371,350,000
Malaysia [Member]                        
Number of shareholders | Integer   7 2         19 67      
Number of restricted common stock shares sold   350,000 1,400,000         2,100,000 17,400,000      
Sale of stock price per share | $ / shares   $ 0.4 $ 0.05         $ 0.2 $ 0.1      
Proceeds from issuance of common stock | $   $ 140,000 $ 70,000         $ 420,000 $ 1,740,000      
Malaysia [Member] | IPO [Member]                        
Number of shareholders | Integer                   298    
Number of restricted common stock shares sold                   2,925,500    
Sale of stock price per share | $ / shares                   $ 1.00    
Proceeds from issuance of common stock | $                   $ 2,925,500    
Greenpro Venture Capital Limited [Member]                        
Number of restricted common stock shares issued, shares       17,500,000                
Common stock par value | $ / shares       $ 0.0001                
Working capital | $       $ 1,750                
Greenpro Asia Strategic Fund SPC [Member]                        
Number of restricted common stock shares issued, shares         17,500,000              
Common stock par value | $ / shares         $ 0.0001              
Working capital | $         $ 1,750              
Adam, Network 1 and Damon [Member] | United States [Member]                        
Number of restricted common stock shares sold 2,000,000                      
Sale of stock price per share | $ / shares $ 0.0001                      
Proceeds from issuance of common stock | $ $ 200                      
HKC Holdings Sdn Bhd [Member]                        
Number of restricted common stock shares issued, shares           70,000,000            
Common stock par value | $ / shares           $ 0.0001            
Working capital | $           $ 31,500            
Mr. How Kok Choong [Member]                        
Number of restricted common stock shares issued, shares           245,000,000 100,000          
Common stock par value | $ / shares           $ 0.0001 $ 0.0001          
Working capital | $           $ 31,500            
XML 54 R34.htm IDEA: XBRL DOCUMENT v3.10.0.1
Cash and Cash Equivalents (Details Narrative) - USD ($)
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2016
Cash and Cash Equivalents [Abstract]      
Cash and cash equivalents $ 3,531,255 $ 2,312,748 $ 10
Cash on hand 1,046,706    
Time deposits $ 2,484,549    
Interest rate 2.95%    
XML 55 R35.htm IDEA: XBRL DOCUMENT v3.10.0.1
Prepayments and Deposits - Schedule of Prepaid Expenses and Deposits (Details) - USD ($)
Jun. 30, 2018
Jun. 30, 2017
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]    
Prepaid expenses $ 264,941
Total prepaid expenses and deposits $ 264,941
XML 56 R36.htm IDEA: XBRL DOCUMENT v3.10.0.1
Investment in Investee Company (Details Narrative) - USD ($)
Jun. 30, 2018
May 17, 2018
Jun. 30, 2017
Investment amount $ 832,335 $ 500,000
Equity interest percentage 4.70%    
Ordinary shares authorized 1,000,000,000   1,000,000,000
Ordinary shares issued 376,275,500   371,350,000
Ordinary shares outstanding 376,275,500   371,350,000
Director [Member]      
Investment amount $ 862,490    
Equity interest percentage 20.00%    
Ordinary shares authorized 2,500,000    
Ordinary shares issued 2,500,000    
Ordinary shares outstanding 2,500,000    
Director [Member] | MYR [Member]      
Investment amount $ 3,500,000    
XML 57 R37.htm IDEA: XBRL DOCUMENT v3.10.0.1
Investment in Investee Company - Schedule of Investments (Details) - USD ($)
Jun. 30, 2018
May 17, 2018
Jun. 30, 2017
Investments Schedule [Abstract]      
Cost of investment $ 862,490  
Less: impairment loss  
Less: share of result of investee company (30,155)  
Investment in investee company $ 832,335 $ 500,000
XML 58 R38.htm IDEA: XBRL DOCUMENT v3.10.0.1
Investment in Marketable Securities (Details Narrative) - USD ($)
Jun. 30, 2018
May 17, 2018
Jun. 30, 2017
Investment amount $ 832,335 $ 500,000
Purchased price per shares   $ 6  
Greenpro Capital Corp. [Member]      
Investment amount   $ 500,000  
Purchased price per shares   $ 6  
XML 59 R39.htm IDEA: XBRL DOCUMENT v3.10.0.1
Other Payables and Accrued Liabilities - Schedule of Other Payables and Accrued Liabilities (Details) - USD ($)
Jun. 30, 2018
Jun. 30, 2017
Other Liabilities Disclosure [Abstract]    
Accrued audit fees $ 19,000 $ 8,000
Accrued professional fees 749
Total payables and accrued liabilities $ 19,749 $ 8,000
XML 60 R40.htm IDEA: XBRL DOCUMENT v3.10.0.1
Related Party Transaction (Details Narrative) - USD ($)
12 Months Ended
Jun. 30, 2018
Jun. 30, 2017
May 17, 2018
Related Party Transactions [Abstract]      
Amounts due to a related party $ 745  
Ownership percentage 4.70%    
Incurred incorporation fees $ 1,419 1,419  
Professional fees 214,000 214,000  
Revenue 487,005  
Investment $ 832,335 $ 500,000
Share price per share     $ 6
XML 61 R41.htm IDEA: XBRL DOCUMENT v3.10.0.1
Amount Due to a Director (Details Narrative) - USD ($)
Jun. 30, 2018
Jun. 30, 2017
Due to related party $ 3,922 $ 100
Director [Member]    
Due to related party $ 3,827  
XML 62 R42.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes (Details Narrative) - USD ($)
12 Months Ended
Jun. 30, 2018
Jun. 30, 2017
United States of America [Member]    
Cumulative net operating loss $ 362,118  
Operating loss carryforwards expire year 2038  
Valuation allowance $ 76,045 $ 35,070
Labuan [Member]    
Tax percentage 3.00%  
Labuan [Member] | MYR [Member]    
Fixed rate of foreign income tax amount $ 20,000  
Hong Kong [Member]    
Statutory income tax rate 16.50%  
XML 63 R43.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes - Schedule of Components of Income/(Loss) Before Income Tax (Details) - USD ($)
12 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Local $ (261,918) $ (75,200)
Loss before income tax (94,785) (75,362)
Labuan [Member]    
Foreign 134,806 (162)
Hong Kong [Member]    
Foreign $ 2,172
XML 64 R44.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes - Schedule of Provision for Income Tax (Details) - USD ($)
12 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Income Tax Disclosure [Abstract]    
Current, Local
Current, Foreign 5,334
Deferred, Local
Deferred, Foreign
Income tax expense $ 5,334
XML 65 R45.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes - Schedule of Deferred Tax Assets (Details) - USD ($)
Jun. 30, 2018
Jun. 30, 2017
Less: valuation allowance $ (76,045) $ (35,070)
Deferred tax asset
United States of America [Member]    
Net operating loss carryforwards 76,045 35,070
Hong Kong [Member]    
Net operating loss carryforwards
XML 66 R46.htm IDEA: XBRL DOCUMENT v3.10.0.1
Concentrations of Risks - Schedule of Concentrations of Risk (Details) - USD ($)
12 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Revenues $ 487,005
Purchase 441,409
Accounts Payable [Member]    
Accounts payable, trade  
Vendor A [Member] | Accounts Payable [Member]    
Accounts payable, trade  
Sales Revenue, Net [Member]    
Revenues $ 487,005  
Concentrations of risk percentage 100.00%  
Sales Revenue, Net [Member] | Customer A [Member]    
Revenues $ 487,005  
Concentrations of risk percentage 100.00%  
Accounts Receivable [Member]    
Accounts receivable, trade  
Accounts Receivable [Member] | Customer A [Member]    
Accounts receivable, trade  
Cost of Sales [Member]    
Concentrations of risk percentage 100.00%  
Purchase $ 441,409  
Cost of Sales [Member] | Vendor A [Member]    
Concentrations of risk percentage 100.00%  
Purchase $ 441,409  
XML 67 R47.htm IDEA: XBRL DOCUMENT v3.10.0.1
Concentrations of Risks - Schedule of Concentrations of Risk (Details) (Parenthetical)
12 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Customer [Member]    
Concentrations of risk percentage 10.00% 10.00%
Vendor [Member]    
Concentrations of risk percentage 10.00% 10.00%
EXCEL 68 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 69 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 70 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 72 FilingSummary.xml IDEA: XBRL DOCUMENT 3.10.0.1 html 93 172 1 false 32 0 false 5 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://agapeatp.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://agapeatp.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://agapeatp.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveLoss Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity Sheet http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity Consolidated Statements of Changes in Stockholders' Equity Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Parenthetical) Sheet http://agapeatp.com/role/StatementsOfChangesInStockholdersEquityParenthetical Consolidated Statements of Changes in Stockholders' Equity (Parenthetical) Statements 6 false false R7.htm 00000007 - Statement - Consolidated Statement of Cash Flows Sheet http://agapeatp.com/role/StatementOfCashFlows Consolidated Statement of Cash Flows Statements 7 false false R8.htm 00000008 - Disclosure - Organization and Business Background Sheet http://agapeatp.com/role/OrganizationAndBusinessBackground Organization and Business Background Notes 8 false false R9.htm 00000009 - Disclosure - Summary of Significant Accounting Policies Sheet http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 00000010 - Disclosure - Stockholders’ Equity Sheet http://agapeatp.com/role/StockholdersEquity Stockholders’ Equity Notes 10 false false R11.htm 00000011 - Disclosure - Cash and Cash Equivalents Sheet http://agapeatp.com/role/CashAndCashEquivalents Cash and Cash Equivalents Notes 11 false false R12.htm 00000012 - Disclosure - Prepayments and Deposits Sheet http://agapeatp.com/role/PrepaymentsAndDeposits Prepayments and Deposits Notes 12 false false R13.htm 00000013 - Disclosure - Investment in Investee Company Sheet http://agapeatp.com/role/InvestmentInInvesteeCompany Investment in Investee Company Notes 13 false false R14.htm 00000014 - Disclosure - Investment in Marketable Securities Sheet http://agapeatp.com/role/InvestmentInMarketableSecurities Investment in Marketable Securities Notes 14 false false R15.htm 00000015 - Disclosure - Other Payables and Accrued Liabilities Sheet http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities Other Payables and Accrued Liabilities Notes 15 false false R16.htm 00000016 - Disclosure - Related Party Transaction Sheet http://agapeatp.com/role/RelatedPartyTransaction Related Party Transaction Notes 16 false false R17.htm 00000017 - Disclosure - Amount Due to a Director Sheet http://agapeatp.com/role/AmountDueToDirector Amount Due to a Director Notes 17 false false R18.htm 00000018 - Disclosure - Income Taxes Sheet http://agapeatp.com/role/IncomeTaxes Income Taxes Notes 18 false false R19.htm 00000019 - Disclosure - Concentrations of Risks Sheet http://agapeatp.com/role/ConcentrationsOfRisks Concentrations of Risks Notes 19 false false R20.htm 00000020 - Disclosure - Subsequent Events Sheet http://agapeatp.com/role/SubsequentEvents Subsequent Events Notes 20 false false R21.htm 00000021 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies 21 false false R22.htm 00000022 - Disclosure - Organization and Business Background (Tables) Sheet http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables Organization and Business Background (Tables) Tables http://agapeatp.com/role/OrganizationAndBusinessBackground 22 false false R23.htm 00000023 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies 23 false false R24.htm 00000024 - Disclosure - Prepayments and Deposits (Tables) Sheet http://agapeatp.com/role/PrepaymentsAndDepositsTables Prepayments and Deposits (Tables) Tables http://agapeatp.com/role/PrepaymentsAndDeposits 24 false false R25.htm 00000025 - Disclosure - Investment in Investee Company (Tables) Sheet http://agapeatp.com/role/InvestmentInInvesteeCompanyTables Investment in Investee Company (Tables) Tables http://agapeatp.com/role/InvestmentInInvesteeCompany 25 false false R26.htm 00000026 - Disclosure - Other Payables and Accrued Liabilities (Tables) Sheet http://agapeatp.com/role/OtherPayablesAndAccruedLiabilitiesTables Other Payables and Accrued Liabilities (Tables) Tables http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities 26 false false R27.htm 00000027 - Disclosure - Income Taxes (Tables) Sheet http://agapeatp.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://agapeatp.com/role/IncomeTaxes 27 false false R28.htm 00000028 - Disclosure - Concentrations of Risks (Tables) Sheet http://agapeatp.com/role/ConcentrationsOfRisksTables Concentrations of Risks (Tables) Tables http://agapeatp.com/role/ConcentrationsOfRisks 28 false false R29.htm 00000029 - Disclosure - Organization and Business Background (Details Narrative) Sheet http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative Organization and Business Background (Details Narrative) Details http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables 29 false false R30.htm 00000030 - Disclosure - Organization and Business Background - Schedule of Subsidiaries and Associates (Details) Sheet http://agapeatp.com/role/OrganizationAndBusinessBackground-ScheduleOfSubsidiariesAndAssociatesDetails Organization and Business Background - Schedule of Subsidiaries and Associates (Details) Details 30 false false R31.htm 00000031 - Disclosure - Summary of Significant Accounting Policies - Schedule of Translation Exchange Rates (Details) Sheet http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfTranslationExchangeRatesDetails Summary of Significant Accounting Policies - Schedule of Translation Exchange Rates (Details) Details 31 false false R32.htm 00000032 - Disclosure - Summary of Significant Accounting Policies - Schedule of Translation Exchange Rates (Details) (Parenthetical) Sheet http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfTranslationExchangeRatesDetailsParenthetical Summary of Significant Accounting Policies - Schedule of Translation Exchange Rates (Details) (Parenthetical) Details 32 false false R33.htm 00000033 - Disclosure - Stockholders’ Equity (Details Narrative) Sheet http://agapeatp.com/role/StockholdersEquityDetailsNarrative Stockholders’ Equity (Details Narrative) Details http://agapeatp.com/role/StockholdersEquity 33 false false R34.htm 00000034 - Disclosure - Cash and Cash Equivalents (Details Narrative) Sheet http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative Cash and Cash Equivalents (Details Narrative) Details http://agapeatp.com/role/CashAndCashEquivalents 34 false false R35.htm 00000035 - Disclosure - Prepayments and Deposits - Schedule of Prepaid Expenses and Deposits (Details) Sheet http://agapeatp.com/role/PrepaymentsAndDeposits-ScheduleOfPrepaidExpensesAndDepositsDetails Prepayments and Deposits - Schedule of Prepaid Expenses and Deposits (Details) Details 35 false false R36.htm 00000036 - Disclosure - Investment in Investee Company (Details Narrative) Sheet http://agapeatp.com/role/InvestmentInInvesteeCompanyDetailsNarrative Investment in Investee Company (Details Narrative) Details http://agapeatp.com/role/InvestmentInInvesteeCompanyTables 36 false false R37.htm 00000037 - Disclosure - Investment in Investee Company - Schedule of Investments (Details) Sheet http://agapeatp.com/role/InvestmentInInvesteeCompany-ScheduleOfInvestmentsDetails Investment in Investee Company - Schedule of Investments (Details) Details 37 false false R38.htm 00000038 - Disclosure - Investment in Marketable Securities (Details Narrative) Sheet http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative Investment in Marketable Securities (Details Narrative) Details http://agapeatp.com/role/InvestmentInMarketableSecurities 38 false false R39.htm 00000039 - Disclosure - Other Payables and Accrued Liabilities - Schedule of Other Payables and Accrued Liabilities (Details) Sheet http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities-ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails Other Payables and Accrued Liabilities - Schedule of Other Payables and Accrued Liabilities (Details) Details 39 false false R40.htm 00000040 - Disclosure - Related Party Transaction (Details Narrative) Sheet http://agapeatp.com/role/RelatedPartyTransactionDetailsNarrative Related Party Transaction (Details Narrative) Details http://agapeatp.com/role/RelatedPartyTransaction 40 false false R41.htm 00000041 - Disclosure - Amount Due to a Director (Details Narrative) Sheet http://agapeatp.com/role/AmountDueToDirectorDetailsNarrative Amount Due to a Director (Details Narrative) Details http://agapeatp.com/role/AmountDueToDirector 41 false false R42.htm 00000042 - Disclosure - Income Taxes (Details Narrative) Sheet http://agapeatp.com/role/IncomeTaxesDetailsNarrative Income Taxes (Details Narrative) Details http://agapeatp.com/role/IncomeTaxesTables 42 false false R43.htm 00000043 - Disclosure - Income Taxes - Schedule of Components of Income/(Loss) Before Income Tax (Details) Sheet http://agapeatp.com/role/IncomeTaxes-ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails Income Taxes - Schedule of Components of Income/(Loss) Before Income Tax (Details) Details 43 false false R44.htm 00000044 - Disclosure - Income Taxes - Schedule of Provision for Income Tax (Details) Sheet http://agapeatp.com/role/IncomeTaxes-ScheduleOfProvisionForIncomeTaxDetails Income Taxes - Schedule of Provision for Income Tax (Details) Details 44 false false R45.htm 00000045 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets (Details) Sheet http://agapeatp.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsDetails Income Taxes - Schedule of Deferred Tax Assets (Details) Details 45 false false R46.htm 00000046 - Disclosure - Concentrations of Risks - Schedule of Concentrations of Risk (Details) Sheet http://agapeatp.com/role/ConcentrationsOfRisks-ScheduleOfConcentrationsOfRiskDetails Concentrations of Risks - Schedule of Concentrations of Risk (Details) Details 46 false false R47.htm 00000047 - Disclosure - Concentrations of Risks - Schedule of Concentrations of Risk (Details) (Parenthetical) Sheet http://agapeatp.com/role/ConcentrationsOfRisks-ScheduleOfConcentrationsOfRiskDetailsParenthetical Concentrations of Risks - Schedule of Concentrations of Risk (Details) (Parenthetical) Details 47 false false All Reports Book All Reports aac-20180630.xml aac-20180630.xsd aac-20180630_cal.xml aac-20180630_def.xml aac-20180630_lab.xml aac-20180630_pre.xml http://xbrl.sec.gov/invest/2013-01-31 http://xbrl.sec.gov/currency/2017-01-31 http://xbrl.sec.gov/country/2017-01-31 http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/srt/2018-01-31 http://fasb.org/us-gaap/2018-01-31 true true ZIP 74 0001493152-18-013792-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-18-013792-xbrl.zip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end